{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 1: Retrive the list of PubmedID and PMC IDs about a particular Disease "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Use Entrez to Search PubMed and Fetch Details ( Using E-utilities API.)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "from Bio import Entrez\n",
    "import requests\n",
    "import json\n",
    "import requests\n",
    "import json\n",
    "import os\n",
    "import time  \n",
    "import pandas as pd\n",
    "import yaml\n",
    "\n",
    "\n",
    "# Always provide your email when using NCBI's API\n",
    "Entrez.email = \"enockniyonkuru250@gmail.com\"\n",
    "KEY = \"a0de528ff3ee8d27c192c9106d0f75396008\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "def fetch_mesh_ids(pmid, retries=3, delay=2):\n",
    "    \"\"\"\n",
    "    Fetch MeSH IDs and their descriptor names for a given PubMed ID.\n",
    "\n",
    "    Parameters:\n",
    "    - pmid: PubMed ID.\n",
    "    - retries: Number of retries in case of an HTTP error.\n",
    "    - delay: Delay in seconds before retrying.\n",
    "\n",
    "    Returns:\n",
    "    - Dictionary with MeSH IDs as keys and descriptor names as values.\n",
    "    \"\"\"\n",
    "    for attempt in range(retries):\n",
    "        try:\n",
    "            handle = Entrez.efetch(db=\"pubmed\", id=pmid, retmode=\"xml\")\n",
    "            article = Entrez.read(handle)\n",
    "            handle.close()\n",
    "\n",
    "            # Extract MeSH IDs and descriptor names from the article\n",
    "            mesh_info = {}\n",
    "            if 'PubmedArticle' in article:\n",
    "                mesh_heading_list = article['PubmedArticle'][0].get('MedlineCitation', {}).get('MeshHeadingList', [])\n",
    "                for mesh_heading in mesh_heading_list:\n",
    "                    descriptor_name = mesh_heading.get('DescriptorName')\n",
    "                    if descriptor_name:\n",
    "                        mesh_id = descriptor_name.attributes.get('UI')\n",
    "                        if mesh_id:\n",
    "                            mesh_info[mesh_id] = str(descriptor_name)\n",
    "\n",
    "            return mesh_info\n",
    "        except Exception as e:\n",
    "            print(f\"Error fetching MeSH IDs for PMID {pmid}: {e}. Attempt {attempt + 1} of {retries}. Retrying in {delay} seconds.\")\n",
    "            time.sleep(delay)\n",
    "    raise Exception(f\"Failed to fetch MeSH IDs for PMID {pmid} after {retries} attempts.\")\n",
    "\n",
    "def search_articles_with_mesh_info(disease_name: str, mesh_list_path: str, max_pmid_retrieve: int):\n",
    "    \"\"\"\n",
    "    Search articles related to a disease and treatments using combined MeSH IDs from a .tsv file, \n",
    "    and return their PubMed IDs along with the MeSH IDs and their descriptor names that contributed to their selection.\n",
    "    \n",
    "    Parameters:\n",
    "    - disease_name: Name of the disease.\n",
    "    - mesh_list_path: Path to the .tsv file containing MeSH IDs.\n",
    "    - max_pmid_retrieve: Maximum number of PubMed IDs to retrieve.\n",
    "    \n",
    "    Returns:\n",
    "    - Dictionary with PubMed IDs as keys and a dictionary of contributing MeSH IDs and descriptor names as values.\n",
    "    \"\"\"\n",
    "    # Read the .tsv file and create a set of combined MeSH IDs\n",
    "    df = pd.read_csv(mesh_list_path, sep='\\t', header=None)\n",
    "    \n",
    "    combined_mesh_ids = {mesh_id for mesh_ids in df.iloc[:, 2] for mesh_id in mesh_ids.split(';')}\n",
    "\n",
    "    # Combine disease name and treatment search terms\n",
    "    treatment_search = \"(diagnosis[MeSH Terms] OR therapeutics[MeSH Terms])\"\n",
    "    search_term = f\"({disease_name}[Title/Abstract]) AND ({treatment_search})\"\n",
    "\n",
    "    # Perform the search\n",
    "    handle = Entrez.esearch(db=\"pubmed\", term=search_term, retmax=max_pmid_retrieve)\n",
    "    record = Entrez.read(handle)\n",
    "    handle.close()\n",
    "\n",
    "    # Retrieve MeSH IDs and descriptor names for each PubMed ID and filter based on the combined mesh set\n",
    "    pmid_mesh_info = {}\n",
    "    for pmid in record[\"IdList\"]:\n",
    "        mesh_info = fetch_mesh_ids(pmid)\n",
    "        filtered_mesh_info = {mesh_id: descriptor_name for mesh_id, descriptor_name in mesh_info.items() if mesh_id in combined_mesh_ids}\n",
    "        pmid_mesh_info[pmid] = filtered_mesh_info\n",
    "\n",
    "    return pmid_mesh_info\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [],
   "source": [
    "disease_name = \"sickle cell\"\n",
    "mesh_list_path = \"/Users/niyone/Desktop/maxo/automaxo/data/mesh_sets.tsv\"  \n",
    "max_pmid_retrieve = 5\n",
    "results = search_articles_with_mesh_info(disease_name, mesh_list_path, max_pmid_retrieve)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'38429041': {'D059408': 'Pain Management'}, '38428445': {'D010360': 'Patient Transfer'}, '38422317': {'D001803': 'Blood Transfusion'}, '38418238': {'D041623': 'Tomography, Optical Coherence'}, '38409146': {'D011296': 'Prenatal Diagnosis', 'D015193': 'Chorionic Villi Sampling', 'D003955': 'Diagnostic Tests, Routine'}}\n"
     ]
    }
   ],
   "source": [
    "print(results)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [],
   "source": [
    "pmids_list = list(results.keys())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['38429041', '38428445', '38422317', '38418238', '38409146']"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pmids_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "pmid = \"36776881\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Retrieve MeSH terms for each PubMed ID\n",
    "pmid_mesh_info = {}\n",
    "handle = Entrez.efetch(db=\"pubmed\", id=pmid, retmode=\"xml\")\n",
    "article = Entrez.read(handle)\n",
    "handle.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Bio.Entrez.Parser.DictionaryElement"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "type(article)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'PubmedBookArticle': [], 'PubmedArticle': [{'MedlineCitation': DictElement({'GeneralNote': [], 'SpaceFlightMission': [], 'OtherAbstract': [], 'InvestigatorList': [], 'OtherID': [], 'KeywordList': [ListElement([StringElement('COVID-19', attributes={'MajorTopicYN': 'N'}), StringElement('Janus kinase inhibitors', attributes={'MajorTopicYN': 'N'}), StringElement('antiviral agents', attributes={'MajorTopicYN': 'N'}), StringElement('neutralizing antibody therapy', attributes={'MajorTopicYN': 'N'}), StringElement('treatments', attributes={'MajorTopicYN': 'N'})], attributes={'Owner': 'NOTNLM'})], 'CitationSubset': ['IM'], 'PMID': StringElement('36776881', attributes={'Version': '1'}), 'DateCompleted': {'Year': '2023', 'Month': '02', 'Day': '14'}, 'DateRevised': {'Year': '2023', 'Month': '03', 'Day': '28'}, 'Article': DictElement({'Language': ['eng'], 'ArticleDate': [DictElement({'Year': '2023', 'Month': '01', 'Day': '26'}, attributes={'DateType': 'Electronic'})], 'ELocationID': [StringElement('1125246', attributes={'EIdType': 'pii', 'ValidYN': 'Y'}), StringElement('10.3389/fimmu.2023.1125246', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'Journal': {'ISSN': StringElement('1664-3224', attributes={'IssnType': 'Electronic'}), 'JournalIssue': DictElement({'Volume': '14', 'PubDate': {'Year': '2023'}}, attributes={'CitedMedium': 'Internet'}), 'Title': 'Frontiers in immunology', 'ISOAbbreviation': 'Front Immunol'}, 'ArticleTitle': 'The development of COVID-19 treatment.', 'Pagination': {'StartPage': '1125246', 'MedlinePgn': '1125246'}, 'Abstract': {'AbstractText': ['The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest worldwide public health threat of this century. Recent studies have unraveled numerous mysteries of SARS-CoV-2 pathogenesis and thus largely improved the studies of COVID-19 vaccines and therapeutic strategies. However, important questions remain regarding its therapy. In this review, the recent research advances on COVID-19 mechanism are quickly summarized. We mainly discuss current therapy strategies for COVID-19, with an emphasis on antiviral agents, neutralizing antibody therapies, Janus kinase inhibitors, and steroids. When necessary, specific mechanisms and the history of therapy are present, and representative strategies are described in detail. Finally, we discuss key outstanding questions regarding future directions of the development of COVID-19 treatment.'], 'CopyrightInformation': 'Copyright © 2023 Yuan, Jiao, Qu, Yang and Liu.'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.'}], 'Identifier': [], 'LastName': 'Yuan', 'ForeName': 'Yongliang', 'Initials': 'Y'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Division of Nephrology, Department of Medicine, School of Medicine, University of Connecticut Health Center, Farmington, CT, United States.'}], 'Identifier': [], 'LastName': 'Jiao', 'ForeName': 'Baihai', 'Initials': 'B'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Immunology, School of Medicine, University of Connecticut Health Center, Farmington, CT, United States.'}], 'Identifier': [], 'LastName': 'Qu', 'ForeName': 'Lili', 'Initials': 'L'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Immunology, School of Medicine, University of Connecticut Health Center, Farmington, CT, United States.'}], 'Identifier': [], 'LastName': 'Yang', 'ForeName': 'Duomeng', 'Initials': 'D'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.'}], 'Identifier': [], 'LastName': 'Liu', 'ForeName': 'Ruijuan', 'Initials': 'R'}, attributes={'ValidYN': 'Y'})], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Journal Article', attributes={'UI': 'D016428'}), StringElement('Review', attributes={'UI': 'D016454'}), StringElement(\"Research Support, Non-U.S. Gov't\", attributes={'UI': 'D013485'})]}, attributes={'PubModel': 'Electronic-eCollection'}), 'MedlineJournalInfo': {'Country': 'Switzerland', 'MedlineTA': 'Front Immunol', 'NlmUniqueID': '101560960', 'ISSNLinking': '1664-3224'}, 'ChemicalList': [{'RegistryNumber': '0', 'NameOfSubstance': StringElement('COVID-19 Vaccines', attributes={'UI': 'D000086663'})}, {'RegistryNumber': '0', 'NameOfSubstance': StringElement('Antiviral Agents', attributes={'UI': 'D000998'})}], 'MeshHeadingList': [{'QualifierName': [], 'DescriptorName': StringElement('Humans', attributes={'UI': 'D006801', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('COVID-19', attributes={'UI': 'D000086382', 'MajorTopicYN': 'Y'})}, {'QualifierName': [], 'DescriptorName': StringElement('SARS-CoV-2', attributes={'UI': 'D000086402', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('COVID-19 Vaccines', attributes={'UI': 'D000086663', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('COVID-19 Drug Treatment', attributes={'UI': 'D000093485', 'MajorTopicYN': 'N'})}, {'QualifierName': [StringElement('pharmacology', attributes={'UI': 'Q000494', 'MajorTopicYN': 'N'})], 'DescriptorName': StringElement('Antiviral Agents', attributes={'UI': 'D000998', 'MajorTopicYN': 'N'})}], 'CoiStatement': 'The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.'}, attributes={'Status': 'MEDLINE', 'Owner': 'NLM', 'IndexingMethod': 'Automated'}), 'PubmedData': {'ReferenceList': [{'Reference': [{'Citation': 'Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta BioMed (2020) 91(1):157–60. doi:\\xa010.23750/abm.v91i1.9397', 'ArticleIdList': [StringElement('10.23750/abm.v91i1.9397', attributes={'IdType': 'doi'}), StringElement('PMC7569573', attributes={'IdType': 'pmc'}), StringElement('32191675', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Abbasi J. Fourth COVID-19 vaccine dose increases low antibodies. JAMA (2022) 327(6):517. doi: 10.1001/jama.2022.0727', 'ArticleIdList': [StringElement('10.1001/jama.2022.0727', attributes={'IdType': 'doi'}), StringElement('35133429', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Altmann DM, Boyton RJ. COVID-19 vaccination: The road ahead. Science (2022) 375(6585):1127–32. doi: 10.1126/science.abn1755', 'ArticleIdList': [StringElement('10.1126/science.abn1755', attributes={'IdType': 'doi'}), StringElement('35271316', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Dube E, MacDonald NE. COVID-19 vaccine hesitancy. Nat Rev Nephrol (2022) 18(7):409–10. doi: 10.1038/s41581-022-00571-2', 'ArticleIdList': [StringElement('10.1038/s41581-022-00571-2', attributes={'IdType': 'doi'}), StringElement('PMC9004449', attributes={'IdType': 'pmc'}), StringElement('35414006', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Niknam Z, Golchin A, Danesh Pouya F, Nemati M, Rezaei-Tavirani M. Potential therapeutic options for COVID-19: an update on current evidence. Eur J Med Res (2022) 27(1):6. doi: 10.1186/s40001-021-00626-3', 'ArticleIdList': [StringElement('10.1186/s40001-021-00626-3', attributes={'IdType': 'doi'}), StringElement('PMC8755901', attributes={'IdType': 'pmc'}), StringElement('35027080', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Drozdzal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Przybycinski J, et al. . An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment. Drug Resist Update (2021) 59:100794. doi: 10.1016/j.drup.2021.100794', 'ArticleIdList': [StringElement('10.1016/j.drup.2021.100794', attributes={'IdType': 'doi'}), StringElement('PMC8654464', attributes={'IdType': 'pmc'}), StringElement('34991982', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature (2020) 579(7798):270–3. doi: 10.1038/s41586-020-2012-7', 'ArticleIdList': [StringElement('10.1038/s41586-020-2012-7', attributes={'IdType': 'doi'}), StringElement('PMC7095418', attributes={'IdType': 'pmc'}), StringElement('32015507', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet (2020) 395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5', 'ArticleIdList': [StringElement('10.1016/S0140-6736(20)30183-5', attributes={'IdType': 'doi'}), StringElement('PMC7159299', attributes={'IdType': 'pmc'}), StringElement('31986264', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Coronaviridae Study Group of the International Committee on Taxonomy of, V . The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol (2020) 5(4):536–44. doi: 10.1038/s41564-020-0695-z', 'ArticleIdList': [StringElement('10.1038/s41564-020-0695-z', attributes={'IdType': 'doi'}), StringElement('PMC7095448', attributes={'IdType': 'pmc'}), StringElement('32123347', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (2020) 395(10224):565–74. doi: 10.1016/S0140-6736(20)30251-8', 'ArticleIdList': [StringElement('10.1016/S0140-6736(20)30251-8', attributes={'IdType': 'doi'}), StringElement('PMC7159086', attributes={'IdType': 'pmc'}), StringElement('32007145', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell (2020) 181(2):271–280 e8. doi: 10.1016/j.cell.2020.02.052', 'ArticleIdList': [StringElement('10.1016/j.cell.2020.02.052', attributes={'IdType': 'doi'}), StringElement('PMC7102627', attributes={'IdType': 'pmc'}), StringElement('32142651', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol (2020) 41(12):1100–15. doi: 10.1016/j.it.2020.10.004', 'ArticleIdList': [StringElement('10.1016/j.it.2020.10.004', attributes={'IdType': 'doi'}), StringElement('PMC7556779', attributes={'IdType': 'pmc'}), StringElement('33132005', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mizrahi B, Shilo S, Rossman H, Kalkstein N, Marcus K, Barer Y, et al. . Longitudinal symptom dynamics of COVID-19 infection. Nat Commun (2020) 11(1):6208. doi: 10.1038/s41467-020-20053-y', 'ArticleIdList': [StringElement('10.1038/s41467-020-20053-y', attributes={'IdType': 'doi'}), StringElement('PMC7718370', attributes={'IdType': 'pmc'}), StringElement('33277494', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med (2022) 28(8):1706–14. doi: 10.1038/s41591-022-01909-w', 'ArticleIdList': [StringElement('10.1038/s41591-022-01909-w', attributes={'IdType': 'doi'}), StringElement('PMC9388369', attributes={'IdType': 'pmc'}), StringElement('35879616', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang W, Chua BY, Selva KJ, Kedzierski L, Ashhurst TM, Haycroft ER, et al. . SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity. Nat Commun (2022) 13(1):2774. doi: 10.1038/s41467-022-30088-y', 'ArticleIdList': [StringElement('10.1038/s41467-022-30088-y', attributes={'IdType': 'doi'}), StringElement('PMC9120039', attributes={'IdType': 'pmc'}), StringElement('35589689', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med (2021) 27(1):28–33. doi: 10.1038/s41591-020-01202-8', 'ArticleIdList': [StringElement('10.1038/s41591-020-01202-8', attributes={'IdType': 'doi'}), StringElement('33442016', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther (2021) 6(1):291. doi: 10.1038/s41392-021-00687-0', 'ArticleIdList': [StringElement('10.1038/s41392-021-00687-0', attributes={'IdType': 'doi'}), StringElement('PMC8333067', attributes={'IdType': 'pmc'}), StringElement('34344870', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kanneganti TD. Intracellular innate immune receptors: Life inside the cell. Immunol Rev (2020) 297(1):5–12. doi: 10.1111/imr.12912', 'ArticleIdList': [StringElement('10.1111/imr.12912', attributes={'IdType': 'doi'}), StringElement('PMC7592123', attributes={'IdType': 'pmc'}), StringElement('32856334', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Loo YM, Gale M, Jr. Immune signaling by RIG-i-like receptors. Immunity (2011) 34(5):680–92. doi: 10.1016/j.immuni.2011.05.003', 'ArticleIdList': [StringElement('10.1016/j.immuni.2011.05.003', attributes={'IdType': 'doi'}), StringElement('PMC3177755', attributes={'IdType': 'pmc'}), StringElement('21616437', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Horner SM, Liu HM, Park HS, Briley J, Gale M, Jr. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis c virus. Proc Natl Acad Sci U.S.A. (2011) 108(35):14590–5. doi: 10.1073/pnas.1110133108', 'ArticleIdList': [StringElement('10.1073/pnas.1110133108', attributes={'IdType': 'doi'}), StringElement('PMC3167523', attributes={'IdType': 'pmc'}), StringElement('21844353', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yin X, Riva L, Pu Y, Martin-Sancho L, Kanamune J, Yamamoto Y, et al. . MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells. Cell Rep (2021) 34(2):108628. doi: 10.1016/j.celrep.2020.108628', 'ArticleIdList': [StringElement('10.1016/j.celrep.2020.108628', attributes={'IdType': 'doi'}), StringElement('PMC7832566', attributes={'IdType': 'pmc'}), StringElement('33440148', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yang DM, Geng TT, Harrison AG, Wang PH. Differential roles of RIG-I like receptors in SARS-CoV-2 infection. Mil Med Res (2021) 8(1):49. doi: 10.1186/s40779-021-00340-5', 'ArticleIdList': [StringElement('10.1186/s40779-021-00340-5', attributes={'IdType': 'doi'}), StringElement('PMC8421188', attributes={'IdType': 'pmc'}), StringElement('34488908', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rebendenne A, Valadao ALC, Tauziet M, Maarifi G, Bonaventure B, McKellar J, et al. . SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. J Virol (2021) 95(8):e02415–20. doi: 10.1128/JVI.02415-20', 'ArticleIdList': [StringElement('10.1128/JVI.02415-20', attributes={'IdType': 'doi'}), StringElement('PMC8103705', attributes={'IdType': 'pmc'}), StringElement('33514628', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Thorne LG, Reuschl AK, Zuliani-Alvarez L, Whelan MVX, Turner J, Noursadeghi M. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. EMBO J (2021) 40(15):e107826. doi: 10.15252/embj.2021107826', 'ArticleIdList': [StringElement('10.15252/embj.2021107826', attributes={'IdType': 'doi'}), StringElement('PMC8209947', attributes={'IdType': 'pmc'}), StringElement('34101213', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yamada T, Sato S, Sotoyama Y, Orba Y, Sawa H, Yamauchi H, et al. . RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells. Nat Immunol (2021) 22(7):820–8. doi: 10.1038/s41590-021-00942-0', 'ArticleIdList': [StringElement('10.1038/s41590-021-00942-0', attributes={'IdType': 'doi'}), StringElement('33976430', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol (2004) 4(7):499–511. doi: 10.1038/nri1391', 'ArticleIdList': [StringElement('10.1038/nri1391', attributes={'IdType': 'doi'}), StringElement('15229469', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zheng M, Karki R, Williams EP, Yang D, Fitzpatrick E, Vogel P, et al. . TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol (2021) 22(7):829–38. doi: 10.1038/s41590-021-00937-x', 'ArticleIdList': [StringElement('10.1038/s41590-021-00937-x', attributes={'IdType': 'doi'}), StringElement('PMC8882317', attributes={'IdType': 'pmc'}), StringElement('33963333', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhao Y, Kuang M, Li J, Zhu L, Jia Z, Guo X, et al. . SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res (2021) 31(7):818–20. doi: 10.1038/s41422-021-00495-9', 'ArticleIdList': [StringElement('10.1038/s41422-021-00495-9', attributes={'IdType': 'doi'}), StringElement('PMC7975240', attributes={'IdType': 'pmc'}), StringElement('33742149', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Pan P, Shen M, Yu Z, Ge W, Chen K, Tian M, et al. . SARS-CoV-2 n protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat Commun (2021) 12(1):4664. doi: 10.1038/s41467-021-25015-6', 'ArticleIdList': [StringElement('10.1038/s41467-021-25015-6', attributes={'IdType': 'doi'}), StringElement('PMC8329225', attributes={'IdType': 'pmc'}), StringElement('34341353', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rodrigues TS, de Sa KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. . Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med (2021) 218(3):e20201707. doi:\\xa010.1084/jem.20201707', 'ArticleIdList': [StringElement('10.1084/jem.20201707', attributes={'IdType': 'doi'}), StringElement('PMC7684031', attributes={'IdType': 'pmc'}), StringElement('33231615', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ferreira AC, Soares VC, de Azevedo-Quintanilha IG, Dias S, Fintelman-Rodrigues N, Sacramento CQ, et al. . SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discovery (2021) 7(1):43. doi:\\xa010.1038/s41420-021-00428-w', 'ArticleIdList': [StringElement('10.1038/s41420-021-00428-w', attributes={'IdType': 'doi'}), StringElement('PMC7919254', attributes={'IdType': 'pmc'}), StringElement('33649297', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rui Y, Su J, Shen S, Hu Y, Huang D, Zheng W, et al. . Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins. Signal Transduct Target Ther (2021) 6(1):123. doi: 10.1038/s41392-021-00515-5', 'ArticleIdList': [StringElement('10.1038/s41392-021-00515-5', attributes={'IdType': 'doi'}), StringElement('PMC7958565', attributes={'IdType': 'pmc'}), StringElement('33723219', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li M, Ferretti M, Ying B, Descamps H, Lee E, Dittmar M, et al. . Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci Immunol (2021) 6(59):eabi9007. doi: 10.1126/sciimmunol.abi9007', 'ArticleIdList': [StringElement('10.1126/sciimmunol.abi9007', attributes={'IdType': 'doi'}), StringElement('PMC10021026', attributes={'IdType': 'pmc'}), StringElement('34010142', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Humphries F, Shmuel-Galia L, Jiang Z, Wilson R, Landis P, Ng SL, et al. . A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Sci Immunol (2021) 6(59):eabi9002. doi: 10.1126/sciimmunol.abi9002', 'ArticleIdList': [StringElement('10.1126/sciimmunol.abi9002', attributes={'IdType': 'doi'}), StringElement('PMC8158975', attributes={'IdType': 'pmc'}), StringElement('34010139', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hadjadj J, et al. . Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science (2020) 369(6504):718–24. doi: 10.1126/science.abc6027', 'ArticleIdList': [StringElement('10.1126/science.abc6027', attributes={'IdType': 'doi'}), StringElement('PMC7402632', attributes={'IdType': 'pmc'}), StringElement('32661059', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. . Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell (2021) 184(1):149–168 e17. doi:\\xa010.1016/j.cell.2020.11.025.', 'ArticleIdList': [StringElement('10.1016/j.cell.2020.11.025.', attributes={'IdType': 'doi'}), StringElement('PMC7674074', attributes={'IdType': 'pmc'}), StringElement('33278357', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang F, Mears JR, Shakib L, Beynor JI, Shanaj S, Korsunsky I, et al. . IFN-gamma and TNF-alpha drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation. Genome Med (2021) 13(1):64. doi:\\xa010.1186/s13073-021-00881-3', 'ArticleIdList': [StringElement('10.1186/s13073-021-00881-3', attributes={'IdType': 'doi'}), StringElement('PMC8057009', attributes={'IdType': 'pmc'}), StringElement('33879239', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Belhadjer Z, Meot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. . Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation (2020) 142(5):429–36. doi: 10.1161/CIRCULATIONAHA.120.048360', 'ArticleIdList': [StringElement('10.1161/CIRCULATIONAHA.120.048360', attributes={'IdType': 'doi'}), StringElement('32418446', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol (2022) 23(2):194–202. doi: 10.1038/s41590-021-01104-y', 'ArticleIdList': [StringElement('10.1038/s41590-021-01104-y', attributes={'IdType': 'doi'}), StringElement('PMC9127978', attributes={'IdType': 'pmc'}), StringElement('35105985', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, et al. . Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol (2020) 146(1):128–136 e4. doi: 10.1016/j.jaci.2020.05.008', 'ArticleIdList': [StringElement('10.1016/j.jaci.2020.05.008', attributes={'IdType': 'doi'}), StringElement('PMC7233239', attributes={'IdType': 'pmc'}), StringElement('32425269', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. . Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis (2020) 71(8):1937–42. doi: 10.1093/cid/ciaa449', 'ArticleIdList': [StringElement('10.1093/cid/ciaa449', attributes={'IdType': 'doi'}), StringElement('PMC7184354', attributes={'IdType': 'pmc'}), StringElement('32301997', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Roltgen K, Boyd SD. Antibody and b cell responses to SARS-CoV-2 infection and vaccination. Cell Host Microbe (2021) 29(7):1063–75. doi: 10.1016/j.chom.2021.06.009', 'ArticleIdList': [StringElement('10.1016/j.chom.2021.06.009', attributes={'IdType': 'doi'}), StringElement('PMC8233571', attributes={'IdType': 'pmc'}), StringElement('34174992', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol (2022) 23(2):186–93. doi: 10.1038/s41590-021-01122-w', 'ArticleIdList': [StringElement('10.1038/s41590-021-01122-w', attributes={'IdType': 'doi'}), StringElement('35105982', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res (2020) 30(3):269–71. doi: 10.1038/s41422-020-0282-0', 'ArticleIdList': [StringElement('10.1038/s41422-020-0282-0', attributes={'IdType': 'doi'}), StringElement('PMC7054408', attributes={'IdType': 'pmc'}), StringElement('32020029', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Williamson BN, Feldmann F, Schwarz B, Meade-White K, Porter DP, Schulz J, et al. . Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature (2020) 585(7824):273–6. doi: 10.1038/s41586-020-2423-5', 'ArticleIdList': [StringElement('10.1038/s41586-020-2423-5', attributes={'IdType': 'doi'}), StringElement('PMC7486271', attributes={'IdType': 'pmc'}), StringElement('32516797', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, et al. . Early remdesivir to prevent progression to severe covid-19 in outpatients. N Engl J Med (2022) 386(4):305–15. doi: 10.1056/NEJMoa2116846', 'ArticleIdList': [StringElement('10.1056/NEJMoa2116846', attributes={'IdType': 'doi'}), StringElement('PMC8757570', attributes={'IdType': 'pmc'}), StringElement('34937145', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. . Remdesivir for the treatment of covid-19 - final report. N Engl J Med (2020) 383(19):1813–26. doi: 10.1056/NEJMoa2007764', 'ArticleIdList': [StringElement('10.1056/NEJMoa2007764', attributes={'IdType': 'doi'}), StringElement('PMC7262788', attributes={'IdType': 'pmc'}), StringElement('32445440', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Spinner CD, Gottlieb RL, Criner GJ, Arribas Lopez JR, Cattelan AM, Soriano Viladomiu A, et al. . Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: A randomized clinical trial. JAMA (2020) 324(11):1048–57. doi: 10.1001/jama.2020.16349', 'ArticleIdList': [StringElement('10.1001/jama.2020.16349', attributes={'IdType': 'doi'}), StringElement('PMC7442954', attributes={'IdType': 'pmc'}), StringElement('32821939', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, et al. . Remdesivir for 5 or 10 days in patients with severe covid-19. N Engl J Med (2020) 383(19):1827–37. doi: 10.1056/NEJMoa2015301', 'ArticleIdList': [StringElement('10.1056/NEJMoa2015301', attributes={'IdType': 'doi'}), StringElement('PMC7377062', attributes={'IdType': 'pmc'}), StringElement('32459919', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Singh KP, Tong SYC. In adults hospitalized with COVID-19, adding remdesivir to standard care did not reduce in-hospital mortality. Ann Intern Med (2022) 175(5):JC51. doi: 10.7326/J22-0025', 'ArticleIdList': [StringElement('10.7326/J22-0025', attributes={'IdType': 'doi'}), StringElement('35500262', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, et al. . Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Lancet Infect Dis (2022) 22(2):209–21. doi: 10.1016/S1473-3099(21)00485-0', 'ArticleIdList': [StringElement('10.1016/S1473-3099(21)00485-0', attributes={'IdType': 'doi'}), StringElement('PMC8439621', attributes={'IdType': 'pmc'}), StringElement('34534511', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. . Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet (2020) 395(10236):1569–78. doi: 10.1016/S0140-6736(20)31022-9', 'ArticleIdList': [StringElement('10.1016/S0140-6736(20)31022-9', attributes={'IdType': 'doi'}), StringElement('PMC7190303', attributes={'IdType': 'pmc'}), StringElement('32423584', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, et al. . Baricitinib plus remdesivir for hospitalized adults with covid-19. N Engl J Med (2021) 384(9):795–807. doi: 10.1056/NEJMoa2031994', 'ArticleIdList': [StringElement('10.1056/NEJMoa2031994', attributes={'IdType': 'doi'}), StringElement('PMC7745180', attributes={'IdType': 'pmc'}), StringElement('33306283', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Delang L, Abdelnabi R, Neyts J. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses. Antiviral Res (2018) 153:85–94. doi: 10.1016/j.antiviral.2018.03.003', 'ArticleIdList': [StringElement('10.1016/j.antiviral.2018.03.003', attributes={'IdType': 'doi'}), StringElement('29524445', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res (2013) 100(2):446–54. doi: 10.1016/j.antiviral.2013.09.015', 'ArticleIdList': [StringElement('10.1016/j.antiviral.2013.09.015', attributes={'IdType': 'doi'}), StringElement('PMC3880838', attributes={'IdType': 'pmc'}), StringElement('24084488', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Udwadia ZF, Singh P, Barkate H, Patil S, Rangwala S, Pendse A, et al. . Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial. Int J Infect Dis (2021) 103:62–71. doi: 10.1016/j.ijid.2020.11.142', 'ArticleIdList': [StringElement('10.1016/j.ijid.2020.11.142', attributes={'IdType': 'doi'}), StringElement('PMC7668212', attributes={'IdType': 'pmc'}), StringElement('33212256', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yao TT, Qian JD, Zhu WY, Wang Y, Wang GQ. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-a possible reference for coronavirus disease-19 treatment option. J Med Virol (2020) 92(6):556–63. doi: 10.1002/jmv.25729', 'ArticleIdList': [StringElement('10.1002/jmv.25729', attributes={'IdType': 'doi'}), StringElement('PMC7217143', attributes={'IdType': 'pmc'}), StringElement('32104907', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. . A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. N Engl J Med (2020) 382(19):1787–99. doi: 10.1056/NEJMoa2001282', 'ArticleIdList': [StringElement('10.1056/NEJMoa2001282', attributes={'IdType': 'doi'}), StringElement('PMC7121492', attributes={'IdType': 'pmc'}), StringElement('32187464', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Group RC. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet (2020) 396(10259):1345–52. doi:\\xa010.1016/S0140-6736(20)32013-4', 'ArticleIdList': [StringElement('10.1016/S0140-6736(20)32013-4', attributes={'IdType': 'doi'}), StringElement('PMC7535623', attributes={'IdType': 'pmc'}), StringElement('33031764', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wang Z, Chen X, Lu Y, Chen F, Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends (2020) 14(1):64–8. doi: 10.5582/bst.2020.01030', 'ArticleIdList': [StringElement('10.5582/bst.2020.01030', attributes={'IdType': 'doi'}), StringElement('32037389', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hung IF, Lung KC, Tso EY, Liu R, Chung TW, Chu MY, et al. . Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet (2020) 395(10238):1695–704. doi: 10.1016/S0140-6736(20)31042-4', 'ArticleIdList': [StringElement('10.1016/S0140-6736(20)31042-4', attributes={'IdType': 'doi'}), StringElement('PMC7211500', attributes={'IdType': 'pmc'}), StringElement('32401715', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, et al. . An oral SARS-CoV-2 m(pro) inhibitor clinical candidate for the treatment of COVID-19. Science (2021) 374(6575):1586–93. doi: 10.1126/science.abl4784', 'ArticleIdList': [StringElement('10.1126/science.abl4784', attributes={'IdType': 'doi'}), StringElement('34726479', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. . Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19. N Engl J Med (2022) 386(15):1397–408. doi: 10.1056/NEJMoa2118542', 'ArticleIdList': [StringElement('10.1056/NEJMoa2118542', attributes={'IdType': 'doi'}), StringElement('PMC8908851', attributes={'IdType': 'pmc'}), StringElement('35172054', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang JL, Li YH, Wang LL, Liu HQ, Lu SY, Liu Y, et al. . Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients. Signal Transduct Target Ther (2021) 6(1):414. doi: 10.1038/s41392-021-00835-6', 'ArticleIdList': [StringElement('10.1038/s41392-021-00835-6', attributes={'IdType': 'doi'}), StringElement('PMC8646019', attributes={'IdType': 'pmc'}), StringElement('34873151', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ren Z, Luo H, Yu Z, Song J, Liang L, Wang L, et al. . A randomized, open-label, controlled clinical trial of azvudine tablets in the treatment of mild and common COVID-19, a pilot study. Adv Sci (Weinh) (2020) 7(19):e2001435. doi: 10.1002/advs.202001435', 'ArticleIdList': [StringElement('10.1002/advs.202001435', attributes={'IdType': 'doi'}), StringElement('PMC7404576', attributes={'IdType': 'pmc'}), StringElement('35403380', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yu B, Chang J. Azvudine (FNC): a promising clinical candidate for COVID-19 treatment. Signal Transduct Target Ther (2020) 5(1):236. doi:\\xa010.1038/s41392-020-00351-z', 'ArticleIdList': [StringElement('10.1038/s41392-020-00351-z', attributes={'IdType': 'doi'}), StringElement('PMC7547293', attributes={'IdType': 'pmc'}), StringElement('33040075', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wahl A, Gralinski LE, Johnson CE, Yao W, Kovarova M, Dinnon KH, 3rd, et al. . SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature (2021) 591(7850):451–7. doi:\\xa010.1038/s41586-021-03312-w', 'ArticleIdList': [StringElement('10.1038/s41586-021-03312-w', attributes={'IdType': 'doi'}), StringElement('PMC7979515', attributes={'IdType': 'pmc'}), StringElement('33561864', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mahase E. Covid-19: Molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, MSD reports. BMJ (2021) 375:n2422. doi:\\xa010.1136/bmj.n2422', 'ArticleIdList': [StringElement('10.1136/bmj.n2422', attributes={'IdType': 'doi'}), StringElement('34607801', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, et al. . Molnupiravir for oral treatment of covid-19 in nonhospitalized patients. N Engl J Med (2022) 386(6):509–20. doi:\\xa010.1056/NEJMoa2116044', 'ArticleIdList': [StringElement('10.1056/NEJMoa2116044', attributes={'IdType': 'doi'}), StringElement('PMC8693688', attributes={'IdType': 'pmc'}), StringElement('34914868', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mahase E. Covid-19: UK becomes first country to authorise antiviral molnupiravir. BMJ (2021) 375:n2697. doi:\\xa010.1136/bmj.n2697', 'ArticleIdList': [StringElement('10.1136/bmj.n2697', attributes={'IdType': 'doi'}), StringElement('34737216', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Whitley R. Molnupiravir - a step toward orally bioavailable therapies for covid-19. N Engl J Med (2022) 386(6):592–3. doi: 10.1056/NEJMe2117814', 'ArticleIdList': [StringElement('10.1056/NEJMe2117814', attributes={'IdType': 'doi'}), StringElement('PMC8693684', attributes={'IdType': 'pmc'}), StringElement('34914869', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Araujo R, Aranda-Martinez JD, Aranda-Abreu GE. Amantadine treatment for people with COVID-19. Arch Med Res (2020) 51(7):739–40. doi: 10.1016/j.arcmed.2020.06.009', 'ArticleIdList': [StringElement('10.1016/j.arcmed.2020.06.009', attributes={'IdType': 'doi'}), StringElement('PMC7290190', attributes={'IdType': 'pmc'}), StringElement('32571606', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Smieszek SP, Przychodzen BP, Polymeropoulos MH. Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment. Int J Antimicrob Agents (2020) 55(6):106004. doi: 10.1016/j.ijantimicag.2020.106004', 'ArticleIdList': [StringElement('10.1016/j.ijantimicag.2020.106004', attributes={'IdType': 'doi'}), StringElement('PMC7191300', attributes={'IdType': 'pmc'}), StringElement('32361028', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rejdak K, Grieb P. Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment. Mult Scler Relat Disord (2020) 42:102163. doi: 10.1016/j.msard.2020.102163', 'ArticleIdList': [StringElement('10.1016/j.msard.2020.102163', attributes={'IdType': 'doi'}), StringElement('PMC7190496', attributes={'IdType': 'pmc'}), StringElement('32388458', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ahmadi K, Farasat A, Rostamian M, Johari B, Madanchi H. Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study. J Biomol Struct Dyn (2022) 40(12):5566–76. doi: 10.1080/07391102.2021.1871958', 'ArticleIdList': [StringElement('10.1080/07391102.2021.1871958', attributes={'IdType': 'doi'}), StringElement('PMC7814568', attributes={'IdType': 'pmc'}), StringElement('33438525', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Oliver ME, Hinks TSC. Azithromycin in viral infections. Rev Med Virol (2021) 31(2):e2163. doi: 10.1002/rmv.2163', 'ArticleIdList': [StringElement('10.1002/rmv.2163', attributes={'IdType': 'doi'}), StringElement('PMC7536932', attributes={'IdType': 'pmc'}), StringElement('32969125', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Dontcheff L. [Discontinuous evolution of oxygen consumption in relation to weight, during fasting in rats]. C R Seances Soc Biol Fil (1970) 164(6):1370–1.', 'ArticleIdList': [StringElement('4252378', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Group PTC. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet (2021) 397(10279):1063–74. doi:\\xa010.1016/S0140-6736(21)00461-X', 'ArticleIdList': [StringElement('10.1016/S0140-6736(21)00461-X', attributes={'IdType': 'doi'}), StringElement('PMC7972318', attributes={'IdType': 'pmc'}), StringElement('33676597', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ferner RE, Aronson JK. Chloroquine and hydroxychloroquine in covid-19. BMJ (2020) 369:m1432. doi: 10.1136/bmj.m1432', 'ArticleIdList': [StringElement('10.1136/bmj.m1432', attributes={'IdType': 'doi'}), StringElement('32269046', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Group RC, Horby P, Mafham M, Linsell L, Bell JL, Staplin N, et al. . Effect of hydroxychloroquine in hospitalized patients with covid-19. N Engl J Med (2020) 383(21):2030–40. doi:\\xa010.1056/NEJMoa2022926', 'ArticleIdList': [StringElement('10.1056/NEJMoa2022926', attributes={'IdType': 'doi'}), StringElement('PMC7556338', attributes={'IdType': 'pmc'}), StringElement('33031652', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Correction: Hydroxychloroquine in nonhospitalized adults with early COVID-19. Ann Intern Med (2021) 174(3):435. doi:\\xa010.7326/L20-1220', 'ArticleIdList': [StringElement('10.7326/L20-1220', attributes={'IdType': 'doi'}), StringElement('33721537', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, et al. . A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19. N Engl J Med (2020) 383(6):517–25. doi: 10.1056/NEJMoa2016638', 'ArticleIdList': [StringElement('10.1056/NEJMoa2016638', attributes={'IdType': 'doi'}), StringElement('PMC7289276', attributes={'IdType': 'pmc'}), StringElement('32492293', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mitja O, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, et al. . A cluster-randomized trial of hydroxychloroquine for prevention of covid-19. N Engl J Med (2021) 384(5):417–27. doi: 10.1056/NEJMoa2021801', 'ArticleIdList': [StringElement('10.1056/NEJMoa2021801', attributes={'IdType': 'doi'}), StringElement('PMC7722693', attributes={'IdType': 'pmc'}), StringElement('33289973', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Furtado RHM, Berwanger O, Fonseca HA, Correa TD, Ferraz LR, Lapa MG, et al. . Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet (2020) 396(10256):959–67. doi: 10.1016/S0140-6736(20)31862-6', 'ArticleIdList': [StringElement('10.1016/S0140-6736(20)31862-6', attributes={'IdType': 'doi'}), StringElement('PMC7836431', attributes={'IdType': 'pmc'}), StringElement('32896292', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A, et al. . Hydroxychloroquine with or without azithromycin in mild-to-Moderate covid-19. N Engl J Med (2020) 383(21):2041–52. doi: 10.1056/NEJMoa2019014', 'ArticleIdList': [StringElement('10.1056/NEJMoa2019014', attributes={'IdType': 'doi'}), StringElement('PMC7397242', attributes={'IdType': 'pmc'}), StringElement('32706953', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Sposito B, Broggi A, Pandolfi L, Crotta S, Clementi N, Ferrarese R, et al. . The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell (2021) 184(19):4953–4968 e16. doi: 10.1016/j.cell.2021.08.016', 'ArticleIdList': [StringElement('10.1016/j.cell.2021.08.016', attributes={'IdType': 'doi'}), StringElement('PMC8373821', attributes={'IdType': 'pmc'}), StringElement('34492226', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ramasamy S, Subbian S. Erratum for ramasamy and subbian, “Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis”. Clin Microbiol Rev (2021) 34(4):e0016321. doi:\\xa010.1128/CMR.00163-21', 'ArticleIdList': [StringElement('10.1128/CMR.00163-21', attributes={'IdType': 'doi'}), StringElement('PMC8404690', attributes={'IdType': 'pmc'}), StringElement('34259566', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kalil AC, Mehta AK, Patterson TF, Erdmann N, Gomez CA, Jain MK, et al. . Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. Lancet Respir Med (2021) 9(12):1365–76. doi: 10.1016/S2213-2600(21)00384-2', 'ArticleIdList': [StringElement('10.1016/S2213-2600(21)00384-2', attributes={'IdType': 'doi'}), StringElement('PMC8523116', attributes={'IdType': 'pmc'}), StringElement('34672949', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Nakhlband A, Fakhari A, Azizi H. Interferon-alpha position in combating with COVID-19: A systematic review. J Med Virol (2021) 93(9):5277–84. doi: 10.1002/jmv.27072', 'ArticleIdList': [StringElement('10.1002/jmv.27072', attributes={'IdType': 'doi'}), StringElement('PMC8242473', attributes={'IdType': 'pmc'}), StringElement('34101851', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Porter RR. The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J (1959) 73(1):119–26. doi: 10.1042/bj0730119', 'ArticleIdList': [StringElement('10.1042/bj0730119', attributes={'IdType': 'doi'}), StringElement('PMC1197021', attributes={'IdType': 'pmc'}), StringElement('14434282', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Edelman GM, Benacerraf B, Ovary Z, Poulik MD. Structural differences among antibodies of different specificities. Proc Natl Acad Sci U.S.A. (1961) 47(11):1751–8. doi: 10.1073/pnas.47.11.1751', 'ArticleIdList': [StringElement('10.1073/pnas.47.11.1751', attributes={'IdType': 'doi'}), StringElement('PMC223206', attributes={'IdType': 'pmc'}), StringElement('13889151', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Todd PA, Brogden RN. Muromonab CD3. a review of its pharmacology and therapeutic potential. Drugs (1989) 37(6):871–99. doi: 10.2165/00003495-198937060-00004', 'ArticleIdList': [StringElement('10.2165/00003495-198937060-00004', attributes={'IdType': 'doi'}), StringElement('2503348', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rajewsky K. The advent and rise of monoclonal antibodies. Nature (2019) 575(7781):47–9. doi: 10.1038/d41586-019-02840-w', 'ArticleIdList': [StringElement('10.1038/d41586-019-02840-w', attributes={'IdType': 'doi'}), StringElement('31686050', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, et al. . Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: A randomized clinical trial. JAMA (2020) 324(5):460–70. doi: 10.1001/jama.2020.10044', 'ArticleIdList': [StringElement('10.1001/jama.2020.10044', attributes={'IdType': 'doi'}), StringElement('PMC7270883', attributes={'IdType': 'pmc'}), StringElement('32492084', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Marconato M, Abela IA, Hauser A, Schwarzmüller M, Katzensteiner R, Braun DL, et al. . Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response. J Clin Invest (2022) 132(12):e158190. doi: 10.1172/JCI158190', 'ArticleIdList': [StringElement('10.1172/JCI158190', attributes={'IdType': 'doi'}), StringElement('PMC9197521', attributes={'IdType': 'pmc'}), StringElement('35482408', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Alemany A, Millat-Martinez P, Corbacho-Monne M, Malchair P, Ouchi D, Ruiz-Comellas A, et al. . High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial. Lancet Respir Med (2022) 10(3):278–88. doi: 10.1016/S2213-2600(21)00545-2', 'ArticleIdList': [StringElement('10.1016/S2213-2600(21)00545-2', attributes={'IdType': 'doi'}), StringElement('PMC8828369', attributes={'IdType': 'pmc'}), StringElement('35150610', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, et al. . Early outpatient treatment for covid-19 with convalescent plasma. N Engl J Med (2022) 386(18):1700–11. doi: 10.1056/NEJMoa2119657', 'ArticleIdList': [StringElement('10.1056/NEJMoa2119657', attributes={'IdType': 'doi'}), StringElement('PMC9006786', attributes={'IdType': 'pmc'}), StringElement('35353960', attributes={'IdType': 'pubmed'})]}, {'Citation': 'RECOVERY Collaborative Group . Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet (2021) 397(10289):2049–59. doi:\\xa010.1016/S0140-6736(21)00897-7', 'ArticleIdList': [StringElement('10.1016/S0140-6736(21)00897-7', attributes={'IdType': 'doi'}), StringElement('PMC8121538', attributes={'IdType': 'pmc'}), StringElement('34000257', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Estcourt L, Callum J. Convalescent plasma for covid-19 - making sense of the inconsistencies. N Engl J Med (2022) 386(18):1753–4. doi: 10.1056/NEJMe2204332', 'ArticleIdList': [StringElement('10.1056/NEJMe2204332', attributes={'IdType': 'doi'}), StringElement('PMC9093717', attributes={'IdType': 'pmc'}), StringElement('35507487', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Jones BE, Brown-Augsburger PL, Corbett KS, Westendorf K, Davies J, Cujec TP, et al. . The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci Transl Med (2021) 13(593):eabf1906. doi:\\xa010.1126/scitranslmed.abf1906', 'ArticleIdList': [StringElement('10.1126/scitranslmed.abf1906', attributes={'IdType': 'doi'}), StringElement('PMC8284311', attributes={'IdType': 'pmc'}), StringElement('33820835', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Matz AJ, Qu L, Karlinsey K, Zhou B. MicroRNA-regulated b cells in obesity. Immunometabolism (Cobham) (2022) 4(3):e00005. doi: 10.1097/IN9.0000000000000005', 'ArticleIdList': [StringElement('10.1097/IN9.0000000000000005', attributes={'IdType': 'doi'}), StringElement('PMC9359068', attributes={'IdType': 'pmc'}), StringElement('35966635', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, et al. . SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with covid-19. N Engl J Med (2021) 384(3):229–37. doi: 10.1056/NEJMoa2029849', 'ArticleIdList': [StringElement('10.1056/NEJMoa2029849', attributes={'IdType': 'doi'}), StringElement('PMC7646625', attributes={'IdType': 'pmc'}), StringElement('33113295', attributes={'IdType': 'pubmed'})]}, {'Citation': 'ACTIV-3/TICO LY-CoV555 Study Group. Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, et al. . A neutralizing monoclonal antibody for hospitalized patients with covid-19. N Engl J Med (2021) 384(10):905–14. doi:\\xa010.1056/NEJMoa2033130', 'ArticleIdList': [StringElement('10.1056/NEJMoa2033130', attributes={'IdType': 'doi'}), StringElement('PMC7781100', attributes={'IdType': 'pmc'}), StringElement('33356051', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Matz A, Qu L, Karlinsey K, Zhou B. Impact of microRNA regulated macrophage actions on adipose tissue function in obesity. Cells (2022) 11(8):1336. doi: 10.3390/cells11081336', 'ArticleIdList': [StringElement('10.3390/cells11081336', attributes={'IdType': 'doi'}), StringElement('PMC9024513', attributes={'IdType': 'pmc'}), StringElement('35456015', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Qu L, Matz AJ, Karlinsey K, Cao Z, Vella AT, Zhou B, et al. . Macrophages at the crossroad of meta-inflammation and inflammaging. Genes (Basel) (2022) 13(11):2074. doi: 10.3390/genes13112074', 'ArticleIdList': [StringElement('10.3390/genes13112074', attributes={'IdType': 'doi'}), StringElement('PMC9690997', attributes={'IdType': 'pmc'}), StringElement('36360310', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Gottlieb RL, Nirula A, Chen P, Boscia J, Heller B, Morris J, et al. . Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: A randomized clinical trial. JAMA (2021) 325(7):632–44. doi: 10.1001/jama.2021.0202', 'ArticleIdList': [StringElement('10.1001/jama.2021.0202', attributes={'IdType': 'doi'}), StringElement('PMC7821080', attributes={'IdType': 'pmc'}), StringElement('33475701', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Karlinsey K, Qu L, Matz AJ, Zhou B. A novel strategy to dissect multifaceted macrophage function in human diseases. J Leukoc Biol (2022) 112(6):1535–42. doi: 10.1002/JLB.6MR0522-685R', 'ArticleIdList': [StringElement('10.1002/JLB.6MR0522-685R', attributes={'IdType': 'doi'}), StringElement('35726704', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, et al. . Bamlanivimab plus etesevimab in mild or moderate covid-19. N Engl J Med (2021) 385(15):1382–92. doi: 10.1056/NEJMoa2102685', 'ArticleIdList': [StringElement('10.1056/NEJMoa2102685', attributes={'IdType': 'doi'}), StringElement('PMC8314785', attributes={'IdType': 'pmc'}), StringElement('34260849', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li C, Phoon YP, Karlinsey K, Tian YF, Thapaliya S, Thongkum A, et al. . A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients. J Exp Med (2022) 219(1):e20202084. doi: 10.1084/jem.20202084', 'ArticleIdList': [StringElement('10.1084/jem.20202084', attributes={'IdType': 'doi'}), StringElement('PMC8611729', attributes={'IdType': 'pmc'}), StringElement('34807232', attributes={'IdType': 'pubmed'})]}, {'Citation': 'VanBlargan LA, Errico JM, Halfmann PJ, Zost SJ, Crowe JE, Jr, Purcell LA, et al. . An infectious SARS-CoV-2 B.1.1.529 omicron virus escapes neutralization by therapeutic monoclonal antibodies. Nat Med (2022) 28(3):490–5. doi:\\xa010.1038/s41591-021-01678-y', 'ArticleIdList': [StringElement('10.1038/s41591-021-01678-y', attributes={'IdType': 'doi'}), StringElement('PMC8767531', attributes={'IdType': 'pmc'}), StringElement('35046573', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, et al. . Antibody evasion properties of SARS-CoV-2 omicron sublineages. Nature (2022) 604(7906):553–6. doi: 10.1038/s41586-022-04594-4', 'ArticleIdList': [StringElement('10.1038/s41586-022-04594-4', attributes={'IdType': 'doi'}), StringElement('PMC9021018', attributes={'IdType': 'pmc'}), StringElement('35240676', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li C, Qu L, Matz AJ, Murphy PA, Liu Y, Manichaikul AW, et al. . AtheroSpectrum reveals novel macrophage foam cell gene signatures associated with atherosclerotic cardiovascular disease risk. Circulation (2022) 145(3):206–18. doi: 10.1161/CIRCULATIONAHA.121.054285', 'ArticleIdList': [StringElement('10.1161/CIRCULATIONAHA.121.054285', attributes={'IdType': 'doi'}), StringElement('PMC8766929', attributes={'IdType': 'pmc'}), StringElement('34913723', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Westendorf K, Zentelis S, Wang L, Foster D, Vaillancourt P, Wiggin M, et al. . LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. Cell Rep (2022) 39(7):110812. doi: 10.1016/j.celrep.2022.110812', 'ArticleIdList': [StringElement('10.1016/j.celrep.2022.110812', attributes={'IdType': 'doi'}), StringElement('PMC9035363', attributes={'IdType': 'pmc'}), StringElement('35568025', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li C, Qu L, Farragher C, Vella A, Zhou B. MicroRNA regulated macrophage activation in obesity. J Transl Int Med (2019) 7(2):46–52. doi: 10.2478/jtim-2019-0011', 'ArticleIdList': [StringElement('10.2478/jtim-2019-0011', attributes={'IdType': 'doi'}), StringElement('PMC6661877', attributes={'IdType': 'pmc'}), StringElement('31380236', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wang Q, Guo Y, Iketani S, Nair MS, Li Z, Mohri H, et al. . Antibody evasion by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature (2022) 608(7923):603–8. doi:\\xa010.1038/s41586-022-05053-w', 'ArticleIdList': [StringElement('10.1038/s41586-022-05053-w', attributes={'IdType': 'doi'}), StringElement('PMC9385487', attributes={'IdType': 'pmc'}), StringElement('35790190', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Qu LL, Yu B, Li Z, Jiang WX, Jiang JD, Kong WJ. Gastrodin ameliorates oxidative stress and proinflammatory response in nonalcoholic fatty liver disease through the AMPK/Nrf2 pathway. Phytother Res (2016) 30(3):402–11. doi: 10.1002/ptr.5541', 'ArticleIdList': [StringElement('10.1002/ptr.5541', attributes={'IdType': 'doi'}), StringElement('26634892', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hoang TN, Pino M, Boddapati AK, Viox EG, Starke CE, Upadhyay AA, et al. . Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques. Cell (2021) 184(2):460–475 e21. doi: 10.1016/j.cell.2020.11.007', 'ArticleIdList': [StringElement('10.1016/j.cell.2020.11.007', attributes={'IdType': 'doi'}), StringElement('PMC7654323', attributes={'IdType': 'pmc'}), StringElement('33278358', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Duan X, Li S, Holmes JA, Tu Z, Li Y, Cai D, et al. . MicroRNA 130a regulates both hepatitis c virus and hepatitis b virus replication through a central metabolic pathway. J Virol (2018) 92(7):e02009-17. doi: 10.1128/JVI.02009-17', 'ArticleIdList': [StringElement('10.1128/JVI.02009-17', attributes={'IdType': 'doi'}), StringElement('PMC5972888', attributes={'IdType': 'pmc'}), StringElement('29321333', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Chen X, Ye H, Li S, Jiao B, Wu J, Zeng P, et al. . Severe fever with thrombocytopenia syndrome virus inhibits exogenous type I IFN signaling pathway through its NSs invitro. PloS One (2017) 12(2):e0172744. doi: 10.1371/journal.pone.0172744', 'ArticleIdList': [StringElement('10.1371/journal.pone.0172744', attributes={'IdType': 'doi'}), StringElement('PMC5325526', attributes={'IdType': 'pmc'}), StringElement('28234991', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hu X, Li J, Fu M, Zhao X, Wang W. The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther (2021) 6(1):402. doi: 10.1038/s41392-021-00791-1', 'ArticleIdList': [StringElement('10.1038/s41392-021-00791-1', attributes={'IdType': 'doi'}), StringElement('PMC8617206', attributes={'IdType': 'pmc'}), StringElement('34824210', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Jiao B, Shi X, Chen Y, Ye H, Yao M, Hong W, et al. . Insulin receptor substrate-4 interacts with ubiquitin-specific protease 18 to activate the Jak/STAT signaling pathway. Oncotarget (2017) 8(62):105923–35. doi: 10.18632/oncotarget.22510', 'ArticleIdList': [StringElement('10.18632/oncotarget.22510', attributes={'IdType': 'doi'}), StringElement('PMC5739690', attributes={'IdType': 'pmc'}), StringElement('29285303', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Shi X, Jiao B, Chen Y, Li S, Chen L. MxA is a positive regulator of type I IFN signaling in HCV infection. J Med Virol (2017) 89(12):2173–80. doi: 10.1002/jmv.24867', 'ArticleIdList': [StringElement('10.1002/jmv.24867', attributes={'IdType': 'doi'}), StringElement('28561372', attributes={'IdType': 'pubmed'})]}, {'Citation': \"Villarino AV, Gadina M, O'Shea JJ, Kanno Y. SnapShot: Jak-STAT signaling II. Cell (2020) 181(7):1696–1696 e1. doi: 10.1016/j.cell.2020.04.052\", 'ArticleIdList': [StringElement('10.1016/j.cell.2020.04.052', attributes={'IdType': 'doi'}), StringElement('32589961', attributes={'IdType': 'pubmed'})]}, {'Citation': 'O’Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med (2015) 66:311–28. doi: 10.1146/annurev-med-051113-024537', 'ArticleIdList': [StringElement('10.1146/annurev-med-051113-024537', attributes={'IdType': 'doi'}), StringElement('PMC5634336', attributes={'IdType': 'pmc'}), StringElement('25587654', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li Y, Li S, Duan X, Chen Y, Jiao B, Ye H, et al. . Interferon-stimulated gene 15 conjugation stimulates hepatitis b virus production independent of type I interferon signaling pathway in vitro. Mediators Inflammation (2016) 2016:7417648. doi: 10.1155/2016/7417648', 'ArticleIdList': [StringElement('10.1155/2016/7417648', attributes={'IdType': 'doi'}), StringElement('PMC5102744', attributes={'IdType': 'pmc'}), StringElement('27867263', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Chen Y, Jiao B, Yao M, Shi X, Zheng Z, Li S, et al. . ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-alpha through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis. Virus Res (2017) 227:231–9. doi: 10.1016/j.virusres.2016.10.013', 'ArticleIdList': [StringElement('10.1016/j.virusres.2016.10.013', attributes={'IdType': 'doi'}), StringElement('27777077', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Jiao B, An C, Du H, Tran M, Wang P, Zhou D, et al. . STAT6 deficiency attenuates myeloid fibroblast activation and macrophage polarization in experimental folic acid nephropathy. Cells (2021) 10(11):3057. doi: 10.3390/cells10113057', 'ArticleIdList': [StringElement('10.3390/cells10113057', attributes={'IdType': 'doi'}), StringElement('PMC8623460', attributes={'IdType': 'pmc'}), StringElement('34831280', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM. JAK-STAT signaling as a target for inflammatory and autoimmune diseases: Current and future prospects. Drugs (2017) 77(5):521–46. doi: 10.1007/s40265-017-0701-9', 'ArticleIdList': [StringElement('10.1007/s40265-017-0701-9', attributes={'IdType': 'doi'}), StringElement('PMC7102286', attributes={'IdType': 'pmc'}), StringElement('28255960', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Villarino AV, Kanno Y, O’Shea JJ. Mechanisms and consequences of jak-STAT signaling in the immune system. Nat Immunol (2017) 18(4):374–84. doi: 10.1038/ni.3691', 'ArticleIdList': [StringElement('10.1038/ni.3691', attributes={'IdType': 'doi'}), StringElement('28323260', attributes={'IdType': 'pubmed'})]}, {'Citation': 'O’Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity (2012) 36(4):542–50. doi: 10.1016/j.immuni.2012.03.014', 'ArticleIdList': [StringElement('10.1016/j.immuni.2012.03.014', attributes={'IdType': 'doi'}), StringElement('PMC3499974', attributes={'IdType': 'pmc'}), StringElement('22520847', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Jiao B, An C, Tran M, Du H, Wang P, Zhou D, et al. . Pharmacological inhibition of STAT6 ameliorates myeloid fibroblast activation and alternative macrophage polarization in renal fibrosis. Front Immunol (2021) 12:735014. doi: 10.3389/fimmu.2021.735014', 'ArticleIdList': [StringElement('10.3389/fimmu.2021.735014', attributes={'IdType': 'doi'}), StringElement('PMC8426438', attributes={'IdType': 'pmc'}), StringElement('34512669', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Lin CM, Cooles FA, Isaacs JD. Basic mechanisms of JAK inhibition. Mediterr J Rheumatol (2020) 31(Suppl 1):100–4. doi: 10.31138/mjr.31.1.100', 'ArticleIdList': [StringElement('10.31138/mjr.31.1.100', attributes={'IdType': 'doi'}), StringElement('PMC7361186', attributes={'IdType': 'pmc'}), StringElement('32676567', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zarrin AA, Bao K, Lupardus P, Vucic D. Kinase inhibition in autoimmunity and inflammation. Nat Rev Drug Discovery (2021) 20(1):39–63. doi: 10.1038/s41573-020-0082-8', 'ArticleIdList': [StringElement('10.1038/s41573-020-0082-8', attributes={'IdType': 'doi'}), StringElement('PMC7569567', attributes={'IdType': 'pmc'}), StringElement('33077936', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Baldini C, Moriconi FR, Galimberti S, Libby P, De Caterina R. The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms. Eur Heart J (2021) 42(42):4389–400. doi: 10.1093/eurheartj/ehab447', 'ArticleIdList': [StringElement('10.1093/eurheartj/ehab447', attributes={'IdType': 'doi'}), StringElement('PMC8572559', attributes={'IdType': 'pmc'}), StringElement('34343257', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wolfe L. Ruxolitinib in myelofibrosis and polycythemia Vera. J Adv Pract Oncol (2016) 7(4):436–44.', 'ArticleIdList': [StringElement('PMC5679032', attributes={'IdType': 'pmc'}), StringElement('29226001', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Sorensen AL, Mikkelsen SU, Knudsen TA, Bjorn ME, Andersen CL, Bjerrum OW, et al. . Ruxolitinib and interferon-alpha2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study. Haematologica (2020) 105(9):2262–72. doi: 10.3324/haematol.2019.235648', 'ArticleIdList': [StringElement('10.3324/haematol.2019.235648', attributes={'IdType': 'doi'}), StringElement('PMC7556624', attributes={'IdType': 'pmc'}), StringElement('33054051', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Alvarez-Larran A, Garrote M, Ferrer-Marin F, Perez-Encinas M, Mata-Vazquez MI, Bellosillo B, et al. . Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. Cancer (2022) 128(13):2441–8. doi: 10.1002/cncr.34195', 'ArticleIdList': [StringElement('10.1002/cncr.34195', attributes={'IdType': 'doi'}), StringElement('PMC9324831', attributes={'IdType': 'pmc'}), StringElement('35417564', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Shrock E, Fujimura E, Kula T, Timms RT, Lee IH, Leng Y, et al. . Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science (2020) 370(6520):eabd4250. doi: 10.1126/science.abd4250', 'ArticleIdList': [StringElement('10.1126/science.abd4250', attributes={'IdType': 'doi'}), StringElement('PMC7857405', attributes={'IdType': 'pmc'}), StringElement('32994364', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol (2021) 21(4):245–56. doi: 10.1038/s41577-021-00522-1', 'ArticleIdList': [StringElement('10.1038/s41577-021-00522-1', attributes={'IdType': 'doi'}), StringElement('PMC7958099', attributes={'IdType': 'pmc'}), StringElement('33723416', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, et al. . The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The perspectives of clinical immunologists from China. Clin Immunol (2020) 214:108393. doi: 10.1016/j.clim.2020.108393', 'ArticleIdList': [StringElement('10.1016/j.clim.2020.108393', attributes={'IdType': 'doi'}), StringElement('PMC7102614', attributes={'IdType': 'pmc'}), StringElement('32222466', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Smolen JS, Landewe RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, et al. . EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis (2020) 79(6):685–99. doi: 10.1136/annrheumdis-2019-216655', 'ArticleIdList': [StringElement('10.1136/annrheumdis-2019-216655', attributes={'IdType': 'doi'}), StringElement('31969328', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, et al. . Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis (2020) 79(6):744–59. doi: 10.1136/annrheumdis-2019-216656', 'ArticleIdList': [StringElement('10.1136/annrheumdis-2019-216656', attributes={'IdType': 'doi'}), StringElement('PMC7286044', attributes={'IdType': 'pmc'}), StringElement('32033937', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, et al. . COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis (2020) 20(4):400–2. doi: 10.1016/S1473-3099(20)30132-8', 'ArticleIdList': [StringElement('10.1016/S1473-3099(20)30132-8', attributes={'IdType': 'doi'}), StringElement('PMC7158903', attributes={'IdType': 'pmc'}), StringElement('32113509', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, et al. . Repurposed immunomodulatory drugs for covid-19 in pre-ICu patients - mulTi-arm therapeutic study in pre-ICu patients admitted with covid-19 - repurposed drugs (TACTIC-r): A structured summary of a study protocol for a randomised controlled trial. Trials (2020) 21(1):626. doi: 10.1186/s13063-020-04535-4', 'ArticleIdList': [StringElement('10.1186/s13063-020-04535-4', attributes={'IdType': 'doi'}), StringElement('PMC7341462', attributes={'IdType': 'pmc'}), StringElement('32641154', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Moreno-Gonzalez G, Mussetti A, Albasanz-Puig A, Salvador I, Sureda A, Gudiol C, et al. . A phase I/II clinical trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Trials (2021) 22(1):116. doi: 10.1186/s13063-021-05072-4', 'ArticleIdList': [StringElement('10.1186/s13063-021-05072-4', attributes={'IdType': 'doi'}), StringElement('PMC7862837', attributes={'IdType': 'pmc'}), StringElement('33546739', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Bronte V, Ugel S, Tinazzi E, Vella A, De Sanctis F, Cane S, et al. . Baricitinib restrains the immune dysregulation in patients with severe COVID-19. J Clin Invest (2020) 130(12):6409–16. doi: 10.1172/JCI141772', 'ArticleIdList': [StringElement('10.1172/JCI141772', attributes={'IdType': 'doi'}), StringElement('PMC8016181', attributes={'IdType': 'pmc'}), StringElement('32809969', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Patoulias D, Doumas M, Papadopoulos C, Karagiannis A. Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of janus! a meta-analysis of randomized controlled trials. Clin Rheumatol (2021) 40(11):4671–4. doi: 10.1007/s10067-021-05884-4', 'ArticleIdList': [StringElement('10.1007/s10067-021-05884-4', attributes={'IdType': 'doi'}), StringElement('PMC8384394', attributes={'IdType': 'pmc'}), StringElement('34431004', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ely EW, Ramanan AV, Kartman CE, de Bono S, Liao R, Piruzeli MLB, et al. . Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial. Lancet Respir Med (2022) 10(4):327–36. doi: 10.1016/S2213-2600(22)00006-6', 'ArticleIdList': [StringElement('10.1016/S2213-2600(22)00006-6', attributes={'IdType': 'doi'}), StringElement('PMC8813065', attributes={'IdType': 'pmc'}), StringElement('35123660', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Stebbing J, Sánchez Nievas G, Falcone M, Youhanna S, Richardson P, Ottaviani S, et al. . JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv (2021) 7(1):eabe4724. doi: 10.1126/sciadv.abe4724', 'ArticleIdList': [StringElement('10.1126/sciadv.abe4724', attributes={'IdType': 'doi'}), StringElement('PMC7775747', attributes={'IdType': 'pmc'}), StringElement('33187978', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Abizanda P, Calbo Mayo JM, Mas Romero M, Cortes Zamora EB, Tabernero Sahuquillo MT, Romero Rizos L, et al. . Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia. J Am Geriatr Soc (2021) 69(10):2752–8. doi: 10.1111/jgs.17357', 'ArticleIdList': [StringElement('10.1111/jgs.17357', attributes={'IdType': 'doi'}), StringElement('PMC8447356', attributes={'IdType': 'pmc'}), StringElement('34235720', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Chen CY, Chen WC, Hsu CK, Chao CM, Lai CC. Clinical efficacy and safety of janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials. Int Immunopharmacol (2021) 99:108027. doi: 10.1016/j.intimp.2021.108027', 'ArticleIdList': [StringElement('10.1016/j.intimp.2021.108027', attributes={'IdType': 'doi'}), StringElement('PMC8324418', attributes={'IdType': 'pmc'}), StringElement('34343937', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Pillaiyar T, Laufer S. Kinases as potential therapeutic targets for anti-coronaviral therapy. J Med Chem (2022) 65(2):955–82. doi: 10.1021/acs.jmedchem.1c00335', 'ArticleIdList': [StringElement('10.1021/acs.jmedchem.1c00335', attributes={'IdType': 'doi'}), StringElement('34081439', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mease P, Hall S, FitzGerald O, van der Heijde D, Merola JF, Avila-Zapata F, et al. . Tofacitinib or adalimumab versus placebo for psoriatic arthritis. N Engl J Med (2017) 377(16):1537–50. doi: 10.1056/NEJMoa1615975', 'ArticleIdList': [StringElement('10.1056/NEJMoa1615975', attributes={'IdType': 'doi'}), StringElement('29045212', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Dhillon S. Tofacitinib: A review in rheumatoid arthritis. Drugs (2017) 77(18):1987–2001. doi: 10.1007/s40265-017-0835-9', 'ArticleIdList': [StringElement('10.1007/s40265-017-0835-9', attributes={'IdType': 'doi'}), StringElement('29139090', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wollenhaupt J, Lee EB, Curtis JR, Silverfield J, Terry K, Soma K, et al. . Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study. Arthritis Res Ther (2019) 21(1):89. doi:\\xa010.1186/s13075-019-1866-2', 'ArticleIdList': [StringElement('10.1186/s13075-019-1866-2', attributes={'IdType': 'doi'}), StringElement('PMC6451219', attributes={'IdType': 'pmc'}), StringElement('30953540', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Guimaraes PO, Quirk D, Furtado RH, Maia LN, Saraiva JF, Antunes MO, et al. . Tofacitinib in patients hospitalized with covid-19 pneumonia. N Engl J Med (2021) 385(5):406–15. doi: 10.1056/NEJMoa2101643', 'ArticleIdList': [StringElement('10.1056/NEJMoa2101643', attributes={'IdType': 'doi'}), StringElement('PMC8220898', attributes={'IdType': 'pmc'}), StringElement('34133856', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Maslennikov R, Ivashkin V, Vasilieva E, Chipurik M, Semikova P, Semenets V, et al. . Tofacitinib reduces mortality in coronavirus disease 2019 tofacitinib in COVID-19. Pulm Pharmacol Ther (2021) 69:102039. doi: 10.1016/j.pupt.2021.102039', 'ArticleIdList': [StringElement('10.1016/j.pupt.2021.102039', attributes={'IdType': 'doi'}), StringElement('PMC8137353', attributes={'IdType': 'pmc'}), StringElement('34023513', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yan B, Freiwald T, Chauss D, Wang L, West E, Mirabelli C, et al. . SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation. Sci Immunol (2021) 6(58):eabg0833. doi: 10.1126/sciimmunol.abg0833', 'ArticleIdList': [StringElement('10.1126/sciimmunol.abg0833', attributes={'IdType': 'doi'}), StringElement('PMC8139422', attributes={'IdType': 'pmc'}), StringElement('33827897', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Verstovsek S, Mesa RA, Gotlib J, Levy RS, Gupta V, DiPersio JF, et al. . A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N Engl J Med (2012) 366(9):799–807. doi: 10.1056/NEJMoa1110557', 'ArticleIdList': [StringElement('10.1056/NEJMoa1110557', attributes={'IdType': 'doi'}), StringElement('PMC4822164', attributes={'IdType': 'pmc'}), StringElement('22375971', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mascarenhas J, Hoffman R, Talpaz M, Gerds AT, Stein B, Gupta V, et al. . Pacritinib vs best available therapy, including ruxolitinib, in patients with myelofibrosis: A randomized clinical trial. JAMA Oncol (2018) 4(5):652–9. doi: 10.1001/jamaoncol.2017.5818', 'ArticleIdList': [StringElement('10.1001/jamaoncol.2017.5818', attributes={'IdType': 'doi'}), StringElement('PMC5885169', attributes={'IdType': 'pmc'}), StringElement('29522138', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Vannucchi AM, Kiladjian JJ, Griesshammer M, Masszi T, Durrant S, Passamonti F, et al. . Ruxolitinib versus standard therapy for the treatment of polycythemia vera. N Engl J Med (2015) 372(5):426–35. doi: 10.1056/NEJMoa1409002', 'ArticleIdList': [StringElement('10.1056/NEJMoa1409002', attributes={'IdType': 'doi'}), StringElement('PMC4358820', attributes={'IdType': 'pmc'}), StringElement('25629741', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, et al. . Ruxolitinib for glucocorticoid-refractory acute graft-versus-Host disease. N Engl J Med (2020) 382(19):1800–10. doi: 10.1056/NEJMoa1917635', 'ArticleIdList': [StringElement('10.1056/NEJMoa1917635', attributes={'IdType': 'doi'}), StringElement('32320566', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Gratwohl A. Ruxolitinib for acute graft-versus-Host disease. N Engl J Med (2020) 383(5):501–2. doi:\\xa010.1056/NEJMc2020763', 'ArticleIdList': [StringElement('10.1056/NEJMc2020763', attributes={'IdType': 'doi'}), StringElement('32726541', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang Q, Zhao YZ, Ma HH, Wang D, Cui L, Li WJ, et al. . A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis. Blood (2022) 139(24):3493–504. doi: 10.1182/blood.2021014860', 'ArticleIdList': [StringElement('10.1182/blood.2021014860', attributes={'IdType': 'doi'}), StringElement('35344583', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Marconi VC, Moser C, Gavegnano C, Deeks SG, Lederman MM, Overton ET, et al. . Randomized trial of ruxolitinib in antiretroviral-treated adults with human immunodeficiency virus. Clin Infect Dis (2022) 74(1):95–104. doi: 10.1093/cid/ciab212', 'ArticleIdList': [StringElement('10.1093/cid/ciab212', attributes={'IdType': 'doi'}), StringElement('PMC8752257', attributes={'IdType': 'pmc'}), StringElement('33693561', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Han MK, Antila M, Ficker JH, Gordeev I, Guerreros A, Bernus AL, et al. . Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Rheumatol (2022) 4(5):e351–61. doi: 10.1016/S2665-9913(22)00044-3', 'ArticleIdList': [StringElement('10.1016/S2665-9913(22)00044-3', attributes={'IdType': 'doi'}), StringElement('PMC8963773', attributes={'IdType': 'pmc'}), StringElement('35368384', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Levy G, Guglielmelli P, Langmuir P, Constantinescu SN. JAK inhibitors and COVID-19. J Immunother Cancer (2022) 10(4):e002838. doi: 10.1136/jitc-2021-002838', 'ArticleIdList': [StringElement('10.1136/jitc-2021-002838', attributes={'IdType': 'doi'}), StringElement('PMC9035837', attributes={'IdType': 'pmc'}), StringElement('35459733', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Cao Y, Wei J, Zou L, Jiang T, Wang G, Chen L, et al. . Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol (2020) 146(1):137–146 e3. doi: 10.1016/j.jaci.2020.05.019', 'ArticleIdList': [StringElement('10.1016/j.jaci.2020.05.019', attributes={'IdType': 'doi'}), StringElement('PMC7250105', attributes={'IdType': 'pmc'}), StringElement('32470486', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Singh D, Bogus M, Moskalenko V, Lord R, Moran EJ, Crater GD, et al. . A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19. Eur Respir J (2021) 58(4):2100673. doi: 10.1183/13993003.00673-2021', 'ArticleIdList': [StringElement('10.1183/13993003.00673-2021', attributes={'IdType': 'doi'}), StringElement('PMC8859971', attributes={'IdType': 'pmc'}), StringElement('34210790', attributes={'IdType': 'pubmed'})]}, {'Citation': 'WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, et al. . Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis. JAMA (2020) 324(13):1330–41. doi:\\xa010.1001/jama.2020.17023', 'ArticleIdList': [StringElement('10.1001/jama.2020.17023', attributes={'IdType': 'doi'}), StringElement('PMC7489434', attributes={'IdType': 'pmc'}), StringElement('32876694', attributes={'IdType': 'pubmed'})]}, {'Citation': 'RECOVERY Collaborative Group. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. . Dexamethasone in hospitalized patients with covid-19. N Engl J Med (2021) 384(8):693–704. doi:\\xa010.1056/NEJMoa2021436', 'ArticleIdList': [StringElement('10.1056/NEJMoa2021436', attributes={'IdType': 'doi'}), StringElement('PMC7383595', attributes={'IdType': 'pmc'}), StringElement('32678530', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. . Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: The CoDEX randomized clinical trial. JAMA (2020) 324(13):1307–16. doi: 10.1001/jama.2020.17021', 'ArticleIdList': [StringElement('10.1001/jama.2020.17021', attributes={'IdType': 'doi'}), StringElement('PMC7489411', attributes={'IdType': 'pmc'}), StringElement('32876695', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Granholm A, Kjaer MN, Munch MW, Myatra SN, Vijayaraghavan BKT, Cronhjort M, et al. . Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia. Intensive Care Med (2022) 48(5):580–9. doi: 10.1007/s00134-022-06677-2', 'ArticleIdList': [StringElement('10.1007/s00134-022-06677-2', attributes={'IdType': 'doi'}), StringElement('PMC8970069', attributes={'IdType': 'pmc'}), StringElement('35359168', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Incorrect equivalent dose and p values in figure 3. JAMA (2022) 327(3):286. doi:\\xa010.1001/jama.2021.24153', 'ArticleIdList': [StringElement('10.1001/jama.2021.24153', attributes={'IdType': 'doi'}), StringElement('PMC8767435', attributes={'IdType': 'pmc'}), StringElement('35040905', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Granholm A, Munch MW, Myatra SN, Vijayaraghavan BKT, Cronhjort M, Wahlin RR, et al. . Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial. Intensive Care Med (2022) 48(1):45–55. doi: 10.1007/s00134-021-06573-1', 'ArticleIdList': [StringElement('10.1007/s00134-021-06573-1', attributes={'IdType': 'doi'}), StringElement('PMC8579417', attributes={'IdType': 'pmc'}), StringElement('34757439', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Taboada M, Rodríguez N, Varela PM, Rodríguez MT, Abelleira R, González A, et al. . Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trial. Eur Respir J (2022) 60(2):2102518. doi: 10.1183/13993003.02518-2021', 'ArticleIdList': [StringElement('10.1183/13993003.02518-2021', attributes={'IdType': 'doi'}), StringElement('PMC8678498', attributes={'IdType': 'pmc'}), StringElement('34916266', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Agusti A, De Stefano G, Levi A, Muñoz X, Romero-Mesones C, Sibila O, et al. . Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial. Eur Respir J (2022) 59(3):2103036. doi: 10.1183/13993003.03036-2021', 'ArticleIdList': [StringElement('10.1183/13993003.03036-2021', attributes={'IdType': 'doi'}), StringElement('PMC8832375', attributes={'IdType': 'pmc'}), StringElement('35144989', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yu LM, Bafadhel M, Dorward J, Hayward G, Saville BR, Gbinigie O, et al. . Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet (2021) 398(10303):843–55. doi: 10.1016/S0140-6736(21)01744-X', 'ArticleIdList': [StringElement('10.1016/S0140-6736(21)01744-X', attributes={'IdType': 'doi'}), StringElement('PMC8354567', attributes={'IdType': 'pmc'}), StringElement('34388395', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ramakrishnan S, Nicolau DV, Jr, Langford B, Mahdi M, Jeffers H, Mwasuku C, et al. et al. . Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med (2021) 9(7):763–72. doi: 10.1016/S2213-2600(21)00160-0', 'ArticleIdList': [StringElement('10.1016/S2213-2600(21)00160-0', attributes={'IdType': 'doi'}), StringElement('PMC8040526', attributes={'IdType': 'pmc'}), StringElement('33844996', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Baker JR, Mahdi M, Nicolau DV, Jr, Ramakrishnan S, Barnes PJ, Simpson JL, et al. . Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis. Lancet Respir Med (2022) 10(6):545–56. doi: 10.1016/S2213-2600(22)00002-9', 'ArticleIdList': [StringElement('10.1016/S2213-2600(22)00002-9', attributes={'IdType': 'doi'}), StringElement('PMC8989397', attributes={'IdType': 'pmc'}), StringElement('35397798', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ezer N, Belga S, Daneman N, Chan A, Smith BM, Daniels SA, et al. . Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial. BMJ (2021) 375:e068060. doi: 10.1136/bmj-2021-068060', 'ArticleIdList': [StringElement('10.1136/bmj-2021-068060', attributes={'IdType': 'doi'}), StringElement('PMC8561042', attributes={'IdType': 'pmc'}), StringElement('34728476', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Clemency BM, Varughese R, Gonzalez-Rojas Y, Morse CG, Phipatanakul W, Koster DJ, et al. . Efficacy of inhaled ciclesonide for outpatient treatment of adolescents and adults with symptomatic COVID-19: A randomized clinical trial. JAMA Intern Med (2022) 182(1):42–9. doi: 10.1001/jamainternmed.2021.6759', 'ArticleIdList': [StringElement('10.1001/jamainternmed.2021.6759', attributes={'IdType': 'doi'}), StringElement('PMC8609464', attributes={'IdType': 'pmc'}), StringElement('34807241', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, et al. . Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: The REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA (2020) 324(13):1317–29. doi:\\xa010.1001/jama.2020.17022', 'ArticleIdList': [StringElement('10.1001/jama.2020.17022', attributes={'IdType': 'doi'}), StringElement('PMC7489418', attributes={'IdType': 'pmc'}), StringElement('32876697', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Edalatifard M, Akhtari M, Salehi M, Naderi Z, Jamshidi A, Mostafaei S, et al. . Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J (2020) 56(6):2002808. doi: 10.1183/13993003.02808-2020', 'ArticleIdList': [StringElement('10.1183/13993003.02808-2020', attributes={'IdType': 'doi'}), StringElement('PMC7758541', attributes={'IdType': 'pmc'}), StringElement('32943404', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Dhooria S, Chaudhary S, Sehgal IS, Agarwal R, Arora S, Garg M, et al. . High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial). Eur Respir J (2022) 59(2):2102930. doi: 10.1183/13993003.02930-2021', 'ArticleIdList': [StringElement('10.1183/13993003.02930-2021', attributes={'IdType': 'doi'}), StringElement('PMC8850687', attributes={'IdType': 'pmc'}), StringElement('34887325', attributes={'IdType': 'pubmed'})]}], 'ReferenceList': []}], 'History': [DictElement({'Year': '2022', 'Month': '12', 'Day': '16'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2023', 'Month': '1', 'Day': '3'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2023', 'Month': '2', 'Day': '13', 'Hour': '3', 'Minute': '26'}, attributes={'PubStatus': 'entrez'}), DictElement({'Year': '2023', 'Month': '2', 'Day': '14', 'Hour': '6', 'Minute': '0'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2023', 'Month': '2', 'Day': '15', 'Hour': '6', 'Minute': '0'}, attributes={'PubStatus': 'medline'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('36776881', attributes={'IdType': 'pubmed'}), StringElement('PMC9909293', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2023.1125246', attributes={'IdType': 'doi'})]}}]}"
      ]
     },
     "execution_count": 68,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "article"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys(['PubmedBookArticle', 'PubmedArticle'])"
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "article.keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['MedlineCitation', 'PubmedData'])\n"
     ]
    }
   ],
   "source": [
    "PubmedArticle = (article.get('PubmedArticle'))[0]\n",
    "print(PubmedArticle.keys())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "mesh_heading_list = article.get('PubmedArticle')[0].get('MedlineCitation').get('MeshHeadingList')\n",
    "# mesh_heading_list = article.get('PubmedArticle')[0].get('MedlineCitation', {}).get('MeshHeadingList', [])\n",
    "for mesh_heading in mesh_heading_list:\n",
    "    descriptor_name = mesh_heading.get('DescriptorName')\n",
    "    if descriptor_name:\n",
    "        mesh_id = descriptor_name.attributes.get('UI')\n",
    "        print(mesh_id)\n",
    "        mesh_ids.append(mesh_id)\n",
    "        # if mesh_id in formatted_mesh_ids:\n",
    "        #     mesh_ids.append(mesh_id)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "COVID-19 Vaccines\n"
     ]
    }
   ],
   "source": [
    "print(article.get('PubmedArticle')[0].get('MedlineCitation').get('MeshHeadingList')[3].get('DescriptorName'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {},
   "outputs": [],
   "source": [
    "MeshHeadingList = article.get('PubmedArticle')[0].get('MedlineCitation').get('MeshHeadingList')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'QualifierName': [], 'DescriptorName': StringElement('COVID-19', attributes={'UI': 'D000086382', 'MajorTopicYN': 'Y'})}\n"
     ]
    }
   ],
   "source": [
    "MeshHeadingList = article.get('PubmedArticle')[0].get('MedlineCitation').get('MeshHeadingList')\n",
    "mesh_term = (MeshHeadingList[1])\n",
    "print(mesh_term)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "import yaml"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "pmid_mesh_info = {}\n",
    "pmid = \"12345678\"  # Replace with the actual PubMed ID you want to retrieve\n",
    "\n",
    "handle = Entrez.efetch(db=\"pubmed\", id=pmid, retmode=\"xml\")\n",
    "article = Entrez.read(handle)\n",
    "handle.close()\n",
    "\n",
    "# Extract MeSH IDs from the article\n",
    "mesh_ids = []\n",
    "mesh_heading_list = article.get('PubmedArticle')[0].get('MedlineCitation').get('MeshHeadingList', [])\n",
    "for mesh_heading in mesh_heading_list:\n",
    "    descriptor_name = mesh_heading.get('DescriptorName')\n",
    "    if descriptor_name:\n",
    "        mesh_id = descriptor_name.attributes.get('UI')\n",
    "        if mesh_id:\n",
    "            mesh_ids.append(mesh_id)\n",
    "\n",
    "pmid_mesh_info[pmid] = mesh_ids\n",
    "\n",
    "# Save the dictionary as a YAML file\n",
    "with open('temp_pmid_mesh_info.yaml', 'w') as yaml_file:\n",
    "    yaml.dump(pmid_mesh_info, yaml_file, default_flow_style=False)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "pmid = \"36776881\"\n",
    "# Retrieve MeSH terms for each PubMed ID\n",
    "pmid_mesh_info = {}\n",
    "handle = Entrez.efetch(db=\"pubmed\", id=pmid, retmode=\"xml\")\n",
    "article = Entrez.read(handle)\n",
    "handle.close()\n",
    "\n",
    "# Save the dictionary as a YAML file\n",
    "with open('test_pmid_mesh_info.yaml', 'w') as yaml_file:\n",
    "    yaml.dump(article, yaml_file, default_flow_style=False)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'PubmedBookArticle': [], 'PubmedArticle': [{'MedlineCitation': DictElement({'GeneralNote': [], 'SpaceFlightMission': [], 'CitationSubset': ['IM'], 'InvestigatorList': [], 'OtherAbstract': [], 'OtherID': [], 'KeywordList': [ListElement([StringElement('COVID-19', attributes={'MajorTopicYN': 'N'}), StringElement('Janus kinase inhibitors', attributes={'MajorTopicYN': 'N'}), StringElement('antiviral agents', attributes={'MajorTopicYN': 'N'}), StringElement('neutralizing antibody therapy', attributes={'MajorTopicYN': 'N'}), StringElement('treatments', attributes={'MajorTopicYN': 'N'})], attributes={'Owner': 'NOTNLM'})], 'PMID': StringElement('36776881', attributes={'Version': '1'}), 'DateCompleted': {'Year': '2023', 'Month': '02', 'Day': '14'}, 'DateRevised': {'Year': '2023', 'Month': '03', 'Day': '28'}, 'Article': DictElement({'Language': ['eng'], 'ELocationID': [StringElement('1125246', attributes={'EIdType': 'pii', 'ValidYN': 'Y'}), StringElement('10.3389/fimmu.2023.1125246', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'ArticleDate': [DictElement({'Year': '2023', 'Month': '01', 'Day': '26'}, attributes={'DateType': 'Electronic'})], 'Journal': {'ISSN': StringElement('1664-3224', attributes={'IssnType': 'Electronic'}), 'JournalIssue': DictElement({'Volume': '14', 'PubDate': {'Year': '2023'}}, attributes={'CitedMedium': 'Internet'}), 'Title': 'Frontiers in immunology', 'ISOAbbreviation': 'Front Immunol'}, 'ArticleTitle': 'The development of COVID-19 treatment.', 'Pagination': {'StartPage': '1125246', 'MedlinePgn': '1125246'}, 'Abstract': {'AbstractText': ['The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest worldwide public health threat of this century. Recent studies have unraveled numerous mysteries of SARS-CoV-2 pathogenesis and thus largely improved the studies of COVID-19 vaccines and therapeutic strategies. However, important questions remain regarding its therapy. In this review, the recent research advances on COVID-19 mechanism are quickly summarized. We mainly discuss current therapy strategies for COVID-19, with an emphasis on antiviral agents, neutralizing antibody therapies, Janus kinase inhibitors, and steroids. When necessary, specific mechanisms and the history of therapy are present, and representative strategies are described in detail. Finally, we discuss key outstanding questions regarding future directions of the development of COVID-19 treatment.'], 'CopyrightInformation': 'Copyright © 2023 Yuan, Jiao, Qu, Yang and Liu.'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.'}], 'Identifier': [], 'LastName': 'Yuan', 'ForeName': 'Yongliang', 'Initials': 'Y'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Division of Nephrology, Department of Medicine, School of Medicine, University of Connecticut Health Center, Farmington, CT, United States.'}], 'Identifier': [], 'LastName': 'Jiao', 'ForeName': 'Baihai', 'Initials': 'B'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Immunology, School of Medicine, University of Connecticut Health Center, Farmington, CT, United States.'}], 'Identifier': [], 'LastName': 'Qu', 'ForeName': 'Lili', 'Initials': 'L'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Immunology, School of Medicine, University of Connecticut Health Center, Farmington, CT, United States.'}], 'Identifier': [], 'LastName': 'Yang', 'ForeName': 'Duomeng', 'Initials': 'D'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.'}], 'Identifier': [], 'LastName': 'Liu', 'ForeName': 'Ruijuan', 'Initials': 'R'}, attributes={'ValidYN': 'Y'})], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Journal Article', attributes={'UI': 'D016428'}), StringElement('Review', attributes={'UI': 'D016454'}), StringElement(\"Research Support, Non-U.S. Gov't\", attributes={'UI': 'D013485'})]}, attributes={'PubModel': 'Electronic-eCollection'}), 'MedlineJournalInfo': {'Country': 'Switzerland', 'MedlineTA': 'Front Immunol', 'NlmUniqueID': '101560960', 'ISSNLinking': '1664-3224'}, 'ChemicalList': [{'RegistryNumber': '0', 'NameOfSubstance': StringElement('COVID-19 Vaccines', attributes={'UI': 'D000086663'})}, {'RegistryNumber': '0', 'NameOfSubstance': StringElement('Antiviral Agents', attributes={'UI': 'D000998'})}], 'MeshHeadingList': [{'QualifierName': [], 'DescriptorName': StringElement('Humans', attributes={'UI': 'D006801', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('COVID-19', attributes={'UI': 'D000086382', 'MajorTopicYN': 'Y'})}, {'QualifierName': [], 'DescriptorName': StringElement('SARS-CoV-2', attributes={'UI': 'D000086402', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('COVID-19 Vaccines', attributes={'UI': 'D000086663', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('COVID-19 Drug Treatment', attributes={'UI': 'D000093485', 'MajorTopicYN': 'N'})}, {'QualifierName': [StringElement('pharmacology', attributes={'UI': 'Q000494', 'MajorTopicYN': 'N'})], 'DescriptorName': StringElement('Antiviral Agents', attributes={'UI': 'D000998', 'MajorTopicYN': 'N'})}], 'CoiStatement': 'The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.'}, attributes={'Status': 'MEDLINE', 'Owner': 'NLM', 'IndexingMethod': 'Automated'}), 'PubmedData': {'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta BioMed (2020) 91(1):157–60. doi:\\xa010.23750/abm.v91i1.9397', 'ArticleIdList': [StringElement('10.23750/abm.v91i1.9397', attributes={'IdType': 'doi'}), StringElement('PMC7569573', attributes={'IdType': 'pmc'}), StringElement('32191675', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Abbasi J. Fourth COVID-19 vaccine dose increases low antibodies. JAMA (2022) 327(6):517. doi: 10.1001/jama.2022.0727', 'ArticleIdList': [StringElement('10.1001/jama.2022.0727', attributes={'IdType': 'doi'}), StringElement('35133429', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Altmann DM, Boyton RJ. COVID-19 vaccination: The road ahead. Science (2022) 375(6585):1127–32. doi: 10.1126/science.abn1755', 'ArticleIdList': [StringElement('10.1126/science.abn1755', attributes={'IdType': 'doi'}), StringElement('35271316', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Dube E, MacDonald NE. COVID-19 vaccine hesitancy. Nat Rev Nephrol (2022) 18(7):409–10. doi: 10.1038/s41581-022-00571-2', 'ArticleIdList': [StringElement('10.1038/s41581-022-00571-2', attributes={'IdType': 'doi'}), StringElement('PMC9004449', attributes={'IdType': 'pmc'}), StringElement('35414006', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Niknam Z, Golchin A, Danesh Pouya F, Nemati M, Rezaei-Tavirani M. Potential therapeutic options for COVID-19: an update on current evidence. Eur J Med Res (2022) 27(1):6. doi: 10.1186/s40001-021-00626-3', 'ArticleIdList': [StringElement('10.1186/s40001-021-00626-3', attributes={'IdType': 'doi'}), StringElement('PMC8755901', attributes={'IdType': 'pmc'}), StringElement('35027080', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Drozdzal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Przybycinski J, et al. . An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment. Drug Resist Update (2021) 59:100794. doi: 10.1016/j.drup.2021.100794', 'ArticleIdList': [StringElement('10.1016/j.drup.2021.100794', attributes={'IdType': 'doi'}), StringElement('PMC8654464', attributes={'IdType': 'pmc'}), StringElement('34991982', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature (2020) 579(7798):270–3. doi: 10.1038/s41586-020-2012-7', 'ArticleIdList': [StringElement('10.1038/s41586-020-2012-7', attributes={'IdType': 'doi'}), StringElement('PMC7095418', attributes={'IdType': 'pmc'}), StringElement('32015507', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet (2020) 395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5', 'ArticleIdList': [StringElement('10.1016/S0140-6736(20)30183-5', attributes={'IdType': 'doi'}), StringElement('PMC7159299', attributes={'IdType': 'pmc'}), StringElement('31986264', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Coronaviridae Study Group of the International Committee on Taxonomy of, V . The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol (2020) 5(4):536–44. doi: 10.1038/s41564-020-0695-z', 'ArticleIdList': [StringElement('10.1038/s41564-020-0695-z', attributes={'IdType': 'doi'}), StringElement('PMC7095448', attributes={'IdType': 'pmc'}), StringElement('32123347', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (2020) 395(10224):565–74. doi: 10.1016/S0140-6736(20)30251-8', 'ArticleIdList': [StringElement('10.1016/S0140-6736(20)30251-8', attributes={'IdType': 'doi'}), StringElement('PMC7159086', attributes={'IdType': 'pmc'}), StringElement('32007145', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell (2020) 181(2):271–280 e8. doi: 10.1016/j.cell.2020.02.052', 'ArticleIdList': [StringElement('10.1016/j.cell.2020.02.052', attributes={'IdType': 'doi'}), StringElement('PMC7102627', attributes={'IdType': 'pmc'}), StringElement('32142651', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol (2020) 41(12):1100–15. doi: 10.1016/j.it.2020.10.004', 'ArticleIdList': [StringElement('10.1016/j.it.2020.10.004', attributes={'IdType': 'doi'}), StringElement('PMC7556779', attributes={'IdType': 'pmc'}), StringElement('33132005', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mizrahi B, Shilo S, Rossman H, Kalkstein N, Marcus K, Barer Y, et al. . Longitudinal symptom dynamics of COVID-19 infection. Nat Commun (2020) 11(1):6208. doi: 10.1038/s41467-020-20053-y', 'ArticleIdList': [StringElement('10.1038/s41467-020-20053-y', attributes={'IdType': 'doi'}), StringElement('PMC7718370', attributes={'IdType': 'pmc'}), StringElement('33277494', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med (2022) 28(8):1706–14. doi: 10.1038/s41591-022-01909-w', 'ArticleIdList': [StringElement('10.1038/s41591-022-01909-w', attributes={'IdType': 'doi'}), StringElement('PMC9388369', attributes={'IdType': 'pmc'}), StringElement('35879616', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang W, Chua BY, Selva KJ, Kedzierski L, Ashhurst TM, Haycroft ER, et al. . SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity. Nat Commun (2022) 13(1):2774. doi: 10.1038/s41467-022-30088-y', 'ArticleIdList': [StringElement('10.1038/s41467-022-30088-y', attributes={'IdType': 'doi'}), StringElement('PMC9120039', attributes={'IdType': 'pmc'}), StringElement('35589689', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med (2021) 27(1):28–33. doi: 10.1038/s41591-020-01202-8', 'ArticleIdList': [StringElement('10.1038/s41591-020-01202-8', attributes={'IdType': 'doi'}), StringElement('33442016', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther (2021) 6(1):291. doi: 10.1038/s41392-021-00687-0', 'ArticleIdList': [StringElement('10.1038/s41392-021-00687-0', attributes={'IdType': 'doi'}), StringElement('PMC8333067', attributes={'IdType': 'pmc'}), StringElement('34344870', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kanneganti TD. Intracellular innate immune receptors: Life inside the cell. Immunol Rev (2020) 297(1):5–12. doi: 10.1111/imr.12912', 'ArticleIdList': [StringElement('10.1111/imr.12912', attributes={'IdType': 'doi'}), StringElement('PMC7592123', attributes={'IdType': 'pmc'}), StringElement('32856334', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Loo YM, Gale M, Jr. Immune signaling by RIG-i-like receptors. Immunity (2011) 34(5):680–92. doi: 10.1016/j.immuni.2011.05.003', 'ArticleIdList': [StringElement('10.1016/j.immuni.2011.05.003', attributes={'IdType': 'doi'}), StringElement('PMC3177755', attributes={'IdType': 'pmc'}), StringElement('21616437', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Horner SM, Liu HM, Park HS, Briley J, Gale M, Jr. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis c virus. Proc Natl Acad Sci U.S.A. (2011) 108(35):14590–5. doi: 10.1073/pnas.1110133108', 'ArticleIdList': [StringElement('10.1073/pnas.1110133108', attributes={'IdType': 'doi'}), StringElement('PMC3167523', attributes={'IdType': 'pmc'}), StringElement('21844353', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yin X, Riva L, Pu Y, Martin-Sancho L, Kanamune J, Yamamoto Y, et al. . MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells. Cell Rep (2021) 34(2):108628. doi: 10.1016/j.celrep.2020.108628', 'ArticleIdList': [StringElement('10.1016/j.celrep.2020.108628', attributes={'IdType': 'doi'}), StringElement('PMC7832566', attributes={'IdType': 'pmc'}), StringElement('33440148', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yang DM, Geng TT, Harrison AG, Wang PH. Differential roles of RIG-I like receptors in SARS-CoV-2 infection. Mil Med Res (2021) 8(1):49. doi: 10.1186/s40779-021-00340-5', 'ArticleIdList': [StringElement('10.1186/s40779-021-00340-5', attributes={'IdType': 'doi'}), StringElement('PMC8421188', attributes={'IdType': 'pmc'}), StringElement('34488908', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rebendenne A, Valadao ALC, Tauziet M, Maarifi G, Bonaventure B, McKellar J, et al. . SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. J Virol (2021) 95(8):e02415–20. doi: 10.1128/JVI.02415-20', 'ArticleIdList': [StringElement('10.1128/JVI.02415-20', attributes={'IdType': 'doi'}), StringElement('PMC8103705', attributes={'IdType': 'pmc'}), StringElement('33514628', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Thorne LG, Reuschl AK, Zuliani-Alvarez L, Whelan MVX, Turner J, Noursadeghi M. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. EMBO J (2021) 40(15):e107826. doi: 10.15252/embj.2021107826', 'ArticleIdList': [StringElement('10.15252/embj.2021107826', attributes={'IdType': 'doi'}), StringElement('PMC8209947', attributes={'IdType': 'pmc'}), StringElement('34101213', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yamada T, Sato S, Sotoyama Y, Orba Y, Sawa H, Yamauchi H, et al. . RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells. Nat Immunol (2021) 22(7):820–8. doi: 10.1038/s41590-021-00942-0', 'ArticleIdList': [StringElement('10.1038/s41590-021-00942-0', attributes={'IdType': 'doi'}), StringElement('33976430', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol (2004) 4(7):499–511. doi: 10.1038/nri1391', 'ArticleIdList': [StringElement('10.1038/nri1391', attributes={'IdType': 'doi'}), StringElement('15229469', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zheng M, Karki R, Williams EP, Yang D, Fitzpatrick E, Vogel P, et al. . TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol (2021) 22(7):829–38. doi: 10.1038/s41590-021-00937-x', 'ArticleIdList': [StringElement('10.1038/s41590-021-00937-x', attributes={'IdType': 'doi'}), StringElement('PMC8882317', attributes={'IdType': 'pmc'}), StringElement('33963333', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhao Y, Kuang M, Li J, Zhu L, Jia Z, Guo X, et al. . SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res (2021) 31(7):818–20. doi: 10.1038/s41422-021-00495-9', 'ArticleIdList': [StringElement('10.1038/s41422-021-00495-9', attributes={'IdType': 'doi'}), StringElement('PMC7975240', attributes={'IdType': 'pmc'}), StringElement('33742149', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Pan P, Shen M, Yu Z, Ge W, Chen K, Tian M, et al. . SARS-CoV-2 n protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat Commun (2021) 12(1):4664. doi: 10.1038/s41467-021-25015-6', 'ArticleIdList': [StringElement('10.1038/s41467-021-25015-6', attributes={'IdType': 'doi'}), StringElement('PMC8329225', attributes={'IdType': 'pmc'}), StringElement('34341353', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rodrigues TS, de Sa KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. . Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med (2021) 218(3):e20201707. doi:\\xa010.1084/jem.20201707', 'ArticleIdList': [StringElement('10.1084/jem.20201707', attributes={'IdType': 'doi'}), StringElement('PMC7684031', attributes={'IdType': 'pmc'}), StringElement('33231615', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ferreira AC, Soares VC, de Azevedo-Quintanilha IG, Dias S, Fintelman-Rodrigues N, Sacramento CQ, et al. . SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discovery (2021) 7(1):43. doi:\\xa010.1038/s41420-021-00428-w', 'ArticleIdList': [StringElement('10.1038/s41420-021-00428-w', attributes={'IdType': 'doi'}), StringElement('PMC7919254', attributes={'IdType': 'pmc'}), StringElement('33649297', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rui Y, Su J, Shen S, Hu Y, Huang D, Zheng W, et al. . Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins. Signal Transduct Target Ther (2021) 6(1):123. doi: 10.1038/s41392-021-00515-5', 'ArticleIdList': [StringElement('10.1038/s41392-021-00515-5', attributes={'IdType': 'doi'}), StringElement('PMC7958565', attributes={'IdType': 'pmc'}), StringElement('33723219', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li M, Ferretti M, Ying B, Descamps H, Lee E, Dittmar M, et al. . Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci Immunol (2021) 6(59):eabi9007. doi: 10.1126/sciimmunol.abi9007', 'ArticleIdList': [StringElement('10.1126/sciimmunol.abi9007', attributes={'IdType': 'doi'}), StringElement('PMC10021026', attributes={'IdType': 'pmc'}), StringElement('34010142', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Humphries F, Shmuel-Galia L, Jiang Z, Wilson R, Landis P, Ng SL, et al. . A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Sci Immunol (2021) 6(59):eabi9002. doi: 10.1126/sciimmunol.abi9002', 'ArticleIdList': [StringElement('10.1126/sciimmunol.abi9002', attributes={'IdType': 'doi'}), StringElement('PMC8158975', attributes={'IdType': 'pmc'}), StringElement('34010139', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hadjadj J, et al. . Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science (2020) 369(6504):718–24. doi: 10.1126/science.abc6027', 'ArticleIdList': [StringElement('10.1126/science.abc6027', attributes={'IdType': 'doi'}), StringElement('PMC7402632', attributes={'IdType': 'pmc'}), StringElement('32661059', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. . Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell (2021) 184(1):149–168 e17. doi:\\xa010.1016/j.cell.2020.11.025.', 'ArticleIdList': [StringElement('10.1016/j.cell.2020.11.025.', attributes={'IdType': 'doi'}), StringElement('PMC7674074', attributes={'IdType': 'pmc'}), StringElement('33278357', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang F, Mears JR, Shakib L, Beynor JI, Shanaj S, Korsunsky I, et al. . IFN-gamma and TNF-alpha drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation. Genome Med (2021) 13(1):64. doi:\\xa010.1186/s13073-021-00881-3', 'ArticleIdList': [StringElement('10.1186/s13073-021-00881-3', attributes={'IdType': 'doi'}), StringElement('PMC8057009', attributes={'IdType': 'pmc'}), StringElement('33879239', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Belhadjer Z, Meot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. . Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation (2020) 142(5):429–36. doi: 10.1161/CIRCULATIONAHA.120.048360', 'ArticleIdList': [StringElement('10.1161/CIRCULATIONAHA.120.048360', attributes={'IdType': 'doi'}), StringElement('32418446', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol (2022) 23(2):194–202. doi: 10.1038/s41590-021-01104-y', 'ArticleIdList': [StringElement('10.1038/s41590-021-01104-y', attributes={'IdType': 'doi'}), StringElement('PMC9127978', attributes={'IdType': 'pmc'}), StringElement('35105985', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, et al. . Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol (2020) 146(1):128–136 e4. doi: 10.1016/j.jaci.2020.05.008', 'ArticleIdList': [StringElement('10.1016/j.jaci.2020.05.008', attributes={'IdType': 'doi'}), StringElement('PMC7233239', attributes={'IdType': 'pmc'}), StringElement('32425269', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. . Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis (2020) 71(8):1937–42. doi: 10.1093/cid/ciaa449', 'ArticleIdList': [StringElement('10.1093/cid/ciaa449', attributes={'IdType': 'doi'}), StringElement('PMC7184354', attributes={'IdType': 'pmc'}), StringElement('32301997', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Roltgen K, Boyd SD. Antibody and b cell responses to SARS-CoV-2 infection and vaccination. Cell Host Microbe (2021) 29(7):1063–75. doi: 10.1016/j.chom.2021.06.009', 'ArticleIdList': [StringElement('10.1016/j.chom.2021.06.009', attributes={'IdType': 'doi'}), StringElement('PMC8233571', attributes={'IdType': 'pmc'}), StringElement('34174992', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol (2022) 23(2):186–93. doi: 10.1038/s41590-021-01122-w', 'ArticleIdList': [StringElement('10.1038/s41590-021-01122-w', attributes={'IdType': 'doi'}), StringElement('35105982', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res (2020) 30(3):269–71. doi: 10.1038/s41422-020-0282-0', 'ArticleIdList': [StringElement('10.1038/s41422-020-0282-0', attributes={'IdType': 'doi'}), StringElement('PMC7054408', attributes={'IdType': 'pmc'}), StringElement('32020029', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Williamson BN, Feldmann F, Schwarz B, Meade-White K, Porter DP, Schulz J, et al. . Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature (2020) 585(7824):273–6. doi: 10.1038/s41586-020-2423-5', 'ArticleIdList': [StringElement('10.1038/s41586-020-2423-5', attributes={'IdType': 'doi'}), StringElement('PMC7486271', attributes={'IdType': 'pmc'}), StringElement('32516797', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, et al. . Early remdesivir to prevent progression to severe covid-19 in outpatients. N Engl J Med (2022) 386(4):305–15. doi: 10.1056/NEJMoa2116846', 'ArticleIdList': [StringElement('10.1056/NEJMoa2116846', attributes={'IdType': 'doi'}), StringElement('PMC8757570', attributes={'IdType': 'pmc'}), StringElement('34937145', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. . Remdesivir for the treatment of covid-19 - final report. N Engl J Med (2020) 383(19):1813–26. doi: 10.1056/NEJMoa2007764', 'ArticleIdList': [StringElement('10.1056/NEJMoa2007764', attributes={'IdType': 'doi'}), StringElement('PMC7262788', attributes={'IdType': 'pmc'}), StringElement('32445440', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Spinner CD, Gottlieb RL, Criner GJ, Arribas Lopez JR, Cattelan AM, Soriano Viladomiu A, et al. . Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: A randomized clinical trial. JAMA (2020) 324(11):1048–57. doi: 10.1001/jama.2020.16349', 'ArticleIdList': [StringElement('10.1001/jama.2020.16349', attributes={'IdType': 'doi'}), StringElement('PMC7442954', attributes={'IdType': 'pmc'}), StringElement('32821939', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, et al. . Remdesivir for 5 or 10 days in patients with severe covid-19. N Engl J Med (2020) 383(19):1827–37. doi: 10.1056/NEJMoa2015301', 'ArticleIdList': [StringElement('10.1056/NEJMoa2015301', attributes={'IdType': 'doi'}), StringElement('PMC7377062', attributes={'IdType': 'pmc'}), StringElement('32459919', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Singh KP, Tong SYC. In adults hospitalized with COVID-19, adding remdesivir to standard care did not reduce in-hospital mortality. Ann Intern Med (2022) 175(5):JC51. doi: 10.7326/J22-0025', 'ArticleIdList': [StringElement('10.7326/J22-0025', attributes={'IdType': 'doi'}), StringElement('35500262', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, et al. . Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Lancet Infect Dis (2022) 22(2):209–21. doi: 10.1016/S1473-3099(21)00485-0', 'ArticleIdList': [StringElement('10.1016/S1473-3099(21)00485-0', attributes={'IdType': 'doi'}), StringElement('PMC8439621', attributes={'IdType': 'pmc'}), StringElement('34534511', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. . Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet (2020) 395(10236):1569–78. doi: 10.1016/S0140-6736(20)31022-9', 'ArticleIdList': [StringElement('10.1016/S0140-6736(20)31022-9', attributes={'IdType': 'doi'}), StringElement('PMC7190303', attributes={'IdType': 'pmc'}), StringElement('32423584', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, et al. . Baricitinib plus remdesivir for hospitalized adults with covid-19. N Engl J Med (2021) 384(9):795–807. doi: 10.1056/NEJMoa2031994', 'ArticleIdList': [StringElement('10.1056/NEJMoa2031994', attributes={'IdType': 'doi'}), StringElement('PMC7745180', attributes={'IdType': 'pmc'}), StringElement('33306283', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Delang L, Abdelnabi R, Neyts J. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses. Antiviral Res (2018) 153:85–94. doi: 10.1016/j.antiviral.2018.03.003', 'ArticleIdList': [StringElement('10.1016/j.antiviral.2018.03.003', attributes={'IdType': 'doi'}), StringElement('29524445', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res (2013) 100(2):446–54. doi: 10.1016/j.antiviral.2013.09.015', 'ArticleIdList': [StringElement('10.1016/j.antiviral.2013.09.015', attributes={'IdType': 'doi'}), StringElement('PMC3880838', attributes={'IdType': 'pmc'}), StringElement('24084488', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Udwadia ZF, Singh P, Barkate H, Patil S, Rangwala S, Pendse A, et al. . Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial. Int J Infect Dis (2021) 103:62–71. doi: 10.1016/j.ijid.2020.11.142', 'ArticleIdList': [StringElement('10.1016/j.ijid.2020.11.142', attributes={'IdType': 'doi'}), StringElement('PMC7668212', attributes={'IdType': 'pmc'}), StringElement('33212256', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yao TT, Qian JD, Zhu WY, Wang Y, Wang GQ. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-a possible reference for coronavirus disease-19 treatment option. J Med Virol (2020) 92(6):556–63. doi: 10.1002/jmv.25729', 'ArticleIdList': [StringElement('10.1002/jmv.25729', attributes={'IdType': 'doi'}), StringElement('PMC7217143', attributes={'IdType': 'pmc'}), StringElement('32104907', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. . A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. N Engl J Med (2020) 382(19):1787–99. doi: 10.1056/NEJMoa2001282', 'ArticleIdList': [StringElement('10.1056/NEJMoa2001282', attributes={'IdType': 'doi'}), StringElement('PMC7121492', attributes={'IdType': 'pmc'}), StringElement('32187464', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Group RC. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet (2020) 396(10259):1345–52. doi:\\xa010.1016/S0140-6736(20)32013-4', 'ArticleIdList': [StringElement('10.1016/S0140-6736(20)32013-4', attributes={'IdType': 'doi'}), StringElement('PMC7535623', attributes={'IdType': 'pmc'}), StringElement('33031764', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wang Z, Chen X, Lu Y, Chen F, Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends (2020) 14(1):64–8. doi: 10.5582/bst.2020.01030', 'ArticleIdList': [StringElement('10.5582/bst.2020.01030', attributes={'IdType': 'doi'}), StringElement('32037389', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hung IF, Lung KC, Tso EY, Liu R, Chung TW, Chu MY, et al. . Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet (2020) 395(10238):1695–704. doi: 10.1016/S0140-6736(20)31042-4', 'ArticleIdList': [StringElement('10.1016/S0140-6736(20)31042-4', attributes={'IdType': 'doi'}), StringElement('PMC7211500', attributes={'IdType': 'pmc'}), StringElement('32401715', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, et al. . An oral SARS-CoV-2 m(pro) inhibitor clinical candidate for the treatment of COVID-19. Science (2021) 374(6575):1586–93. doi: 10.1126/science.abl4784', 'ArticleIdList': [StringElement('10.1126/science.abl4784', attributes={'IdType': 'doi'}), StringElement('34726479', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. . Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19. N Engl J Med (2022) 386(15):1397–408. doi: 10.1056/NEJMoa2118542', 'ArticleIdList': [StringElement('10.1056/NEJMoa2118542', attributes={'IdType': 'doi'}), StringElement('PMC8908851', attributes={'IdType': 'pmc'}), StringElement('35172054', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang JL, Li YH, Wang LL, Liu HQ, Lu SY, Liu Y, et al. . Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients. Signal Transduct Target Ther (2021) 6(1):414. doi: 10.1038/s41392-021-00835-6', 'ArticleIdList': [StringElement('10.1038/s41392-021-00835-6', attributes={'IdType': 'doi'}), StringElement('PMC8646019', attributes={'IdType': 'pmc'}), StringElement('34873151', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ren Z, Luo H, Yu Z, Song J, Liang L, Wang L, et al. . A randomized, open-label, controlled clinical trial of azvudine tablets in the treatment of mild and common COVID-19, a pilot study. Adv Sci (Weinh) (2020) 7(19):e2001435. doi: 10.1002/advs.202001435', 'ArticleIdList': [StringElement('10.1002/advs.202001435', attributes={'IdType': 'doi'}), StringElement('PMC7404576', attributes={'IdType': 'pmc'}), StringElement('35403380', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yu B, Chang J. Azvudine (FNC): a promising clinical candidate for COVID-19 treatment. Signal Transduct Target Ther (2020) 5(1):236. doi:\\xa010.1038/s41392-020-00351-z', 'ArticleIdList': [StringElement('10.1038/s41392-020-00351-z', attributes={'IdType': 'doi'}), StringElement('PMC7547293', attributes={'IdType': 'pmc'}), StringElement('33040075', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wahl A, Gralinski LE, Johnson CE, Yao W, Kovarova M, Dinnon KH, 3rd, et al. . SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature (2021) 591(7850):451–7. doi:\\xa010.1038/s41586-021-03312-w', 'ArticleIdList': [StringElement('10.1038/s41586-021-03312-w', attributes={'IdType': 'doi'}), StringElement('PMC7979515', attributes={'IdType': 'pmc'}), StringElement('33561864', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mahase E. Covid-19: Molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, MSD reports. BMJ (2021) 375:n2422. doi:\\xa010.1136/bmj.n2422', 'ArticleIdList': [StringElement('10.1136/bmj.n2422', attributes={'IdType': 'doi'}), StringElement('34607801', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, et al. . Molnupiravir for oral treatment of covid-19 in nonhospitalized patients. N Engl J Med (2022) 386(6):509–20. doi:\\xa010.1056/NEJMoa2116044', 'ArticleIdList': [StringElement('10.1056/NEJMoa2116044', attributes={'IdType': 'doi'}), StringElement('PMC8693688', attributes={'IdType': 'pmc'}), StringElement('34914868', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mahase E. Covid-19: UK becomes first country to authorise antiviral molnupiravir. BMJ (2021) 375:n2697. doi:\\xa010.1136/bmj.n2697', 'ArticleIdList': [StringElement('10.1136/bmj.n2697', attributes={'IdType': 'doi'}), StringElement('34737216', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Whitley R. Molnupiravir - a step toward orally bioavailable therapies for covid-19. N Engl J Med (2022) 386(6):592–3. doi: 10.1056/NEJMe2117814', 'ArticleIdList': [StringElement('10.1056/NEJMe2117814', attributes={'IdType': 'doi'}), StringElement('PMC8693684', attributes={'IdType': 'pmc'}), StringElement('34914869', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Araujo R, Aranda-Martinez JD, Aranda-Abreu GE. Amantadine treatment for people with COVID-19. Arch Med Res (2020) 51(7):739–40. doi: 10.1016/j.arcmed.2020.06.009', 'ArticleIdList': [StringElement('10.1016/j.arcmed.2020.06.009', attributes={'IdType': 'doi'}), StringElement('PMC7290190', attributes={'IdType': 'pmc'}), StringElement('32571606', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Smieszek SP, Przychodzen BP, Polymeropoulos MH. Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment. Int J Antimicrob Agents (2020) 55(6):106004. doi: 10.1016/j.ijantimicag.2020.106004', 'ArticleIdList': [StringElement('10.1016/j.ijantimicag.2020.106004', attributes={'IdType': 'doi'}), StringElement('PMC7191300', attributes={'IdType': 'pmc'}), StringElement('32361028', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rejdak K, Grieb P. Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment. Mult Scler Relat Disord (2020) 42:102163. doi: 10.1016/j.msard.2020.102163', 'ArticleIdList': [StringElement('10.1016/j.msard.2020.102163', attributes={'IdType': 'doi'}), StringElement('PMC7190496', attributes={'IdType': 'pmc'}), StringElement('32388458', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ahmadi K, Farasat A, Rostamian M, Johari B, Madanchi H. Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study. J Biomol Struct Dyn (2022) 40(12):5566–76. doi: 10.1080/07391102.2021.1871958', 'ArticleIdList': [StringElement('10.1080/07391102.2021.1871958', attributes={'IdType': 'doi'}), StringElement('PMC7814568', attributes={'IdType': 'pmc'}), StringElement('33438525', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Oliver ME, Hinks TSC. Azithromycin in viral infections. Rev Med Virol (2021) 31(2):e2163. doi: 10.1002/rmv.2163', 'ArticleIdList': [StringElement('10.1002/rmv.2163', attributes={'IdType': 'doi'}), StringElement('PMC7536932', attributes={'IdType': 'pmc'}), StringElement('32969125', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Dontcheff L. [Discontinuous evolution of oxygen consumption in relation to weight, during fasting in rats]. C R Seances Soc Biol Fil (1970) 164(6):1370–1.', 'ArticleIdList': [StringElement('4252378', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Group PTC. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet (2021) 397(10279):1063–74. doi:\\xa010.1016/S0140-6736(21)00461-X', 'ArticleIdList': [StringElement('10.1016/S0140-6736(21)00461-X', attributes={'IdType': 'doi'}), StringElement('PMC7972318', attributes={'IdType': 'pmc'}), StringElement('33676597', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ferner RE, Aronson JK. Chloroquine and hydroxychloroquine in covid-19. BMJ (2020) 369:m1432. doi: 10.1136/bmj.m1432', 'ArticleIdList': [StringElement('10.1136/bmj.m1432', attributes={'IdType': 'doi'}), StringElement('32269046', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Group RC, Horby P, Mafham M, Linsell L, Bell JL, Staplin N, et al. . Effect of hydroxychloroquine in hospitalized patients with covid-19. N Engl J Med (2020) 383(21):2030–40. doi:\\xa010.1056/NEJMoa2022926', 'ArticleIdList': [StringElement('10.1056/NEJMoa2022926', attributes={'IdType': 'doi'}), StringElement('PMC7556338', attributes={'IdType': 'pmc'}), StringElement('33031652', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Correction: Hydroxychloroquine in nonhospitalized adults with early COVID-19. Ann Intern Med (2021) 174(3):435. doi:\\xa010.7326/L20-1220', 'ArticleIdList': [StringElement('10.7326/L20-1220', attributes={'IdType': 'doi'}), StringElement('33721537', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, et al. . A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19. N Engl J Med (2020) 383(6):517–25. doi: 10.1056/NEJMoa2016638', 'ArticleIdList': [StringElement('10.1056/NEJMoa2016638', attributes={'IdType': 'doi'}), StringElement('PMC7289276', attributes={'IdType': 'pmc'}), StringElement('32492293', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mitja O, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, et al. . A cluster-randomized trial of hydroxychloroquine for prevention of covid-19. N Engl J Med (2021) 384(5):417–27. doi: 10.1056/NEJMoa2021801', 'ArticleIdList': [StringElement('10.1056/NEJMoa2021801', attributes={'IdType': 'doi'}), StringElement('PMC7722693', attributes={'IdType': 'pmc'}), StringElement('33289973', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Furtado RHM, Berwanger O, Fonseca HA, Correa TD, Ferraz LR, Lapa MG, et al. . Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet (2020) 396(10256):959–67. doi: 10.1016/S0140-6736(20)31862-6', 'ArticleIdList': [StringElement('10.1016/S0140-6736(20)31862-6', attributes={'IdType': 'doi'}), StringElement('PMC7836431', attributes={'IdType': 'pmc'}), StringElement('32896292', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A, et al. . Hydroxychloroquine with or without azithromycin in mild-to-Moderate covid-19. N Engl J Med (2020) 383(21):2041–52. doi: 10.1056/NEJMoa2019014', 'ArticleIdList': [StringElement('10.1056/NEJMoa2019014', attributes={'IdType': 'doi'}), StringElement('PMC7397242', attributes={'IdType': 'pmc'}), StringElement('32706953', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Sposito B, Broggi A, Pandolfi L, Crotta S, Clementi N, Ferrarese R, et al. . The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell (2021) 184(19):4953–4968 e16. doi: 10.1016/j.cell.2021.08.016', 'ArticleIdList': [StringElement('10.1016/j.cell.2021.08.016', attributes={'IdType': 'doi'}), StringElement('PMC8373821', attributes={'IdType': 'pmc'}), StringElement('34492226', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ramasamy S, Subbian S. Erratum for ramasamy and subbian, “Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis”. Clin Microbiol Rev (2021) 34(4):e0016321. doi:\\xa010.1128/CMR.00163-21', 'ArticleIdList': [StringElement('10.1128/CMR.00163-21', attributes={'IdType': 'doi'}), StringElement('PMC8404690', attributes={'IdType': 'pmc'}), StringElement('34259566', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kalil AC, Mehta AK, Patterson TF, Erdmann N, Gomez CA, Jain MK, et al. . Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. Lancet Respir Med (2021) 9(12):1365–76. doi: 10.1016/S2213-2600(21)00384-2', 'ArticleIdList': [StringElement('10.1016/S2213-2600(21)00384-2', attributes={'IdType': 'doi'}), StringElement('PMC8523116', attributes={'IdType': 'pmc'}), StringElement('34672949', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Nakhlband A, Fakhari A, Azizi H. Interferon-alpha position in combating with COVID-19: A systematic review. J Med Virol (2021) 93(9):5277–84. doi: 10.1002/jmv.27072', 'ArticleIdList': [StringElement('10.1002/jmv.27072', attributes={'IdType': 'doi'}), StringElement('PMC8242473', attributes={'IdType': 'pmc'}), StringElement('34101851', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Porter RR. The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J (1959) 73(1):119–26. doi: 10.1042/bj0730119', 'ArticleIdList': [StringElement('10.1042/bj0730119', attributes={'IdType': 'doi'}), StringElement('PMC1197021', attributes={'IdType': 'pmc'}), StringElement('14434282', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Edelman GM, Benacerraf B, Ovary Z, Poulik MD. Structural differences among antibodies of different specificities. Proc Natl Acad Sci U.S.A. (1961) 47(11):1751–8. doi: 10.1073/pnas.47.11.1751', 'ArticleIdList': [StringElement('10.1073/pnas.47.11.1751', attributes={'IdType': 'doi'}), StringElement('PMC223206', attributes={'IdType': 'pmc'}), StringElement('13889151', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Todd PA, Brogden RN. Muromonab CD3. a review of its pharmacology and therapeutic potential. Drugs (1989) 37(6):871–99. doi: 10.2165/00003495-198937060-00004', 'ArticleIdList': [StringElement('10.2165/00003495-198937060-00004', attributes={'IdType': 'doi'}), StringElement('2503348', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rajewsky K. The advent and rise of monoclonal antibodies. Nature (2019) 575(7781):47–9. doi: 10.1038/d41586-019-02840-w', 'ArticleIdList': [StringElement('10.1038/d41586-019-02840-w', attributes={'IdType': 'doi'}), StringElement('31686050', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, et al. . Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: A randomized clinical trial. JAMA (2020) 324(5):460–70. doi: 10.1001/jama.2020.10044', 'ArticleIdList': [StringElement('10.1001/jama.2020.10044', attributes={'IdType': 'doi'}), StringElement('PMC7270883', attributes={'IdType': 'pmc'}), StringElement('32492084', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Marconato M, Abela IA, Hauser A, Schwarzmüller M, Katzensteiner R, Braun DL, et al. . Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response. J Clin Invest (2022) 132(12):e158190. doi: 10.1172/JCI158190', 'ArticleIdList': [StringElement('10.1172/JCI158190', attributes={'IdType': 'doi'}), StringElement('PMC9197521', attributes={'IdType': 'pmc'}), StringElement('35482408', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Alemany A, Millat-Martinez P, Corbacho-Monne M, Malchair P, Ouchi D, Ruiz-Comellas A, et al. . High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial. Lancet Respir Med (2022) 10(3):278–88. doi: 10.1016/S2213-2600(21)00545-2', 'ArticleIdList': [StringElement('10.1016/S2213-2600(21)00545-2', attributes={'IdType': 'doi'}), StringElement('PMC8828369', attributes={'IdType': 'pmc'}), StringElement('35150610', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, et al. . Early outpatient treatment for covid-19 with convalescent plasma. N Engl J Med (2022) 386(18):1700–11. doi: 10.1056/NEJMoa2119657', 'ArticleIdList': [StringElement('10.1056/NEJMoa2119657', attributes={'IdType': 'doi'}), StringElement('PMC9006786', attributes={'IdType': 'pmc'}), StringElement('35353960', attributes={'IdType': 'pubmed'})]}, {'Citation': 'RECOVERY Collaborative Group . Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet (2021) 397(10289):2049–59. doi:\\xa010.1016/S0140-6736(21)00897-7', 'ArticleIdList': [StringElement('10.1016/S0140-6736(21)00897-7', attributes={'IdType': 'doi'}), StringElement('PMC8121538', attributes={'IdType': 'pmc'}), StringElement('34000257', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Estcourt L, Callum J. Convalescent plasma for covid-19 - making sense of the inconsistencies. N Engl J Med (2022) 386(18):1753–4. doi: 10.1056/NEJMe2204332', 'ArticleIdList': [StringElement('10.1056/NEJMe2204332', attributes={'IdType': 'doi'}), StringElement('PMC9093717', attributes={'IdType': 'pmc'}), StringElement('35507487', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Jones BE, Brown-Augsburger PL, Corbett KS, Westendorf K, Davies J, Cujec TP, et al. . The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci Transl Med (2021) 13(593):eabf1906. doi:\\xa010.1126/scitranslmed.abf1906', 'ArticleIdList': [StringElement('10.1126/scitranslmed.abf1906', attributes={'IdType': 'doi'}), StringElement('PMC8284311', attributes={'IdType': 'pmc'}), StringElement('33820835', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Matz AJ, Qu L, Karlinsey K, Zhou B. MicroRNA-regulated b cells in obesity. Immunometabolism (Cobham) (2022) 4(3):e00005. doi: 10.1097/IN9.0000000000000005', 'ArticleIdList': [StringElement('10.1097/IN9.0000000000000005', attributes={'IdType': 'doi'}), StringElement('PMC9359068', attributes={'IdType': 'pmc'}), StringElement('35966635', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, et al. . SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with covid-19. N Engl J Med (2021) 384(3):229–37. doi: 10.1056/NEJMoa2029849', 'ArticleIdList': [StringElement('10.1056/NEJMoa2029849', attributes={'IdType': 'doi'}), StringElement('PMC7646625', attributes={'IdType': 'pmc'}), StringElement('33113295', attributes={'IdType': 'pubmed'})]}, {'Citation': 'ACTIV-3/TICO LY-CoV555 Study Group. Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, et al. . A neutralizing monoclonal antibody for hospitalized patients with covid-19. N Engl J Med (2021) 384(10):905–14. doi:\\xa010.1056/NEJMoa2033130', 'ArticleIdList': [StringElement('10.1056/NEJMoa2033130', attributes={'IdType': 'doi'}), StringElement('PMC7781100', attributes={'IdType': 'pmc'}), StringElement('33356051', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Matz A, Qu L, Karlinsey K, Zhou B. Impact of microRNA regulated macrophage actions on adipose tissue function in obesity. Cells (2022) 11(8):1336. doi: 10.3390/cells11081336', 'ArticleIdList': [StringElement('10.3390/cells11081336', attributes={'IdType': 'doi'}), StringElement('PMC9024513', attributes={'IdType': 'pmc'}), StringElement('35456015', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Qu L, Matz AJ, Karlinsey K, Cao Z, Vella AT, Zhou B, et al. . Macrophages at the crossroad of meta-inflammation and inflammaging. Genes (Basel) (2022) 13(11):2074. doi: 10.3390/genes13112074', 'ArticleIdList': [StringElement('10.3390/genes13112074', attributes={'IdType': 'doi'}), StringElement('PMC9690997', attributes={'IdType': 'pmc'}), StringElement('36360310', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Gottlieb RL, Nirula A, Chen P, Boscia J, Heller B, Morris J, et al. . Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: A randomized clinical trial. JAMA (2021) 325(7):632–44. doi: 10.1001/jama.2021.0202', 'ArticleIdList': [StringElement('10.1001/jama.2021.0202', attributes={'IdType': 'doi'}), StringElement('PMC7821080', attributes={'IdType': 'pmc'}), StringElement('33475701', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Karlinsey K, Qu L, Matz AJ, Zhou B. A novel strategy to dissect multifaceted macrophage function in human diseases. J Leukoc Biol (2022) 112(6):1535–42. doi: 10.1002/JLB.6MR0522-685R', 'ArticleIdList': [StringElement('10.1002/JLB.6MR0522-685R', attributes={'IdType': 'doi'}), StringElement('35726704', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, et al. . Bamlanivimab plus etesevimab in mild or moderate covid-19. N Engl J Med (2021) 385(15):1382–92. doi: 10.1056/NEJMoa2102685', 'ArticleIdList': [StringElement('10.1056/NEJMoa2102685', attributes={'IdType': 'doi'}), StringElement('PMC8314785', attributes={'IdType': 'pmc'}), StringElement('34260849', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li C, Phoon YP, Karlinsey K, Tian YF, Thapaliya S, Thongkum A, et al. . A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients. J Exp Med (2022) 219(1):e20202084. doi: 10.1084/jem.20202084', 'ArticleIdList': [StringElement('10.1084/jem.20202084', attributes={'IdType': 'doi'}), StringElement('PMC8611729', attributes={'IdType': 'pmc'}), StringElement('34807232', attributes={'IdType': 'pubmed'})]}, {'Citation': 'VanBlargan LA, Errico JM, Halfmann PJ, Zost SJ, Crowe JE, Jr, Purcell LA, et al. . An infectious SARS-CoV-2 B.1.1.529 omicron virus escapes neutralization by therapeutic monoclonal antibodies. Nat Med (2022) 28(3):490–5. doi:\\xa010.1038/s41591-021-01678-y', 'ArticleIdList': [StringElement('10.1038/s41591-021-01678-y', attributes={'IdType': 'doi'}), StringElement('PMC8767531', attributes={'IdType': 'pmc'}), StringElement('35046573', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, et al. . Antibody evasion properties of SARS-CoV-2 omicron sublineages. Nature (2022) 604(7906):553–6. doi: 10.1038/s41586-022-04594-4', 'ArticleIdList': [StringElement('10.1038/s41586-022-04594-4', attributes={'IdType': 'doi'}), StringElement('PMC9021018', attributes={'IdType': 'pmc'}), StringElement('35240676', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li C, Qu L, Matz AJ, Murphy PA, Liu Y, Manichaikul AW, et al. . AtheroSpectrum reveals novel macrophage foam cell gene signatures associated with atherosclerotic cardiovascular disease risk. Circulation (2022) 145(3):206–18. doi: 10.1161/CIRCULATIONAHA.121.054285', 'ArticleIdList': [StringElement('10.1161/CIRCULATIONAHA.121.054285', attributes={'IdType': 'doi'}), StringElement('PMC8766929', attributes={'IdType': 'pmc'}), StringElement('34913723', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Westendorf K, Zentelis S, Wang L, Foster D, Vaillancourt P, Wiggin M, et al. . LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. Cell Rep (2022) 39(7):110812. doi: 10.1016/j.celrep.2022.110812', 'ArticleIdList': [StringElement('10.1016/j.celrep.2022.110812', attributes={'IdType': 'doi'}), StringElement('PMC9035363', attributes={'IdType': 'pmc'}), StringElement('35568025', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li C, Qu L, Farragher C, Vella A, Zhou B. MicroRNA regulated macrophage activation in obesity. J Transl Int Med (2019) 7(2):46–52. doi: 10.2478/jtim-2019-0011', 'ArticleIdList': [StringElement('10.2478/jtim-2019-0011', attributes={'IdType': 'doi'}), StringElement('PMC6661877', attributes={'IdType': 'pmc'}), StringElement('31380236', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wang Q, Guo Y, Iketani S, Nair MS, Li Z, Mohri H, et al. . Antibody evasion by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature (2022) 608(7923):603–8. doi:\\xa010.1038/s41586-022-05053-w', 'ArticleIdList': [StringElement('10.1038/s41586-022-05053-w', attributes={'IdType': 'doi'}), StringElement('PMC9385487', attributes={'IdType': 'pmc'}), StringElement('35790190', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Qu LL, Yu B, Li Z, Jiang WX, Jiang JD, Kong WJ. Gastrodin ameliorates oxidative stress and proinflammatory response in nonalcoholic fatty liver disease through the AMPK/Nrf2 pathway. Phytother Res (2016) 30(3):402–11. doi: 10.1002/ptr.5541', 'ArticleIdList': [StringElement('10.1002/ptr.5541', attributes={'IdType': 'doi'}), StringElement('26634892', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hoang TN, Pino M, Boddapati AK, Viox EG, Starke CE, Upadhyay AA, et al. . Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques. Cell (2021) 184(2):460–475 e21. doi: 10.1016/j.cell.2020.11.007', 'ArticleIdList': [StringElement('10.1016/j.cell.2020.11.007', attributes={'IdType': 'doi'}), StringElement('PMC7654323', attributes={'IdType': 'pmc'}), StringElement('33278358', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Duan X, Li S, Holmes JA, Tu Z, Li Y, Cai D, et al. . MicroRNA 130a regulates both hepatitis c virus and hepatitis b virus replication through a central metabolic pathway. J Virol (2018) 92(7):e02009-17. doi: 10.1128/JVI.02009-17', 'ArticleIdList': [StringElement('10.1128/JVI.02009-17', attributes={'IdType': 'doi'}), StringElement('PMC5972888', attributes={'IdType': 'pmc'}), StringElement('29321333', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Chen X, Ye H, Li S, Jiao B, Wu J, Zeng P, et al. . Severe fever with thrombocytopenia syndrome virus inhibits exogenous type I IFN signaling pathway through its NSs invitro. PloS One (2017) 12(2):e0172744. doi: 10.1371/journal.pone.0172744', 'ArticleIdList': [StringElement('10.1371/journal.pone.0172744', attributes={'IdType': 'doi'}), StringElement('PMC5325526', attributes={'IdType': 'pmc'}), StringElement('28234991', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hu X, Li J, Fu M, Zhao X, Wang W. The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther (2021) 6(1):402. doi: 10.1038/s41392-021-00791-1', 'ArticleIdList': [StringElement('10.1038/s41392-021-00791-1', attributes={'IdType': 'doi'}), StringElement('PMC8617206', attributes={'IdType': 'pmc'}), StringElement('34824210', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Jiao B, Shi X, Chen Y, Ye H, Yao M, Hong W, et al. . Insulin receptor substrate-4 interacts with ubiquitin-specific protease 18 to activate the Jak/STAT signaling pathway. Oncotarget (2017) 8(62):105923–35. doi: 10.18632/oncotarget.22510', 'ArticleIdList': [StringElement('10.18632/oncotarget.22510', attributes={'IdType': 'doi'}), StringElement('PMC5739690', attributes={'IdType': 'pmc'}), StringElement('29285303', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Shi X, Jiao B, Chen Y, Li S, Chen L. MxA is a positive regulator of type I IFN signaling in HCV infection. J Med Virol (2017) 89(12):2173–80. doi: 10.1002/jmv.24867', 'ArticleIdList': [StringElement('10.1002/jmv.24867', attributes={'IdType': 'doi'}), StringElement('28561372', attributes={'IdType': 'pubmed'})]}, {'Citation': \"Villarino AV, Gadina M, O'Shea JJ, Kanno Y. SnapShot: Jak-STAT signaling II. Cell (2020) 181(7):1696–1696 e1. doi: 10.1016/j.cell.2020.04.052\", 'ArticleIdList': [StringElement('10.1016/j.cell.2020.04.052', attributes={'IdType': 'doi'}), StringElement('32589961', attributes={'IdType': 'pubmed'})]}, {'Citation': 'O’Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med (2015) 66:311–28. doi: 10.1146/annurev-med-051113-024537', 'ArticleIdList': [StringElement('10.1146/annurev-med-051113-024537', attributes={'IdType': 'doi'}), StringElement('PMC5634336', attributes={'IdType': 'pmc'}), StringElement('25587654', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li Y, Li S, Duan X, Chen Y, Jiao B, Ye H, et al. . Interferon-stimulated gene 15 conjugation stimulates hepatitis b virus production independent of type I interferon signaling pathway in vitro. Mediators Inflammation (2016) 2016:7417648. doi: 10.1155/2016/7417648', 'ArticleIdList': [StringElement('10.1155/2016/7417648', attributes={'IdType': 'doi'}), StringElement('PMC5102744', attributes={'IdType': 'pmc'}), StringElement('27867263', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Chen Y, Jiao B, Yao M, Shi X, Zheng Z, Li S, et al. . ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-alpha through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis. Virus Res (2017) 227:231–9. doi: 10.1016/j.virusres.2016.10.013', 'ArticleIdList': [StringElement('10.1016/j.virusres.2016.10.013', attributes={'IdType': 'doi'}), StringElement('27777077', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Jiao B, An C, Du H, Tran M, Wang P, Zhou D, et al. . STAT6 deficiency attenuates myeloid fibroblast activation and macrophage polarization in experimental folic acid nephropathy. Cells (2021) 10(11):3057. doi: 10.3390/cells10113057', 'ArticleIdList': [StringElement('10.3390/cells10113057', attributes={'IdType': 'doi'}), StringElement('PMC8623460', attributes={'IdType': 'pmc'}), StringElement('34831280', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM. JAK-STAT signaling as a target for inflammatory and autoimmune diseases: Current and future prospects. Drugs (2017) 77(5):521–46. doi: 10.1007/s40265-017-0701-9', 'ArticleIdList': [StringElement('10.1007/s40265-017-0701-9', attributes={'IdType': 'doi'}), StringElement('PMC7102286', attributes={'IdType': 'pmc'}), StringElement('28255960', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Villarino AV, Kanno Y, O’Shea JJ. Mechanisms and consequences of jak-STAT signaling in the immune system. Nat Immunol (2017) 18(4):374–84. doi: 10.1038/ni.3691', 'ArticleIdList': [StringElement('10.1038/ni.3691', attributes={'IdType': 'doi'}), StringElement('28323260', attributes={'IdType': 'pubmed'})]}, {'Citation': 'O’Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity (2012) 36(4):542–50. doi: 10.1016/j.immuni.2012.03.014', 'ArticleIdList': [StringElement('10.1016/j.immuni.2012.03.014', attributes={'IdType': 'doi'}), StringElement('PMC3499974', attributes={'IdType': 'pmc'}), StringElement('22520847', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Jiao B, An C, Tran M, Du H, Wang P, Zhou D, et al. . Pharmacological inhibition of STAT6 ameliorates myeloid fibroblast activation and alternative macrophage polarization in renal fibrosis. Front Immunol (2021) 12:735014. doi: 10.3389/fimmu.2021.735014', 'ArticleIdList': [StringElement('10.3389/fimmu.2021.735014', attributes={'IdType': 'doi'}), StringElement('PMC8426438', attributes={'IdType': 'pmc'}), StringElement('34512669', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Lin CM, Cooles FA, Isaacs JD. Basic mechanisms of JAK inhibition. Mediterr J Rheumatol (2020) 31(Suppl 1):100–4. doi: 10.31138/mjr.31.1.100', 'ArticleIdList': [StringElement('10.31138/mjr.31.1.100', attributes={'IdType': 'doi'}), StringElement('PMC7361186', attributes={'IdType': 'pmc'}), StringElement('32676567', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zarrin AA, Bao K, Lupardus P, Vucic D. Kinase inhibition in autoimmunity and inflammation. Nat Rev Drug Discovery (2021) 20(1):39–63. doi: 10.1038/s41573-020-0082-8', 'ArticleIdList': [StringElement('10.1038/s41573-020-0082-8', attributes={'IdType': 'doi'}), StringElement('PMC7569567', attributes={'IdType': 'pmc'}), StringElement('33077936', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Baldini C, Moriconi FR, Galimberti S, Libby P, De Caterina R. The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms. Eur Heart J (2021) 42(42):4389–400. doi: 10.1093/eurheartj/ehab447', 'ArticleIdList': [StringElement('10.1093/eurheartj/ehab447', attributes={'IdType': 'doi'}), StringElement('PMC8572559', attributes={'IdType': 'pmc'}), StringElement('34343257', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wolfe L. Ruxolitinib in myelofibrosis and polycythemia Vera. J Adv Pract Oncol (2016) 7(4):436–44.', 'ArticleIdList': [StringElement('PMC5679032', attributes={'IdType': 'pmc'}), StringElement('29226001', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Sorensen AL, Mikkelsen SU, Knudsen TA, Bjorn ME, Andersen CL, Bjerrum OW, et al. . Ruxolitinib and interferon-alpha2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study. Haematologica (2020) 105(9):2262–72. doi: 10.3324/haematol.2019.235648', 'ArticleIdList': [StringElement('10.3324/haematol.2019.235648', attributes={'IdType': 'doi'}), StringElement('PMC7556624', attributes={'IdType': 'pmc'}), StringElement('33054051', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Alvarez-Larran A, Garrote M, Ferrer-Marin F, Perez-Encinas M, Mata-Vazquez MI, Bellosillo B, et al. . Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. Cancer (2022) 128(13):2441–8. doi: 10.1002/cncr.34195', 'ArticleIdList': [StringElement('10.1002/cncr.34195', attributes={'IdType': 'doi'}), StringElement('PMC9324831', attributes={'IdType': 'pmc'}), StringElement('35417564', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Shrock E, Fujimura E, Kula T, Timms RT, Lee IH, Leng Y, et al. . Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science (2020) 370(6520):eabd4250. doi: 10.1126/science.abd4250', 'ArticleIdList': [StringElement('10.1126/science.abd4250', attributes={'IdType': 'doi'}), StringElement('PMC7857405', attributes={'IdType': 'pmc'}), StringElement('32994364', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol (2021) 21(4):245–56. doi: 10.1038/s41577-021-00522-1', 'ArticleIdList': [StringElement('10.1038/s41577-021-00522-1', attributes={'IdType': 'doi'}), StringElement('PMC7958099', attributes={'IdType': 'pmc'}), StringElement('33723416', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, et al. . The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The perspectives of clinical immunologists from China. Clin Immunol (2020) 214:108393. doi: 10.1016/j.clim.2020.108393', 'ArticleIdList': [StringElement('10.1016/j.clim.2020.108393', attributes={'IdType': 'doi'}), StringElement('PMC7102614', attributes={'IdType': 'pmc'}), StringElement('32222466', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Smolen JS, Landewe RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, et al. . EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis (2020) 79(6):685–99. doi: 10.1136/annrheumdis-2019-216655', 'ArticleIdList': [StringElement('10.1136/annrheumdis-2019-216655', attributes={'IdType': 'doi'}), StringElement('31969328', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, et al. . Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis (2020) 79(6):744–59. doi: 10.1136/annrheumdis-2019-216656', 'ArticleIdList': [StringElement('10.1136/annrheumdis-2019-216656', attributes={'IdType': 'doi'}), StringElement('PMC7286044', attributes={'IdType': 'pmc'}), StringElement('32033937', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, et al. . COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis (2020) 20(4):400–2. doi: 10.1016/S1473-3099(20)30132-8', 'ArticleIdList': [StringElement('10.1016/S1473-3099(20)30132-8', attributes={'IdType': 'doi'}), StringElement('PMC7158903', attributes={'IdType': 'pmc'}), StringElement('32113509', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, et al. . Repurposed immunomodulatory drugs for covid-19 in pre-ICu patients - mulTi-arm therapeutic study in pre-ICu patients admitted with covid-19 - repurposed drugs (TACTIC-r): A structured summary of a study protocol for a randomised controlled trial. Trials (2020) 21(1):626. doi: 10.1186/s13063-020-04535-4', 'ArticleIdList': [StringElement('10.1186/s13063-020-04535-4', attributes={'IdType': 'doi'}), StringElement('PMC7341462', attributes={'IdType': 'pmc'}), StringElement('32641154', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Moreno-Gonzalez G, Mussetti A, Albasanz-Puig A, Salvador I, Sureda A, Gudiol C, et al. . A phase I/II clinical trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Trials (2021) 22(1):116. doi: 10.1186/s13063-021-05072-4', 'ArticleIdList': [StringElement('10.1186/s13063-021-05072-4', attributes={'IdType': 'doi'}), StringElement('PMC7862837', attributes={'IdType': 'pmc'}), StringElement('33546739', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Bronte V, Ugel S, Tinazzi E, Vella A, De Sanctis F, Cane S, et al. . Baricitinib restrains the immune dysregulation in patients with severe COVID-19. J Clin Invest (2020) 130(12):6409–16. doi: 10.1172/JCI141772', 'ArticleIdList': [StringElement('10.1172/JCI141772', attributes={'IdType': 'doi'}), StringElement('PMC8016181', attributes={'IdType': 'pmc'}), StringElement('32809969', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Patoulias D, Doumas M, Papadopoulos C, Karagiannis A. Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of janus! a meta-analysis of randomized controlled trials. Clin Rheumatol (2021) 40(11):4671–4. doi: 10.1007/s10067-021-05884-4', 'ArticleIdList': [StringElement('10.1007/s10067-021-05884-4', attributes={'IdType': 'doi'}), StringElement('PMC8384394', attributes={'IdType': 'pmc'}), StringElement('34431004', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ely EW, Ramanan AV, Kartman CE, de Bono S, Liao R, Piruzeli MLB, et al. . Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial. Lancet Respir Med (2022) 10(4):327–36. doi: 10.1016/S2213-2600(22)00006-6', 'ArticleIdList': [StringElement('10.1016/S2213-2600(22)00006-6', attributes={'IdType': 'doi'}), StringElement('PMC8813065', attributes={'IdType': 'pmc'}), StringElement('35123660', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Stebbing J, Sánchez Nievas G, Falcone M, Youhanna S, Richardson P, Ottaviani S, et al. . JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv (2021) 7(1):eabe4724. doi: 10.1126/sciadv.abe4724', 'ArticleIdList': [StringElement('10.1126/sciadv.abe4724', attributes={'IdType': 'doi'}), StringElement('PMC7775747', attributes={'IdType': 'pmc'}), StringElement('33187978', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Abizanda P, Calbo Mayo JM, Mas Romero M, Cortes Zamora EB, Tabernero Sahuquillo MT, Romero Rizos L, et al. . Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia. J Am Geriatr Soc (2021) 69(10):2752–8. doi: 10.1111/jgs.17357', 'ArticleIdList': [StringElement('10.1111/jgs.17357', attributes={'IdType': 'doi'}), StringElement('PMC8447356', attributes={'IdType': 'pmc'}), StringElement('34235720', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Chen CY, Chen WC, Hsu CK, Chao CM, Lai CC. Clinical efficacy and safety of janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials. Int Immunopharmacol (2021) 99:108027. doi: 10.1016/j.intimp.2021.108027', 'ArticleIdList': [StringElement('10.1016/j.intimp.2021.108027', attributes={'IdType': 'doi'}), StringElement('PMC8324418', attributes={'IdType': 'pmc'}), StringElement('34343937', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Pillaiyar T, Laufer S. Kinases as potential therapeutic targets for anti-coronaviral therapy. J Med Chem (2022) 65(2):955–82. doi: 10.1021/acs.jmedchem.1c00335', 'ArticleIdList': [StringElement('10.1021/acs.jmedchem.1c00335', attributes={'IdType': 'doi'}), StringElement('34081439', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mease P, Hall S, FitzGerald O, van der Heijde D, Merola JF, Avila-Zapata F, et al. . Tofacitinib or adalimumab versus placebo for psoriatic arthritis. N Engl J Med (2017) 377(16):1537–50. doi: 10.1056/NEJMoa1615975', 'ArticleIdList': [StringElement('10.1056/NEJMoa1615975', attributes={'IdType': 'doi'}), StringElement('29045212', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Dhillon S. Tofacitinib: A review in rheumatoid arthritis. Drugs (2017) 77(18):1987–2001. doi: 10.1007/s40265-017-0835-9', 'ArticleIdList': [StringElement('10.1007/s40265-017-0835-9', attributes={'IdType': 'doi'}), StringElement('29139090', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wollenhaupt J, Lee EB, Curtis JR, Silverfield J, Terry K, Soma K, et al. . Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study. Arthritis Res Ther (2019) 21(1):89. doi:\\xa010.1186/s13075-019-1866-2', 'ArticleIdList': [StringElement('10.1186/s13075-019-1866-2', attributes={'IdType': 'doi'}), StringElement('PMC6451219', attributes={'IdType': 'pmc'}), StringElement('30953540', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Guimaraes PO, Quirk D, Furtado RH, Maia LN, Saraiva JF, Antunes MO, et al. . Tofacitinib in patients hospitalized with covid-19 pneumonia. N Engl J Med (2021) 385(5):406–15. doi: 10.1056/NEJMoa2101643', 'ArticleIdList': [StringElement('10.1056/NEJMoa2101643', attributes={'IdType': 'doi'}), StringElement('PMC8220898', attributes={'IdType': 'pmc'}), StringElement('34133856', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Maslennikov R, Ivashkin V, Vasilieva E, Chipurik M, Semikova P, Semenets V, et al. . Tofacitinib reduces mortality in coronavirus disease 2019 tofacitinib in COVID-19. Pulm Pharmacol Ther (2021) 69:102039. doi: 10.1016/j.pupt.2021.102039', 'ArticleIdList': [StringElement('10.1016/j.pupt.2021.102039', attributes={'IdType': 'doi'}), StringElement('PMC8137353', attributes={'IdType': 'pmc'}), StringElement('34023513', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yan B, Freiwald T, Chauss D, Wang L, West E, Mirabelli C, et al. . SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation. Sci Immunol (2021) 6(58):eabg0833. doi: 10.1126/sciimmunol.abg0833', 'ArticleIdList': [StringElement('10.1126/sciimmunol.abg0833', attributes={'IdType': 'doi'}), StringElement('PMC8139422', attributes={'IdType': 'pmc'}), StringElement('33827897', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Verstovsek S, Mesa RA, Gotlib J, Levy RS, Gupta V, DiPersio JF, et al. . A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N Engl J Med (2012) 366(9):799–807. doi: 10.1056/NEJMoa1110557', 'ArticleIdList': [StringElement('10.1056/NEJMoa1110557', attributes={'IdType': 'doi'}), StringElement('PMC4822164', attributes={'IdType': 'pmc'}), StringElement('22375971', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mascarenhas J, Hoffman R, Talpaz M, Gerds AT, Stein B, Gupta V, et al. . Pacritinib vs best available therapy, including ruxolitinib, in patients with myelofibrosis: A randomized clinical trial. JAMA Oncol (2018) 4(5):652–9. doi: 10.1001/jamaoncol.2017.5818', 'ArticleIdList': [StringElement('10.1001/jamaoncol.2017.5818', attributes={'IdType': 'doi'}), StringElement('PMC5885169', attributes={'IdType': 'pmc'}), StringElement('29522138', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Vannucchi AM, Kiladjian JJ, Griesshammer M, Masszi T, Durrant S, Passamonti F, et al. . Ruxolitinib versus standard therapy for the treatment of polycythemia vera. N Engl J Med (2015) 372(5):426–35. doi: 10.1056/NEJMoa1409002', 'ArticleIdList': [StringElement('10.1056/NEJMoa1409002', attributes={'IdType': 'doi'}), StringElement('PMC4358820', attributes={'IdType': 'pmc'}), StringElement('25629741', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, et al. . Ruxolitinib for glucocorticoid-refractory acute graft-versus-Host disease. N Engl J Med (2020) 382(19):1800–10. doi: 10.1056/NEJMoa1917635', 'ArticleIdList': [StringElement('10.1056/NEJMoa1917635', attributes={'IdType': 'doi'}), StringElement('32320566', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Gratwohl A. Ruxolitinib for acute graft-versus-Host disease. N Engl J Med (2020) 383(5):501–2. doi:\\xa010.1056/NEJMc2020763', 'ArticleIdList': [StringElement('10.1056/NEJMc2020763', attributes={'IdType': 'doi'}), StringElement('32726541', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang Q, Zhao YZ, Ma HH, Wang D, Cui L, Li WJ, et al. . A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis. Blood (2022) 139(24):3493–504. doi: 10.1182/blood.2021014860', 'ArticleIdList': [StringElement('10.1182/blood.2021014860', attributes={'IdType': 'doi'}), StringElement('35344583', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Marconi VC, Moser C, Gavegnano C, Deeks SG, Lederman MM, Overton ET, et al. . Randomized trial of ruxolitinib in antiretroviral-treated adults with human immunodeficiency virus. Clin Infect Dis (2022) 74(1):95–104. doi: 10.1093/cid/ciab212', 'ArticleIdList': [StringElement('10.1093/cid/ciab212', attributes={'IdType': 'doi'}), StringElement('PMC8752257', attributes={'IdType': 'pmc'}), StringElement('33693561', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Han MK, Antila M, Ficker JH, Gordeev I, Guerreros A, Bernus AL, et al. . Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Rheumatol (2022) 4(5):e351–61. doi: 10.1016/S2665-9913(22)00044-3', 'ArticleIdList': [StringElement('10.1016/S2665-9913(22)00044-3', attributes={'IdType': 'doi'}), StringElement('PMC8963773', attributes={'IdType': 'pmc'}), StringElement('35368384', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Levy G, Guglielmelli P, Langmuir P, Constantinescu SN. JAK inhibitors and COVID-19. J Immunother Cancer (2022) 10(4):e002838. doi: 10.1136/jitc-2021-002838', 'ArticleIdList': [StringElement('10.1136/jitc-2021-002838', attributes={'IdType': 'doi'}), StringElement('PMC9035837', attributes={'IdType': 'pmc'}), StringElement('35459733', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Cao Y, Wei J, Zou L, Jiang T, Wang G, Chen L, et al. . Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol (2020) 146(1):137–146 e3. doi: 10.1016/j.jaci.2020.05.019', 'ArticleIdList': [StringElement('10.1016/j.jaci.2020.05.019', attributes={'IdType': 'doi'}), StringElement('PMC7250105', attributes={'IdType': 'pmc'}), StringElement('32470486', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Singh D, Bogus M, Moskalenko V, Lord R, Moran EJ, Crater GD, et al. . A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19. Eur Respir J (2021) 58(4):2100673. doi: 10.1183/13993003.00673-2021', 'ArticleIdList': [StringElement('10.1183/13993003.00673-2021', attributes={'IdType': 'doi'}), StringElement('PMC8859971', attributes={'IdType': 'pmc'}), StringElement('34210790', attributes={'IdType': 'pubmed'})]}, {'Citation': 'WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, et al. . Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis. JAMA (2020) 324(13):1330–41. doi:\\xa010.1001/jama.2020.17023', 'ArticleIdList': [StringElement('10.1001/jama.2020.17023', attributes={'IdType': 'doi'}), StringElement('PMC7489434', attributes={'IdType': 'pmc'}), StringElement('32876694', attributes={'IdType': 'pubmed'})]}, {'Citation': 'RECOVERY Collaborative Group. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. . Dexamethasone in hospitalized patients with covid-19. N Engl J Med (2021) 384(8):693–704. doi:\\xa010.1056/NEJMoa2021436', 'ArticleIdList': [StringElement('10.1056/NEJMoa2021436', attributes={'IdType': 'doi'}), StringElement('PMC7383595', attributes={'IdType': 'pmc'}), StringElement('32678530', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. . Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: The CoDEX randomized clinical trial. JAMA (2020) 324(13):1307–16. doi: 10.1001/jama.2020.17021', 'ArticleIdList': [StringElement('10.1001/jama.2020.17021', attributes={'IdType': 'doi'}), StringElement('PMC7489411', attributes={'IdType': 'pmc'}), StringElement('32876695', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Granholm A, Kjaer MN, Munch MW, Myatra SN, Vijayaraghavan BKT, Cronhjort M, et al. . Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia. Intensive Care Med (2022) 48(5):580–9. doi: 10.1007/s00134-022-06677-2', 'ArticleIdList': [StringElement('10.1007/s00134-022-06677-2', attributes={'IdType': 'doi'}), StringElement('PMC8970069', attributes={'IdType': 'pmc'}), StringElement('35359168', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Incorrect equivalent dose and p values in figure 3. JAMA (2022) 327(3):286. doi:\\xa010.1001/jama.2021.24153', 'ArticleIdList': [StringElement('10.1001/jama.2021.24153', attributes={'IdType': 'doi'}), StringElement('PMC8767435', attributes={'IdType': 'pmc'}), StringElement('35040905', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Granholm A, Munch MW, Myatra SN, Vijayaraghavan BKT, Cronhjort M, Wahlin RR, et al. . Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial. Intensive Care Med (2022) 48(1):45–55. doi: 10.1007/s00134-021-06573-1', 'ArticleIdList': [StringElement('10.1007/s00134-021-06573-1', attributes={'IdType': 'doi'}), StringElement('PMC8579417', attributes={'IdType': 'pmc'}), StringElement('34757439', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Taboada M, Rodríguez N, Varela PM, Rodríguez MT, Abelleira R, González A, et al. . Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trial. Eur Respir J (2022) 60(2):2102518. doi: 10.1183/13993003.02518-2021', 'ArticleIdList': [StringElement('10.1183/13993003.02518-2021', attributes={'IdType': 'doi'}), StringElement('PMC8678498', attributes={'IdType': 'pmc'}), StringElement('34916266', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Agusti A, De Stefano G, Levi A, Muñoz X, Romero-Mesones C, Sibila O, et al. . Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial. Eur Respir J (2022) 59(3):2103036. doi: 10.1183/13993003.03036-2021', 'ArticleIdList': [StringElement('10.1183/13993003.03036-2021', attributes={'IdType': 'doi'}), StringElement('PMC8832375', attributes={'IdType': 'pmc'}), StringElement('35144989', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yu LM, Bafadhel M, Dorward J, Hayward G, Saville BR, Gbinigie O, et al. . Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet (2021) 398(10303):843–55. doi: 10.1016/S0140-6736(21)01744-X', 'ArticleIdList': [StringElement('10.1016/S0140-6736(21)01744-X', attributes={'IdType': 'doi'}), StringElement('PMC8354567', attributes={'IdType': 'pmc'}), StringElement('34388395', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ramakrishnan S, Nicolau DV, Jr, Langford B, Mahdi M, Jeffers H, Mwasuku C, et al. et al. . Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med (2021) 9(7):763–72. doi: 10.1016/S2213-2600(21)00160-0', 'ArticleIdList': [StringElement('10.1016/S2213-2600(21)00160-0', attributes={'IdType': 'doi'}), StringElement('PMC8040526', attributes={'IdType': 'pmc'}), StringElement('33844996', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Baker JR, Mahdi M, Nicolau DV, Jr, Ramakrishnan S, Barnes PJ, Simpson JL, et al. . Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis. Lancet Respir Med (2022) 10(6):545–56. doi: 10.1016/S2213-2600(22)00002-9', 'ArticleIdList': [StringElement('10.1016/S2213-2600(22)00002-9', attributes={'IdType': 'doi'}), StringElement('PMC8989397', attributes={'IdType': 'pmc'}), StringElement('35397798', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ezer N, Belga S, Daneman N, Chan A, Smith BM, Daniels SA, et al. . Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial. BMJ (2021) 375:e068060. doi: 10.1136/bmj-2021-068060', 'ArticleIdList': [StringElement('10.1136/bmj-2021-068060', attributes={'IdType': 'doi'}), StringElement('PMC8561042', attributes={'IdType': 'pmc'}), StringElement('34728476', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Clemency BM, Varughese R, Gonzalez-Rojas Y, Morse CG, Phipatanakul W, Koster DJ, et al. . Efficacy of inhaled ciclesonide for outpatient treatment of adolescents and adults with symptomatic COVID-19: A randomized clinical trial. JAMA Intern Med (2022) 182(1):42–9. doi: 10.1001/jamainternmed.2021.6759', 'ArticleIdList': [StringElement('10.1001/jamainternmed.2021.6759', attributes={'IdType': 'doi'}), StringElement('PMC8609464', attributes={'IdType': 'pmc'}), StringElement('34807241', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, et al. . Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: The REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA (2020) 324(13):1317–29. doi:\\xa010.1001/jama.2020.17022', 'ArticleIdList': [StringElement('10.1001/jama.2020.17022', attributes={'IdType': 'doi'}), StringElement('PMC7489418', attributes={'IdType': 'pmc'}), StringElement('32876697', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Edalatifard M, Akhtari M, Salehi M, Naderi Z, Jamshidi A, Mostafaei S, et al. . Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J (2020) 56(6):2002808. doi: 10.1183/13993003.02808-2020', 'ArticleIdList': [StringElement('10.1183/13993003.02808-2020', attributes={'IdType': 'doi'}), StringElement('PMC7758541', attributes={'IdType': 'pmc'}), StringElement('32943404', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Dhooria S, Chaudhary S, Sehgal IS, Agarwal R, Arora S, Garg M, et al. . High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial). Eur Respir J (2022) 59(2):2102930. doi: 10.1183/13993003.02930-2021', 'ArticleIdList': [StringElement('10.1183/13993003.02930-2021', attributes={'IdType': 'doi'}), StringElement('PMC8850687', attributes={'IdType': 'pmc'}), StringElement('34887325', attributes={'IdType': 'pubmed'})]}]}], 'History': [DictElement({'Year': '2022', 'Month': '12', 'Day': '16'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2023', 'Month': '1', 'Day': '3'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2023', 'Month': '2', 'Day': '13', 'Hour': '3', 'Minute': '26'}, attributes={'PubStatus': 'entrez'}), DictElement({'Year': '2023', 'Month': '2', 'Day': '14', 'Hour': '6', 'Minute': '0'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2023', 'Month': '2', 'Day': '15', 'Hour': '6', 'Minute': '0'}, attributes={'PubStatus': 'medline'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('36776881', attributes={'IdType': 'pubmed'}), StringElement('PMC9909293', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2023.1125246', attributes={'IdType': 'doi'})]}}]}"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "article"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Extract MeSH terms from the article\n",
    "mesh_terms = []\n",
    "if isinstance(article, list) and len(article) > 0:\n",
    "    if 'MedlineCitation' in article[0] and 'MeshHeadingList' in article[0]['MedlineCitation']:\n",
    "        for mesh_heading in article[0]['MedlineCitation']['MeshHeadingList']:\n",
    "            if 'DescriptorName' in mesh_heading:\n",
    "                mesh_term = mesh_heading['DescriptorName']\n",
    "                # if mesh_term.attributes.get('UI') in formatted_mesh_ids:\n",
    "                #     mesh_terms.append((mesh_term.attributes['UI'], str(mesh_term)))\n",
    "\n",
    "pmid_mesh_info[pmid] = mesh_terms"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'36776881': []}"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pmid_mesh_info"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'PubmedBookArticle': [], 'PubmedArticle': [{'MedlineCitation': DictElement({'GeneralNote': [], 'SpaceFlightMission': [], 'CitationSubset': ['IM'], 'InvestigatorList': [], 'OtherAbstract': [], 'OtherID': [], 'KeywordList': [], 'PMID': StringElement('30325033', attributes={'Version': '1'}), 'DateCompleted': {'Year': '2019', 'Month': '04', 'Day': '09'}, 'DateRevised': {'Year': '2020', 'Month': '03', 'Day': '09'}, 'Article': DictElement({'Language': ['eng'], 'ELocationID': [StringElement('10.1111/trf.14901', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'ArticleDate': [DictElement({'Year': '2018', 'Month': '10', 'Day': '16'}, attributes={'DateType': 'Electronic'})], 'Journal': {'ISSN': StringElement('1537-2995', attributes={'IssnType': 'Electronic'}), 'JournalIssue': DictElement({'Volume': '58', 'Issue': '12', 'PubDate': {'Year': '2018', 'Month': 'Dec'}}, attributes={'CitedMedium': 'Internet'}), 'Title': 'Transfusion', 'ISOAbbreviation': 'Transfusion'}, 'ArticleTitle': 'Red blood cell mechanical sensitivity improves in patients with sickle cell disease undergoing chronic transfusion after prolonged, subhemolytic shear exposure.', 'Pagination': {'StartPage': '2788', 'EndPage': '2796', 'MedlinePgn': '2788-2796'}, 'Abstract': {'AbstractText': [StringElement('Sickle cell disease (SCD) is a genetically inherited hemoglobinopathy in which deoxygenated hemoglobin S polymerizes, leading to stiff red blood cells (RBCs) and inefficient microcirculatory blood flow. Transfusion therapy acts as primary and secondary prevention of ischemic stroke in SCD. Whether blood transfusion alters the mechanical sensitivity (MS) of RBCs to prolonged subhemolytic shear stress (shear) is unknown. We hypothesized that individuals with SCD undergoing chronic blood transfusion would have improved sensitivity to shear, compared with patients not undergoing transfusion therapy.', attributes={'Label': 'BACKGROUND'}), StringElement('Blood suspensions from individuals with SCD not receiving (n = 15) and receiving (n = 15) chronic simple transfusion were conditioned to shear (1, 4, 16, 32, and 64 Pa) for various durations (1, 4, 16, 32, and 64 sec), and then deformability of RBCs was immediately measured. Healthy young controls (n = 15) were included for reference. A surface mesh was interpolated using the data to determine the effect of blood transfusion on MS of RBCs.', attributes={'Label': 'STUDY DESIGN AND METHODS'}), StringElement('There was impaired RBC deformability to prolonged supraphysiologic shear in both SCD groups; however, MS improved in transfused patients when exposed to prolonged physiologic shear. Furthermore, in the transfused patients with SCD, the threshold above which subhemolytic damage occurs was similar to controls.', attributes={'Label': 'RESULTS'}), StringElement('We found that chronic transfusion therapy normalizes the MS threshold above which RBC subhemolytic damage occurs after prolonged shear exposure in SCD. An important and novel finding in transfused patients with SCD was the improvement in RBC deformability in response to prolonged shear exposure over the physiologic range.', attributes={'Label': 'CONCLUSION'})], 'CopyrightInformation': '© 2018 AABB.'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Menzies Health Institute Queensland, Griffith University, Queensland, Australia.'}], 'Identifier': [], 'LastName': 'Simmonds', 'ForeName': 'Michael J', 'Initials': 'MJ'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Division of Hematology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California, USA.\"}], 'Identifier': [], 'LastName': 'Suriany', 'ForeName': 'Silvie', 'Initials': 'S'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Division of Cardiology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California, USA.\"}], 'Identifier': [], 'LastName': 'Ponce', 'ForeName': 'Derek', 'Initials': 'D'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Division of Cardiology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California, USA.\"}, {'Identifier': [], 'Affiliation': 'Department of Physiology and Biophysics, University of Southern California Keck School of Medicine, Los Angeles, California, USA.'}], 'Identifier': [], 'LastName': 'Detterich', 'ForeName': 'Jon A', 'Initials': 'JA'}, attributes={'ValidYN': 'Y'})], attributes={'CompleteYN': 'Y'}), 'GrantList': ListElement([{'GrantID': 'K23 HL119627', 'Acronym': 'HL', 'Agency': 'NHLBI NIH HHS', 'Country': 'United States'}, {'GrantID': 'R03 HL138321', 'Acronym': 'HL', 'Agency': 'NHLBI NIH HHS', 'Country': 'United States'}, {'GrantID': 'U01 HL117718', 'Acronym': 'HL', 'Agency': 'NHLBI NIH HHS', 'Country': 'United States'}], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Clinical Trial', attributes={'UI': 'D016430'}), StringElement('Journal Article', attributes={'UI': 'D016428'}), StringElement('Multicenter Study', attributes={'UI': 'D016448'}), StringElement('Research Support, N.I.H., Extramural', attributes={'UI': 'D052061'}), StringElement(\"Research Support, Non-U.S. Gov't\", attributes={'UI': 'D013485'})]}, attributes={'PubModel': 'Print-Electronic'}), 'MedlineJournalInfo': {'Country': 'United States', 'MedlineTA': 'Transfusion', 'NlmUniqueID': '0417360', 'ISSNLinking': '0041-1132'}, 'MeshHeadingList': [{'QualifierName': [], 'DescriptorName': StringElement('Adolescent', attributes={'UI': 'D000293', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('Adult', attributes={'UI': 'D000328', 'MajorTopicYN': 'N'})}, {'QualifierName': [StringElement('blood', attributes={'UI': 'Q000097', 'MajorTopicYN': 'Y'}), StringElement('therapy', attributes={'UI': 'Q000628', 'MajorTopicYN': 'Y'})], 'DescriptorName': StringElement('Anemia, Sickle Cell', attributes={'UI': 'D000755', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('Child', attributes={'UI': 'D002648', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('Erythrocyte Transfusion', attributes={'UI': 'D017707', 'MajorTopicYN': 'Y'})}, {'QualifierName': [StringElement('metabolism', attributes={'UI': 'Q000378', 'MajorTopicYN': 'Y'}), StringElement('pathology', attributes={'UI': 'Q000473', 'MajorTopicYN': 'N'})], 'DescriptorName': StringElement('Erythrocytes', attributes={'UI': 'D004912', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('Female', attributes={'UI': 'D005260', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('Humans', attributes={'UI': 'D006801', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('Male', attributes={'UI': 'D008297', 'MajorTopicYN': 'N'})}, {'QualifierName': [], 'DescriptorName': StringElement('Shear Strength', attributes={'UI': 'D033081', 'MajorTopicYN': 'Y'})}], 'CoiStatement': 'Conflict of Interest Statement. All authors state that there are none to declare.'}, attributes={'Status': 'MEDLINE', 'Owner': 'NLM'}), 'PubmedData': {'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330: 1639–44.', 'ArticleIdList': [StringElement('7993409', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Itano HA, Pauling L. A rapid diagnostic test for sickle cell anemia. Blood 1949;4: 66–8.', 'ArticleIdList': [StringElement('18103217', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mozzarelli A, Hofrichter J, Eaton WA. Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo. Science 1987;237: 500–6.', 'ArticleIdList': [StringElement('3603036', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Coletta M, Hofrichter J, Ferrone FA, Eaton WA. Kinetics of sickle haemoglobin polymerization in single red cells. Nature 1982;300: 194–7.', 'ArticleIdList': [StringElement('7133139', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Dong C, Chadwick RS, Schechter AN. Influence of sickle hemoglobin polymerization and membrane properties on deformability of sickle erythrocytes in the microcirculation. Biophys J 1992;63: 774–83.', 'ArticleIdList': [StringElement('PMC1262210', attributes={'IdType': 'pmc'}), StringElement('1420913', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kuypers FA. Hemoglobin s polymerization and red cell membrane changes. Hematol Oncol Clin North Am 2014;28: 155–79.', 'ArticleIdList': [StringElement('24589260', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007;21: 37–47.', 'ArticleIdList': [StringElement('PMC2048670', attributes={'IdType': 'pmc'}), StringElement('17084951', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wun T, Hassell K. Best practices for transfusion for patients with sickle cell disease. Hematology Reviews 2009;1: e22.'}, {'Citation': 'Huruta RR, Barjas-Castro ML, Saad ST, Costa FF, Fontes A, Barbosa LC, Cesar CL. Mechanical properties of stored red blood cells using optical tweezers. Blood 1998;92: 2975–7.', 'ArticleIdList': [StringElement('9763588', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kirkpatrick UJ, Adams RA, Lardi A, McCollum CN. Rheological properties and function of blood cells in stored bank blood and salvaged blood. Br J Haematol 1998;101: 364–8.', 'ArticleIdList': [StringElement('9609536', attributes={'IdType': 'pubmed'})]}, {'Citation': 'La Celle PL. Alteration of deformability of the erythrocyte membrane in stored blood. Transfusion 1969;9: 238–45.', 'ArticleIdList': [StringElement('5822775', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Koutsiaris AG, Tachmitzi SV, Batis N. Wall shear stress quantification in the human conjunctival pre-capillary arterioles in vivo. Microvasc Res 2013;85: 34–9.', 'ArticleIdList': [StringElement('23154279', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Lee S, Ahn KH, Lee SJ, Sun K, Goedhart PT, Hardeman MR. Shear induced damage of red blood cells monitored by the decrease of their deformability. Korea-Australia Rheology Journal 2004;16: 141–6.'}, {'Citation': 'Simmonds MJ, Meiselman HJ. Prediction of the level and duration of shear stress exposure that induces subhemolytic damage to erythrocytes. Biorheology 2016;53: 237–49.', 'ArticleIdList': [StringElement('28222499', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Paul R, Apel J, Klaus S, Schugner F, Schwindke P, Reul H. Shear stress related blood damage in laminar couette flow. Artif Organs 2003;27: 517–29.', 'ArticleIdList': [StringElement('12780506', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Gillett DS, Gunning KE, Sawicka EH, Bellingham AJ, Ware RJ. Life threatening sickle chest syndrome treated with extracorporeal membrane oxygenation. Br Med J (Clin Res Ed) 1987;294: 81–2.', 'ArticleIdList': [StringElement('PMC1245093', attributes={'IdType': 'pmc'}), StringElement('3105665', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Pelidis MA, Kato GJ, Resar LM, Dover GJ, Nichols DG, Walker LK, Casella JF. Successful treatment of life-threatening acute chest syndrome of sickle cell disease with venovenous extracorporeal membrane oxygenation. J Pediatr Hematol Oncol 1997;19: 459–61.', 'ArticleIdList': [StringElement('9329470', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kuo KW, Cornell TT, Shanley TP, Odetola FO, Annich GM. The use of extracorporeal membrane oxygenation in pediatric patients with sickle cell disease. Perfusion 2013;28: 424–32.', 'ArticleIdList': [StringElement('PMC4414397', attributes={'IdType': 'pmc'}), StringElement('23630196', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Baskurt OK, Boynard M, Cokelet GC, Connes P, Cooke BM, Forconi S, Liao F, Hardeman MR, Jung F, Meiselman HJ, Nash G, Nemeth N, Neu B, Sandhagen B, Shin S, Thurston G, Wautier JL, International Expert Panel for Standardization of Hemorheological M. New guidelines for hemorheological laboratory techniques. Clin Hemorheol Microcirc 2009;42: 75–97.', 'ArticleIdList': [StringElement('19433882', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rabai M, Detterich JA, Wenby RB, Hernandez TM, Toth K, Meiselman HJ, Wood JC. Deformability analysis of sickle blood using ektacytometry. Biorheology 2014;51: 159–70.', 'ArticleIdList': [StringElement('PMC4469365', attributes={'IdType': 'pmc'}), StringElement('24898336', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Baskurt OK, Hardeman MR, Uyuklu M, Ulker P, Cengiz M, Nemeth N, Shin S, Alexy T, Meiselman HJ. Parameterization of red blood cell elongation index--shear stress curves obtained by ektacytometry. Scand J Clin Lab Invest 2009;69: 777–88.', 'ArticleIdList': [StringElement('19929721', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Simmonds MJ, Atac N, Baskurt OK, Meiselman HJ, Yalcin O. Erythrocyte deformability responses to intermittent and continuous subhemolytic shear stress. Biorheology 2014;51: 171–85.', 'ArticleIdList': [StringElement('24948378', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ravelojaona M, Feasson L, Oyono-Enguelle S, Vincent L, Djoubairou B, Ewa’Sama Essoue C, Messonnier LA. Evidence for a profound remodeling of skeletal muscle and its microvasculature in sickle cell anemia. Am J Pathol 2015;185: 1448–56.', 'ArticleIdList': [StringElement('25773175', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hebbel RP, Key NS. Microparticles in sickle cell anaemia: promise and pitfalls. Br J Haematol 2016;174: 16–29.', 'ArticleIdList': [StringElement('27136195', attributes={'IdType': 'pubmed'})]}, {'Citation': 'McNamee AP, Horobin JT, Tansley GD, Simmonds MJ. Oxidative Stress Increases Erythrocyte Sensitivity to Shear-Mediated Damage. Artif Organs 2018;42: 184–92.', 'ArticleIdList': [StringElement('28877350', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kleinbongard P, Schulz R, Rassaf T, Lauer T, Dejam A, Jax T, Kumara I, Gharini P, Kabanova S, Ozuyaman B, Schnurch HG, Godecke A, Weber AA, Robenek M, Robenek H, Bloch W, Rosen P, Kelm M. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006;107: 2943–51.', 'ArticleIdList': [StringElement('16368881', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Belanger AM, Keggi C, Kanias T, Gladwin MT, Kim-Shapiro DB. Effects of nitric oxide and its congeners on sickle red blood cell deformability. Transfusion 2015;55: 2464–72.', 'ArticleIdList': [StringElement('PMC4605849', attributes={'IdType': 'pmc'}), StringElement('25912054', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Simmonds MJ, Detterich JA, Connes P. Nitric oxide, vasodilation and the red blood cell. Biorheology 2014;51: 121–34.', 'ArticleIdList': [StringElement('PMC6441278', attributes={'IdType': 'pmc'}), StringElement('24819865', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Bor-Kucukatay M, Wenby RB, Meiselman HJ, Baskurt OK. Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol 2003;284: H1577–84.', 'ArticleIdList': [StringElement('12521942', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Grau M, Pauly S, Ali J, Walpurgis K, Thevis M, Bloch W, Suhr F. RBC-NOS-dependent S-nitrosylation of cytoskeletal proteins improves RBC deformability. PLoS One 2013;8: e56759.', 'ArticleIdList': [StringElement('PMC3570529', attributes={'IdType': 'pmc'}), StringElement('23424675', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mozar A, Connes P, Collins B, Hardy-Dessources MD, Romana M, Lemonne N, Bloch W, Grau M. Red blood cell nitric oxide synthase modulates red blood cell deformability in sickle cell anemia. Clin Hemorheol Microcirc 2016;64: 47–53.', 'ArticleIdList': [StringElement('26890236', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Grau M, Mozar A, Charlot K, Lamarre Y, Weyel L, Suhr F, Collins B, Jumet S, Hardy-Dessources MD, Romana M, Lemonne N, Etienne-Julan M, Antoine-Jonville S, Bloch W, Connes P. High red blood cell nitric oxide synthase activation is not associated with improved vascular function and red blood cell deformability in sickle cell anaemia. Br J Haematol 2015;168: 728–36.', 'ArticleIdList': [StringElement('25316332', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Detterich JA, Kato RM, Rabai M, Meiselman HJ, Coates TD, Wood JC. Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease. Blood 2015;126: 703–10.', 'ArticleIdList': [StringElement('PMC4528063', attributes={'IdType': 'pmc'}), StringElement('26036801', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Lezcano NE, Odo N, Kutlar A, Brambilla D, Adams RJ. Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke 2006;37: 1424–6.', 'ArticleIdList': [StringElement('16627796', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Selgrade BP, Truskey GA. Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device. Artif Organs 2012;36: E89–96.', 'ArticleIdList': [StringElement('PMC4068006', attributes={'IdType': 'pmc'}), StringElement('22360826', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Almond CS, Morales DL, Blackstone EH, Turrentine MW, Imamura M, Massicotte MP, Jordan LC, Devaney EJ, Ravishankar C, Kanter KR, Holman W, Kroslowitz R, Tjossem C, Thuita L, Cohen GA, Buchholz H, St Louis JD, Nguyen K, Niebler RA, Walters HL 3rd, Reemtsen B, Wearden PD, Reinhartz O, Guleserian KJ, Mitchell MB, Bleiweis MS, Canter CE, Humpl T. Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation 2013;127: 1702–11.', 'ArticleIdList': [StringElement('23538380', attributes={'IdType': 'pubmed'})]}]}], 'History': [DictElement({'Year': '2018', 'Month': '4', 'Day': '9'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2018', 'Month': '7', 'Day': '12'}, attributes={'PubStatus': 'revised'}), DictElement({'Year': '2018', 'Month': '7', 'Day': '13'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2018', 'Month': '10', 'Day': '17', 'Hour': '6', 'Minute': '0'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2019', 'Month': '4', 'Day': '10', 'Hour': '6', 'Minute': '0'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2018', 'Month': '10', 'Day': '17', 'Hour': '6', 'Minute': '0'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'ppublish', 'ArticleIdList': [StringElement('30325033', attributes={'IdType': 'pubmed'}), StringElement('NIHMS993089', attributes={'IdType': 'mid'}), StringElement('PMC6283667', attributes={'IdType': 'pmc'}), StringElement('10.1111/trf.14901', attributes={'IdType': 'doi'})]}}]}"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "article"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'38409769': [],\n",
       " '38361007': [],\n",
       " '38335157': [],\n",
       " '38306546': [],\n",
       " '38260087': []}"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "def search_articles(disease_name, max_results=200):\n",
    "    \"\"\"\n",
    "    Search articles related to a disease and return their PubMed IDs.\n",
    "    \"\"\"\n",
    "    search_term = f\"{disease_name}[Title/Abstract]\"\n",
    "    handle = Entrez.esearch(db=\"pubmed\", term=search_term, retmax=max_results)\n",
    "    record = Entrez.read(handle)\n",
    "    handle.close()\n",
    "    return record[\"IdList\"]\n",
    "\n",
    "def fetch_pmc_ids(pmids_list):\n",
    "    \"\"\"\n",
    "    Fetch PMC IDs corresponding to a list of PubMed IDs, and return three lists:\n",
    "    - pmids_without_pmc: PubMed IDs without corresponding PMC IDs\n",
    "    - pmc_ids_list: PMC IDs in the format 'PMC12345'\n",
    "    - pmids_with_pmc: PubMed IDs with corresponding PMC IDs\n",
    "    \"\"\"\n",
    "    links = Entrez.elink(dbfrom=\"pubmed\", db=\"pmc\", id=pmids_list, linkname=\"pubmed_pmc\")\n",
    "    records = Entrez.read(links)\n",
    "    links.close()\n",
    "    \n",
    "    pmc_ids_list = []    \n",
    "    for record in records:\n",
    "        pmid = record['IdList'][0]\n",
    "        try:\n",
    "            pmc_id = 'PMC' + record['LinkSetDb'][0]['Link'][0]['Id']\n",
    "            pmc_ids_list.append(pmc_id)\n",
    "        except IndexError:  # This PMID does not have a corresponding PMC ID\n",
    "            continue\n",
    "    \n",
    "    # Convert sets to lists for the return value\n",
    "    return  pmc_ids_list\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Example usage\n",
    "disease_name = \"Sickle Cell Anemia\"\n",
    "pmids_list = search_articles(disease_name)\n",
    "pmc_ids_list = fetch_pmc_ids(pmids_list)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Length of PM IDs: 200\n",
      "PM IDs: ['38344818', '38336101', '38335412', '38332651', '38326178']\n",
      "Length of PMC IDs: 113\n",
      "PMC IDs: ['PMC10834466', 'PMC10838028', 'PMC10825386', 'PMC10807523', 'PMC10809526']\n"
     ]
    }
   ],
   "source": [
    "print(\"Length of PM IDs:\", len(pmids_list))\n",
    "print(\"PM IDs:\", pmids_list[:5])\n",
    "\n",
    "print(\"Length of PMC IDs:\", len(pmc_ids_list))\n",
    "print(\"PMC IDs:\", pmc_ids_list[:5])\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 2: Use Pubtator API to get the Annotated Texts for the selected IDs "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Abstract + Title  Text "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "def fetch_and_save_abst_json(pmids_list, base_path, max_articles_to_save):\n",
    "    \"\"\"\n",
    "    Fetches full texts for given PMC IDs in biocjson format and saves them as JSON files in the specified folder.\n",
    "    Tracks the count of articles not found and successfully retrieved. Stops saving articles once a specified limit is reached.\n",
    "    \n",
    "    Parameters:\n",
    "    - pmids_list (list of str): List of PMC IDs.\n",
    "    - base_path (str): The base directory path where the files will be saved.\n",
    "    - max_articles_to_save (int): Maximum number of articles to save before ending the function.\n",
    "    \"\"\"\n",
    "    not_found_count = 0\n",
    "    found_count = 0\n",
    "\n",
    "    for pmid in pmids_list:\n",
    "        if found_count >= max_articles_to_save:\n",
    "            break  # End the loop if the maximum number of articles to save has been reached\n",
    "        \n",
    "        api_url = f\"https://www.ncbi.nlm.nih.gov/research/pubtator3-api/publications/export/biocjson?pmids={pmid}\"\n",
    "        try_again = True  # Flag to control the retry mechanism\n",
    "        while try_again:\n",
    "            response = requests.get(api_url)\n",
    "            if response.status_code == 200 and response.text.strip():\n",
    "                # Check if the response is not empty\n",
    "                try:\n",
    "                    data = response.json()\n",
    "                    if data:  # Additional check to ensure JSON is not empty\n",
    "                        filename = f\"{pmid}.json\"\n",
    "                        full_path = os.path.join(base_path, filename)\n",
    "                        with open(full_path, 'w', encoding='utf-8') as file:\n",
    "                            json.dump(data, file, indent=4)\n",
    "                        print(f\"Saved full text for PM ID {pmid} in '{full_path}'.\")\n",
    "                        found_count += 1\n",
    "                    else:\n",
    "                        print(f\"No content for PM ID {pmid}.\")\n",
    "                        not_found_count += 1\n",
    "                    try_again = False  # No need to retry\n",
    "                except json.JSONDecodeError:\n",
    "                    print(f\"Failed to decode JSON for PM ID {pmid}.\")\n",
    "                    not_found_count += 1\n",
    "                    try_again = False  # No need to retry\n",
    "\n",
    "            elif response.status_code == 429:\n",
    "                # If HTTP status code is 429, wait for 3 seconds and retry once\n",
    "                print(f\"Rate limit exceeded for PM ID {pmid}. Waiting 3 seconds before retrying...\")\n",
    "                time.sleep(3)  # Wait for 3 seconds\n",
    "                # After waiting, the loop will try the request again\n",
    "            else:\n",
    "                print(f\"Failed to fetch full text for PM ID {pmid}: HTTP {response.status_code}\")\n",
    "                not_found_count += 1\n",
    "                try_again = False  # No need to retry\n",
    "\n",
    "    print(f\"Total articles found and saved: {found_count}\")\n",
    "    print(f\"Total articles not found: {not_found_count}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Full Text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "def fetch_and_save_fulltext_json(pmc_ids_list, base_path, max_articles_to_save):\n",
    "    \"\"\"\n",
    "    Fetches full texts for given PMC IDs in biocjson format and saves them as JSON files in the specified folder.\n",
    "    Tracks the count of articles not found and successfully retrieved. Stops saving articles once a specified limit is reached.\n",
    "    \n",
    "    Parameters:\n",
    "    - pmcids (list of str): List of PMC IDs.\n",
    "    - base_path (str): The base directory path where the files will be saved.\n",
    "    - max_articles_to_save (int): Maximum number of articles to save before ending the function.\n",
    "    \"\"\"\n",
    "    not_found_count = 0\n",
    "    found_count = 0\n",
    "\n",
    "    for pmcid in pmc_ids_list:\n",
    "        if found_count >= max_articles_to_save:\n",
    "            print(f\"Reached the maximum limit of {max_articles_to_save} articles to save.\")\n",
    "            break  # Stop the function if the maximum number of articles to save has been reached\n",
    "\n",
    "        api_url = f\"https://www.ncbi.nlm.nih.gov/research/pubtator3-api/publications/pmc_export/biocjson?pmcids={pmcid}\"\n",
    "        try_again = True  # Flag to control the retry mechanism\n",
    "        while try_again:\n",
    "            response = requests.get(api_url)\n",
    "            if response.status_code == 200 and response.text.strip():\n",
    "                # Check if the response is not empty\n",
    "                try:\n",
    "                    data = response.json()\n",
    "                    if data:  # Additional check to ensure JSON is not empty\n",
    "                        filename = f\"{pmcid}.json\"\n",
    "                        full_path = os.path.join(base_path, filename)\n",
    "                        with open(full_path, 'w', encoding='utf-8') as file:\n",
    "                            json.dump(data, file, indent=4)\n",
    "                        print(f\"Saved full text for PMC ID {pmcid} in '{full_path}'.\")\n",
    "                        found_count += 1\n",
    "                    else:\n",
    "                        print(f\"No content for PMC ID {pmcid}.\")\n",
    "                        not_found_count += 1\n",
    "                    try_again = False  # No need to retry\n",
    "                except json.JSONDecodeError:\n",
    "                    print(f\"Failed to decode JSON for PMC ID {pmcid}.\")\n",
    "                    not_found_count += 1\n",
    "                    try_again = False  # No need to retry\n",
    "\n",
    "            elif response.status_code == 429:\n",
    "                # If HTTP status code is 429, wait for 3 seconds and retry once\n",
    "                print(f\"Rate limit exceeded for PMC ID {pmcid}. Waiting 3 seconds before retrying...\")\n",
    "                time.sleep(3)  # Wait for 3 seconds\n",
    "                # After waiting, the loop will try the request again\n",
    "            else:\n",
    "                print(f\"Failed to fetch full text for PMC ID {pmcid}: HTTP {response.status_code}\")\n",
    "                not_found_count += 1\n",
    "                try_again = False  # No need to retry\n",
    "\n",
    "    print(f\"Total articles found and saved: {found_count}\")\n",
    "    print(f\"Total articles not found: {not_found_count}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Failed to fetch full text for PM ID 38344818: HTTP 200\n",
      "Failed to fetch full text for PM ID 38336101: HTTP 200\n",
      "Failed to fetch full text for PM ID 38335412: HTTP 200\n",
      "Failed to fetch full text for PM ID 38332651: HTTP 200\n",
      "Failed to fetch full text for PM ID 38326178: HTTP 200\n",
      "Failed to fetch full text for PM ID 38323371: HTTP 200\n",
      "Rate limit exceeded for PM ID 38319780. Waiting 3 seconds before retrying...\n",
      "Failed to fetch full text for PM ID 38319780: HTTP 200\n",
      "Failed to fetch full text for PM ID 38312689: HTTP 200\n",
      "Failed to fetch full text for PM ID 38310012: HTTP 200\n",
      "Rate limit exceeded for PM ID 38308541. Waiting 3 seconds before retrying...\n",
      "Failed to fetch full text for PM ID 38308541: HTTP 200\n",
      "Failed to fetch full text for PM ID 38307830: HTTP 200\n",
      "Failed to fetch full text for PM ID 38302294: HTTP 200\n",
      "Rate limit exceeded for PM ID 38292987. Waiting 3 seconds before retrying...\n",
      "Failed to fetch full text for PM ID 38292987: HTTP 200\n",
      "Failed to fetch full text for PM ID 38289232: HTTP 200\n",
      "Failed to fetch full text for PM ID 38274968: HTTP 200\n",
      "Failed to fetch full text for PM ID 38268013: HTTP 200\n",
      "Failed to fetch full text for PM ID 38265339: HTTP 200\n",
      "Rate limit exceeded for PM ID 38260726. Waiting 3 seconds before retrying...\n",
      "Failed to fetch full text for PM ID 38260726: HTTP 200\n",
      "Failed to fetch full text for PM ID 38260320: HTTP 200\n",
      "Failed to fetch full text for PM ID 38257151: HTTP 200\n",
      "Failed to fetch full text for PM ID 38253605: HTTP 200\n",
      "Failed to fetch full text for PM ID 38238015: HTTP 200\n",
      "Rate limit exceeded for PM ID 38234649. Waiting 3 seconds before retrying...\n",
      "Failed to fetch full text for PM ID 38234649: HTTP 200\n",
      "Failed to fetch full text for PM ID 38227982: HTTP 200\n",
      "Saved full text for PM ID 38225633 in 'json_files/38225633.json'.\n",
      "Rate limit exceeded for PM ID 38215581. Waiting 3 seconds before retrying...\n",
      "Saved full text for PM ID 38215581 in 'json_files/38215581.json'.\n",
      "Saved full text for PM ID 38215146 in 'json_files/38215146.json'.\n",
      "Saved full text for PM ID 38204310 in 'json_files/38204310.json'.\n",
      "Saved full text for PM ID 38181478 in 'json_files/38181478.json'.\n",
      "Rate limit exceeded for PM ID 38178227. Waiting 3 seconds before retrying...\n",
      "Saved full text for PM ID 38178227 in 'json_files/38178227.json'.\n",
      "Saved full text for PM ID 38169476 in 'json_files/38169476.json'.\n",
      "Saved full text for PM ID 38167227 in 'json_files/38167227.json'.\n",
      "Saved full text for PM ID 38161437 in 'json_files/38161437.json'.\n",
      "Rate limit exceeded for PM ID 38158354. Waiting 3 seconds before retrying...\n",
      "Saved full text for PM ID 38158354 in 'json_files/38158354.json'.\n",
      "Saved full text for PM ID 38153527 in 'json_files/38153527.json'.\n",
      "Saved full text for PM ID 38150801 in 'json_files/38150801.json'.\n",
      "Failed to fetch full text for PM ID 38142410: HTTP 200\n",
      "Saved full text for PM ID 38134753 in 'json_files/38134753.json'.\n",
      "Rate limit exceeded for PM ID 38132168. Waiting 3 seconds before retrying...\n",
      "Saved full text for PM ID 38132168 in 'json_files/38132168.json'.\n",
      "Saved full text for PM ID 38128297 in 'json_files/38128297.json'.\n",
      "Saved full text for PM ID 38116428 in 'json_files/38116428.json'.\n",
      "Saved full text for PM ID 38106733 in 'json_files/38106733.json'.\n",
      "Saved full text for PM ID 38089575 in 'json_files/38089575.json'.\n",
      "Failed to fetch full text for PM ID 38077792: HTTP 200\n",
      "Rate limit exceeded for PM ID 38071276. Waiting 3 seconds before retrying...\n",
      "Saved full text for PM ID 38071276 in 'json_files/38071276.json'.\n",
      "Saved full text for PM ID 38069808 in 'json_files/38069808.json'.\n",
      "Saved full text for PM ID 38069526 in 'json_files/38069526.json'.\n",
      "Saved full text for PM ID 38069073 in 'json_files/38069073.json'.\n",
      "Saved full text for PM ID 38059298 in 'json_files/38059298.json'.\n",
      "Rate limit exceeded for PM ID 38055923. Waiting 3 seconds before retrying...\n",
      "Saved full text for PM ID 38055923 in 'json_files/38055923.json'.\n",
      "Saved full text for PM ID 38050205 in 'json_files/38050205.json'.\n",
      "Saved full text for PM ID 38049244 in 'json_files/38049244.json'.\n",
      "Saved full text for PM ID 38049243 in 'json_files/38049243.json'.\n",
      "Saved full text for PM ID 38049242 in 'json_files/38049242.json'.\n",
      "Rate limit exceeded for PM ID 38046768. Waiting 3 seconds before retrying...\n",
      "Saved full text for PM ID 38046768 in 'json_files/38046768.json'.\n",
      "Saved full text for PM ID 38046719 in 'json_files/38046719.json'.\n",
      "Saved full text for PM ID 38030031 in 'json_files/38030031.json'.\n",
      "Saved full text for PM ID 38024620 in 'json_files/38024620.json'.\n",
      "Rate limit exceeded for PM ID 38024611. Waiting 3 seconds before retrying...\n",
      "Saved full text for PM ID 38024611 in 'json_files/38024611.json'.\n",
      "Saved full text for PM ID 38024048 in 'json_files/38024048.json'.\n",
      "Saved full text for PM ID 38022077 in 'json_files/38022077.json'.\n",
      "Saved full text for PM ID 38021978 in 'json_files/38021978.json'.\n",
      "Saved full text for PM ID 38021750 in 'json_files/38021750.json'.\n",
      "Saved full text for PM ID 38018175 in 'json_files/38018175.json'.\n",
      "Rate limit exceeded for PM ID 38014206. Waiting 3 seconds before retrying...\n",
      "Saved full text for PM ID 38014206 in 'json_files/38014206.json'.\n",
      "Saved full text for PM ID 38013366 in 'json_files/38013366.json'.\n",
      "Saved full text for PM ID 38012683 in 'json_files/38012683.json'.\n",
      "Saved full text for PM ID 38010431 in 'json_files/38010431.json'.\n",
      "Saved full text for PM ID 38006767 in 'json_files/38006767.json'.\n",
      "Saved full text for PM ID 38001830 in 'json_files/38001830.json'.\n",
      "Rate limit exceeded for PM ID 37961383. Waiting 3 seconds before retrying...\n",
      "Saved full text for PM ID 37961383 in 'json_files/37961383.json'.\n",
      "Saved full text for PM ID 37956495 in 'json_files/37956495.json'.\n",
      "Saved full text for PM ID 37942183 in 'json_files/37942183.json'.\n",
      "Saved full text for PM ID 37941817 in 'json_files/37941817.json'.\n",
      "Saved full text for PM ID 37929914 in 'json_files/37929914.json'.\n",
      "Rate limit exceeded for PM ID 37917573. Waiting 3 seconds before retrying...\n",
      "Saved full text for PM ID 37917573 in 'json_files/37917573.json'.\n",
      "Total articles found and saved: 50\n",
      "Total articles not found: 26\n",
      "Failed to fetch full text for PMC ID PMC10834466: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10838028: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10825386: HTTP 200\n",
      "Rate limit exceeded for PMC ID PMC10807523. Waiting 3 seconds before retrying...\n",
      "Saved full text for PMC ID PMC10807523 in 'json_files/PMC10807523.json'.\n",
      "Saved full text for PMC ID PMC10809526 in 'json_files/PMC10809526.json'.\n",
      "Failed to fetch full text for PMC ID PMC10802225: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10800897: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10802762: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10820494: HTTP 200\n",
      "Rate limit exceeded for PMC ID PMC10803371. Waiting 3 seconds before retrying...\n",
      "Saved full text for PMC ID PMC10803371 in 'json_files/PMC10803371.json'.\n",
      "Failed to fetch full text for PMC ID PMC10831295: HTTP 200\n",
      "Saved full text for PMC ID PMC10793861 in 'json_files/PMC10793861.json'.\n",
      "Saved full text for PMC ID PMC10803940 in 'json_files/PMC10803940.json'.\n",
      "Saved full text for PMC ID PMC10790401 in 'json_files/PMC10790401.json'.\n",
      "Rate limit exceeded for PMC ID PMC10783340. Waiting 3 seconds before retrying...\n",
      "Saved full text for PMC ID PMC10783340 in 'json_files/PMC10783340.json'.\n",
      "Saved full text for PMC ID PMC10768257 in 'json_files/PMC10768257.json'.\n",
      "Saved full text for PMC ID PMC10773620 in 'json_files/PMC10773620.json'.\n",
      "Saved full text for PMC ID PMC10755027 in 'json_files/PMC10755027.json'.\n",
      "Rate limit exceeded for PMC ID PMC10799142. Waiting 3 seconds before retrying...\n",
      "Saved full text for PMC ID PMC10799142 in 'json_files/PMC10799142.json'.\n",
      "Saved full text for PMC ID PMC10741507 in 'json_files/PMC10741507.json'.\n",
      "Saved full text for PMC ID PMC10725196 in 'json_files/PMC10725196.json'.\n",
      "Saved full text for PMC ID PMC10713842 in 'json_files/PMC10713842.json'.\n",
      "Failed to fetch full text for PMC ID PMC10710177: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10706143: HTTP 200\n",
      "Rate limit exceeded for PMC ID PMC10820287. Waiting 3 seconds before retrying...\n",
      "Saved full text for PMC ID PMC10820287 in 'json_files/PMC10820287.json'.\n",
      "Saved full text for PMC ID PMC10695528 in 'json_files/PMC10695528.json'.\n",
      "Saved full text for PMC ID PMC10691398 in 'json_files/PMC10691398.json'.\n",
      "Saved full text for PMC ID PMC10691739 in 'json_files/PMC10691739.json'.\n",
      "Failed to fetch full text for PMC ID PMC10660595: HTTP 200\n",
      "Rate limit exceeded for PMC ID PMC10660409. Waiting 3 seconds before retrying...\n",
      "Failed to fetch full text for PMC ID PMC10660409: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10657488: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10667952: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10676759: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10651806: HTTP 200\n",
      "Saved full text for PMC ID PMC10680894 in 'json_files/PMC10680894.json'.\n",
      "Rate limit exceeded for PMC ID PMC10681612. Waiting 3 seconds before retrying...\n",
      "Saved full text for PMC ID PMC10681612 in 'json_files/PMC10681612.json'.\n",
      "Saved full text for PMC ID PMC10680200 in 'json_files/PMC10680200.json'.\n",
      "Saved full text for PMC ID PMC10669666 in 'json_files/PMC10669666.json'.\n",
      "Saved full text for PMC ID PMC10634755 in 'json_files/PMC10634755.json'.\n",
      "Saved full text for PMC ID PMC10661604 in 'json_files/PMC10661604.json'.\n",
      "Saved full text for PMC ID PMC10628107 in 'json_files/PMC10628107.json'.\n",
      "Saved full text for PMC ID PMC10629739 in 'json_files/PMC10629739.json'.\n",
      "Saved full text for PMC ID PMC10626592 in 'json_files/PMC10626592.json'.\n",
      "Saved full text for PMC ID PMC10632539 in 'json_files/PMC10632539.json'.\n",
      "Saved full text for PMC ID PMC10607133 in 'json_files/PMC10607133.json'.\n",
      "Saved full text for PMC ID PMC10605810 in 'json_files/PMC10605810.json'.\n",
      "Rate limit exceeded for PMC ID PMC10594431. Waiting 3 seconds before retrying...\n",
      "Saved full text for PMC ID PMC10594431 in 'json_files/PMC10594431.json'.\n",
      "Failed to fetch full text for PMC ID PMC10562566: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10551275: HTTP 200\n",
      "Saved full text for PMC ID PMC10685159 in 'json_files/PMC10685159.json'.\n",
      "Saved full text for PMC ID PMC10514847 in 'json_files/PMC10514847.json'.\n",
      "Rate limit exceeded for PMC ID PMC10509466. Waiting 3 seconds before retrying...\n",
      "Failed to fetch full text for PMC ID PMC10509466: HTTP 200\n",
      "Saved full text for PMC ID PMC10685164 in 'json_files/PMC10685164.json'.\n",
      "Saved full text for PMC ID PMC10488271 in 'json_files/PMC10488271.json'.\n",
      "Saved full text for PMC ID PMC10469705 in 'json_files/PMC10469705.json'.\n",
      "Rate limit exceeded for PMC ID PMC10465744. Waiting 3 seconds before retrying...\n",
      "Saved full text for PMC ID PMC10465744 in 'json_files/PMC10465744.json'.\n",
      "Saved full text for PMC ID PMC10685236 in 'json_files/PMC10685236.json'.\n",
      "Failed to fetch full text for PMC ID PMC10448924: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10448915: HTTP 200\n",
      "Rate limit exceeded for PMC ID PMC10435708. Waiting 3 seconds before retrying...\n",
      "Saved full text for PMC ID PMC10435708 in 'json_files/PMC10435708.json'.\n",
      "Saved full text for PMC ID PMC10435695 in 'json_files/PMC10435695.json'.\n",
      "Saved full text for PMC ID PMC10438428 in 'json_files/PMC10438428.json'.\n",
      "Failed to fetch full text for PMC ID PMC10427742: HTTP 200\n",
      "Saved full text for PMC ID PMC10420352 in 'json_files/PMC10420352.json'.\n",
      "Failed to fetch full text for PMC ID PMC10406112: HTTP 200\n",
      "Saved full text for PMC ID PMC10409856 in 'json_files/PMC10409856.json'.\n",
      "Failed to fetch full text for PMC ID PMC10370499: HTTP 200\n",
      "Rate limit exceeded for PMC ID PMC10366386. Waiting 3 seconds before retrying...\n",
      "Failed to fetch full text for PMC ID PMC10366386: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10332774: HTTP 200\n",
      "Saved full text for PMC ID PMC10501344 in 'json_files/PMC10501344.json'.\n",
      "Saved full text for PMC ID PMC10635957 in 'json_files/PMC10635957.json'.\n",
      "Failed to fetch full text for PMC ID PMC10350163: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10348089: HTTP 200\n",
      "Rate limit exceeded for PMC ID PMC10343943. Waiting 3 seconds before retrying...\n",
      "Failed to fetch full text for PMC ID PMC10343943: HTTP 200\n",
      "Saved full text for PMC ID PMC10582275 in 'json_files/PMC10582275.json'.\n",
      "Saved full text for PMC ID PMC10685147 in 'json_files/PMC10685147.json'.\n",
      "Failed to fetch full text for PMC ID PMC10318122: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10315176: HTTP 200\n",
      "Failed to fetch full text for PMC ID PMC10308803: HTTP 200\n",
      "Rate limit exceeded for PMC ID PMC10301107. Waiting 3 seconds before retrying...\n",
      "Saved full text for PMC ID PMC10301107 in 'json_files/PMC10301107.json'.\n",
      "Saved full text for PMC ID PMC10303389 in 'json_files/PMC10303389.json'.\n",
      "Saved full text for PMC ID PMC10267409 in 'json_files/PMC10267409.json'.\n",
      "Reached the maximum limit of 50 articles to save.\n",
      "Total articles found and saved: 50\n",
      "Total articles not found: 32\n"
     ]
    }
   ],
   "source": [
    "if __name__ == \"__main__\":\n",
    "    base_path = \"json_files\"\n",
    "    os.makedirs(base_path, exist_ok=True)\n",
    "    pmids_list = pmids_list\n",
    "    pmc_ids_list = pmc_ids_list\n",
    "    max_articles_to_save = 50\n",
    "    fetch_and_save_abst_json(pmids_list, base_path, max_articles_to_save)\n",
    "    fetch_and_save_fulltext_json(pmc_ids_list, base_path, max_articles_to_save)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "from Bio import Entrez"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "def search_articles(disease_name: str, mesh_list_path: str, max_pmid_retrieve: int):\n",
    "    \"\"\"\n",
    "    Search articles related to a disease and treatments using combined MeSH IDs from a .tsv file, and return their PubMed IDs.\n",
    "    \n",
    "    Parameters:\n",
    "    - disease_name: Name of the disease.\n",
    "    - mesh_list_path: Path to the .tsv file containing MeSH IDs.\n",
    "    - max_pmid_retrieve: Maximum number of PubMed IDs to retrieve.\n",
    "    \n",
    "    Returns:\n",
    "    - List of PubMed IDs.\n",
    "    \"\"\"\n",
    "    # Read the .tsv file\n",
    "    df = pd.read_csv(mesh_list_path, sep='\\t', header=None)\n",
    "\n",
    "    # Combine all List_MeSH_IDs from the third column into a single list\n",
    "    combined_mesh_ids = []\n",
    "    for mesh_ids in df.iloc[:, 2]:  # Using the third column (index 2)\n",
    "        combined_mesh_ids.extend(mesh_ids.split(';'))\n",
    "\n",
    "    # Remove duplicates and format MeSH IDs\n",
    "    unique_mesh_ids = set(combined_mesh_ids)\n",
    "    formatted_mesh_ids = [mesh_id.split('meshd')[-1] for mesh_id in unique_mesh_ids if 'meshd' in mesh_id]\n",
    "\n",
    "    # Create a search term for treatments using combined MeSH IDs\n",
    "    treatment_search = \" OR \".join([f\"MeSH:{mesh_id}\" for mesh_id in formatted_mesh_ids])\n",
    "\n",
    "    # Combine disease name and treatment search terms\n",
    "    search_term = f\"({disease_name}[Title/Abstract]) AND ({treatment_search})\"\n",
    "\n",
    "    # Perform the search\n",
    "    handle = Entrez.esearch(db=\"pubmed\", term=search_term, retmax=max_pmid_retrieve)\n",
    "    record = Entrez.read(handle)\n",
    "    handle.close()\n",
    "\n",
    "    return record[\"IdList\"]\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['38326171', '38287736', '38013366', '37200963', '36927679', '36714120', '35283782', '35140852', '34966850', '33596221']\n"
     ]
    }
   ],
   "source": [
    "disease_name = \"sickle cell\"\n",
    "mesh_list_path = \"../data/mesh_sets.tsv\"\n",
    "max_pmid_retrieve = 10\n",
    "\n",
    "pmids = search_articles(disease_name, mesh_list_path, max_pmid_retrieve)\n",
    "print(pmids)\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
